0001628280-19-013835.txt : 20191108 0001628280-19-013835.hdr.sgml : 20191108 20191108165056 ACCESSION NUMBER: 0001628280-19-013835 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 191204717 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 10-Q 1 axdx-093019x10q.htm 10-Q Document
P5Yfalse--12-31Q3201900007272071000001000000.0010.0017500000085000000542318765464118754231876546411870.0323428P5Y17000001100000P6YP2Y0006000002000000.0010.0015000000500000000200000 These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically in a straight-line pattern. 0000727207 2019-01-01 2019-09-30 0000727207 2019-11-05 0000727207 2019-09-30 0000727207 2018-12-31 0000727207 2019-07-01 2019-09-30 0000727207 2018-07-01 2018-09-30 0000727207 2018-01-01 2018-09-30 0000727207 2018-09-30 0000727207 2017-12-31 0000727207 us-gaap:CommonStockMember 2017-12-31 0000727207 us-gaap:CommonStockMember 2019-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-12-31 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000727207 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000727207 us-gaap:CommonStockMember 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-06-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000727207 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000727207 us-gaap:TreasuryStockMember 2019-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-12-31 0000727207 us-gaap:RetainedEarningsMember 2019-09-30 0000727207 us-gaap:TreasuryStockMember 2018-12-31 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-01-01 0000727207 us-gaap:RetainedEarningsMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2017-12-31 0000727207 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2018-06-30 0000727207 us-gaap:TreasuryStockMember 2017-12-31 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000727207 srt:MinimumMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember 2019-01-01 2019-09-30 0000727207 axdx:InstrumentsMember 2019-01-01 2019-09-30 0000727207 2019-06-30 0000727207 2018-06-30 0000727207 srt:MinimumMember 2019-09-30 0000727207 srt:MaximumMember 2019-09-30 0000727207 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000727207 2019-01-01 0000727207 axdx:FinancialInstitutionAMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:FinancialInstitutionBMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:FinancialInstitutionBMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:FinancialInstitutionAMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-03-27 0000727207 2018-04-04 2018-04-04 0000727207 2018-03-27 2018-03-27 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-12-31 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 2018-04-04 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:AssetsLeasedToOthersMember 2019-09-30 0000727207 axdx:InstrumentsMember 2018-12-31 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2018-12-31 0000727207 us-gaap:ConstructionInProgressMember 2018-12-31 0000727207 us-gaap:TechnologyEquipmentMember 2019-09-30 0000727207 us-gaap:ConstructionInProgressMember 2019-09-30 0000727207 us-gaap:ComputerEquipmentMember 2018-12-31 0000727207 axdx:InstrumentsMember 2019-09-30 0000727207 us-gaap:ComputerEquipmentMember 2019-09-30 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2019-09-30 0000727207 us-gaap:TechnologyEquipmentMember 2018-12-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2019-07-01 2019-09-30 0000727207 us-gaap:GrantMember 2018-01-01 2018-01-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-07-01 2018-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2019-01-01 2019-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2015-02-28 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2019-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-01-01 2018-09-30 0000727207 axdx:ProductsandServicesnotYetDeliveredMember 2018-12-31 0000727207 axdx:ProductsandServicesnotYetDeliveredMember 2019-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 us-gaap:AdditionalPaidInCapitalMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 2018-04-04 0000727207 us-gaap:LongTermDebtMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2019-01-01 2019-09-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2019-09-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2018-12-31 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2019-01-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0000727207 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2019-01-01 2019-09-30 0000727207 us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2018-01-01 2018-09-30 0000727207 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0000727207 us-gaap:PerformanceSharesMember 2019-09-30 0000727207 srt:MinimumMember axdx:Grantedin2018Member us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember axdx:Grantedin2018Member us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2019-07-01 2019-09-30 0000727207 srt:MinimumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2018-07-01 2018-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-07-01 2019-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-09-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-12-31 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-07-01 2018-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2019-07-01 2019-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-07-01 2018-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2019-01-01 2019-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-07-01 2018-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-01-01 2018-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2019-07-01 2019-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2019-01-01 2019-09-30 0000727207 axdx:AcceleratePhenoMember 2018-07-01 2018-09-30 0000727207 axdx:AcceleratePhenoMember 2019-07-01 2019-09-30 0000727207 axdx:OtherRevenueMember 2019-01-01 2019-09-30 0000727207 axdx:OtherRevenueMember 2019-07-01 2019-09-30 0000727207 axdx:AcceleratePhenoMember 2018-01-01 2018-09-30 0000727207 axdx:OtherRevenueMember 2018-07-01 2018-09-30 0000727207 axdx:OtherRevenueMember 2018-01-01 2018-09-30 0000727207 axdx:AcceleratePhenoMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2019-09-30 0000727207 us-gaap:ServiceMember 2019-01-01 2019-09-30 0000727207 us-gaap:ProductMember 2018-01-01 2018-09-30 0000727207 us-gaap:ServiceMember 2018-01-01 2018-09-30 0000727207 us-gaap:ServiceMember 2018-07-01 2018-09-30 0000727207 us-gaap:ProductMember 2018-07-01 2018-09-30 0000727207 us-gaap:ProductMember 2019-07-01 2019-09-30 0000727207 us-gaap:ServiceMember 2019-07-01 2019-09-30 0000727207 us-gaap:ProductMember 2019-01-01 2019-09-30 0000727207 srt:ChiefOperatingOfficerMember 2019-08-20 2019-08-20 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2018-03-31 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2019-05-31 0000727207 2019-08-20 2019-08-20 0000727207 2019-08-19 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2019-09-30 iso4217:USD xbrli:shares iso4217:USD axdx:day xbrli:shares xbrli:pure axdx:segment


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____

Commission file number: 001-31822
ACCELERATE DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
84-1072256
(State or other jurisdiction
(I.R.S. Employer Identification No.)
of incorporation or organization)
 
 
 
3950 South Country Club Road,
Suite 470
 
Tucson,
Arizona
85714
(Address of principal executive offices)
(Zip Code)

(520) 365-3100
(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.001 par
AXDX
The Nasdaq Stock Market LLC
value per share
 
(The Nasdaq Capital Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑  Yes ☐  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑  Yes ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
 
☑
Accelerated filer
 
☐
Non-accelerated filer
 
☐
Smaller reporting company
 
☑
Emerging growth company
 
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes  ☑  No

As of November 5, 2019, there were 54,644,960 shares of the registrant’s common stock outstanding.

1


TABLE OF CONTENTS


2
PART I - FINANCIAL INFORMATION


Item 1. Financial Statements

ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
BALANCE SHEET
(in thousands, except share data)
 
September 30,
December 31,
 
2019
2018
 
Unaudited
 
ASSETS
Current assets:
 
 
Cash and cash equivalents
$
92,938

$
66,260

Investments
28,978

100,218

Trade accounts receivable
2,642

1,860

Inventory
7,881

7,746

Prepaid expenses
1,163

980

Other current assets
793

576

Total current assets
134,395

177,640

Property and equipment, net
8,566

7,303

Right of use assets
3,834

—

Other non-current assets
483

322

Total assets
$
147,278

$
185,265

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
Accounts payable
$
2,281

$
1,322

Accrued liabilities
2,985

4,962

Accrued interest
191

1,262

Deferred revenue
250

217

Current operating lease liability
421

—

Total current liabilities
6,128

7,763

Non-current operating lease liability
3,458

—

Other non-current liabilities
28

53

Convertible notes
127,444

120,074

Total liabilities
$
137,058

$
127,890

Commitments and contingencies




 
 
 
Stockholders’ equity:
 
 
Preferred shares, $0.001 par value;
 
 
5,000,000 preferred shares authorized and none outstanding as of September 30, 2019 and December 31, 2018
—

—

Common stock, $0.001 par value;
 
 
85,000,000 common shares authorized with 54,641,187 shares issued and outstanding on September 30, 2019 and 75,000,000 common shares authorized with 54,231,876 shares issued and outstanding on December 31, 2018
55

54

Contributed capital
448,609

432,885

Treasury stock
(45,067
)
(45,067
)
Accumulated deficit
(393,318
)
(330,348
)
Accumulated other comprehensive loss
(59
)
(149
)
Total stockholders’ equity
10,220

57,375

Total liabilities and stockholders’ equity
$
147,278

$
185,265


See accompanying notes to condensed consolidated financial statements.

3


ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Unaudited
(in thousands, except per share data)
 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Net sales
$
2,271

$
1,355

 
$
5,827

$
3,848

 
 
 
 
 
 
Cost of sales
1,117

680

 
2,940

1,889

Gross profit
1,154

675

 
2,887

1,959

 
 
 
 
 
 
Costs and expenses:
 
 
 
 
 
Research and development
6,064

7,891

 
19,145

20,734

Sales, general and administrative
12,743

12,153

 
38,302

41,835

Total costs and expenses
18,807

20,044

 
57,447

62,569

 
 
 
 
 
 
Loss from operations
(17,653
)
(19,369
)
 
(54,560
)
(60,610
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest expense
(3,598
)
(3,357
)
 
(10,585
)
(6,720
)
Foreign currency exchange loss
(89
)
(133
)
 
(142
)
(331
)
Interest income
676

908

 
2,329

1,983

Other expense, net
(9
)
—

 
(12
)
(25
)
Total other expense, net
(3,020
)
(2,582
)
 
(8,410
)
(5,093
)
 
 
 
 
 
 
Net loss before income taxes
(20,673
)
(21,951
)
 
(62,970
)
(65,703
)
Benefit (provision) for income taxes
239

(147
)
 
—

(432
)
Net loss
$
(20,434
)
$
(22,098
)
 
$
(62,970
)
$
(66,135
)
 
 
 
 
 
 
Basic and diluted net loss per share
$
(0.37
)
$
(0.41
)
 
$
(1.16
)
$
(1.21
)
Weighted average shares outstanding
54,553

54,145

 
54,456

54,591

 
 
 
 
 
 
Other comprehensive loss:
 
 
 
 
 
Net loss
$
(20,434
)
$
(22,098
)
 
$
(62,970
)
$
(66,135
)
Net unrealized gain (loss) on available-for-sale investments
10

1

 
229

(54
)
Foreign currency translation adjustment
(113
)
(26
)
 
(139
)
(105
)
Comprehensive loss
$
(20,537
)
$
(22,123
)
 
$
(62,880
)
$
(66,294
)

See accompanying notes to condensed consolidated financial statements.

4


ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
Unaudited
(in thousands)
 
Nine Months Ended
 
September 30,
September 30,
 
2019
2018
Cash flows from operating activities:
 
 
Net loss
$
(62,970
)
$
(66,135
)
Adjustments to reconcile net loss to net cash used in operating activities:




Depreciation and amortization
1,862

1,749

Amortization of investment discount
(400
)
(413
)
Equity-based compensation
9,409

12,476

Amortization of debt discount and issuance costs
7,370

4,529

Loss on disposal of property and equipment
577

540

(Increase) decrease in assets:




Accounts receivable
(782
)
506

Inventory
(3,286
)
(5,206
)
Prepaid expense and other
(319
)
(212
)
Increase (decrease) in liabilities:




Accounts payable
788

(524
)
Accrued liabilities, and other
(2,115
)
(18
)
Accrued interest
(1,071
)
191

Deferred revenue and income
33

(918
)
Deferred compensation
(25
)
5

Net cash used in operating activities
(50,929
)
(53,430
)
Cash flows from investing activities:
 
 
Purchases of equipment
(148
)
(842
)
Purchase of marketable securities
(20,710
)
(115,634
)
Proceeds from sales of marketable securities
13,400

3,000

Maturities of marketable securities
78,922

74,496

Net cash provided by (used in) investing activities
71,464

(38,980
)
Cash flows from financing activities:
 
 
Proceeds from issuance of common stock
1,363

447

Proceeds from exercise of options
4,879

3,710

Proceeds from issuance of convertible note
—

171,500

Prepayment of forward stock repurchase transaction
—

(45,069
)
Payment of debt issuance costs
—

(4,992
)
Net cash provided by financing activities
6,242

125,596

 
 
 
Effect of exchange rate on cash
(99
)
(77
)
 
 
 
Increase in cash and cash equivalents
26,678

33,109

Cash and cash equivalents, beginning of period
66,260

28,513

Cash and cash equivalents, end of period
$
92,938

$
61,622


See accompanying notes to condensed consolidated financial statements.

5



ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS (CONTINUED)
Unaudited
(in thousands)
 
Nine Months Ended
 
September 30,
September 30,
 
2019
2018
Non-cash investing activities:
 
 
Transfer of instruments from inventory to property and equipment
$
3,225

$
4,061

Supplemental cash flow information:
 
 
Interest paid
$
4,288

$
2,001

Income taxes paid
$
54

$
435


See accompanying notes to condensed consolidated financial statements.

6


ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF STOCKHOLDERS' EQUITY
Unaudited
(in thousands)
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Common stock shares outstanding
 
 
 
 
 
Beginning
54,512

54,091

 
54,232

55,674

Proceeds from issuance of common stock
56

—

 
56

—

Exercise of options
66

98

 
334

360

Issuance of common stock under employee purchase plan
7

8

 
19

22

Repurchase of common stock under prepaid forward contract
—

—

 
—

(1,859
)
Ending
54,641

54,197

 
54,641

54,197

 
 
 
 
 
 
Common stock
 
 
 
 
 
Beginning
$
55

$
54

 
$
54

$
56

Proceeds from issuance of common stock
—

—

 
—

—

Exercise of Options
—

—

 
1

—

Repurchase of common stock under prepaid forward contract
—

—

 
—

(2
)
Ending
$
55

$
54

 
$
55

$
54

 
 
 
 
 
 
Contributed capital
 
 
 
 
 
Beginning
$
443,857

$
426,091

 
$
432,885

$
360,620

Proceeds from issuance of common stock
1,000

—

 
1,000

—

Exercise of options
510

954

 
4,879

3,710

Issuance of common stock under employee purchase plan
112

171

 
362

447

Issuance of convertible note
—

—

 
—

53,283

Equity based compensation
3,130

3,518

 
9,483

12,674

Ending
$
448,609

$
430,734

 
$
448,609

$
430,734


See accompanying notes to consolidated financial statements.

7



ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF STOCKHOLDERS' EQUITY (CONTINUED)
Unaudited
(in thousands)
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Accumulated deficit
 
 
 
 
 
Beginning
$
(372,884
)
$
(286,058
)
 
$
(330,348
)
$
(241,972
)
Cumulative effect of accounting changes
—

—

 
—

(49
)
Net loss
(20,434
)
(22,098
)
 
(62,970
)
(66,135
)
Ending
$
(393,318
)
$
(308,156
)
 
$
(393,318
)
$
(308,156
)
 
 
 
 
 
 
Treasury stock
 
 
 
 
 
Beginning
$
(45,067
)
$
(45,067
)
 
$
(45,067
)
$
—

Repurchase of common stock under prepaid forward contract
—

—

 
—

(45,067
)
Ending
$
(45,067
)
$
(45,067
)
 
$
(45,067
)
$
(45,067
)
 
 
 
 
 
 
Accumulated other comprehensive (loss) income
 
 
 
 
 
Beginning
$
44

$
(134
)
 
$
(149
)
$
—

Unrealized gain (loss) on available-for-sale securities
10

1

 
229

(54
)
Foreign currency translation adjustment
(113
)
(26
)
 
(139
)
(105
)
Ending
$
(59
)
$
(159
)
 
$
(59
)
$
(159
)
 
 
 
 
 
 
Total stockholders' equity
$
10,220

$
77,406

 
$
10,220

$
77,406


See accompanying notes to consolidated financial statements.


8


ACCELERATE DIAGNOSTICS, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited

NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES

Accelerate Diagnostics, Inc. (“we” or “us” or “our” or “Accelerate” or the “Company”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the SEC on March 1, 2019.

The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2019, or any future period.

All amounts are rounded to the nearest thousand dollars unless otherwise indicated.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.

Use of Estimates

The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, tax valuation accounts and equity–based compensation. Actual results could differ materially from those estimates.
Estimated Fair Value of Financial Instruments

The Company follows ASC 820, Fair Value Measurement, which has defined fair value and requires the Company to establish a framework for measuring and disclosing fair value. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

•
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


9


•
Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

•
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, and other current liabilities approximate the related fair values due to the short-term maturities of these instruments.

The estimated fair value of the Company’s long-term debt represents a Level 2 measurement. See Note 10, Convertible Notes for further detail on the Company’s long-term debt.
Cash and Cash Equivalents

All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe, however, that the market risk arising from holding these financial instruments is minimal.

Investments

The Company invests in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificates of deposit, U.S. government and agency securities, commercial paper, asset-backed securities, and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive loss, a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive loss.

Inventory

Inventory is stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first out method. The Company estimates the recoverability of inventory by reference to internal estimates of future demands and product life cycles, including expiration. The Company periodically analyzes its inventory levels to identify inventory that may expire prior to expected sale or has a cost basis in excess of its estimated net realizable value and records a charge to expense for such inventory as appropriate.

Accounts Receivable

Accounts receivable consist of amounts due to the Company for sales to customers and are based on what we expect to collect in exchange for goods and services. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis by recording adjustments to revenue, if necessary. No allowances were recorded at September 30, 2019 and December 31, 2018.


10


Property and Equipment

Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one year to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less.

Property and equipment includes Accelerate Pheno™ systems (also referred to as instruments) used for sales demonstrations, instruments under rental agreements and instruments used for research and development. Depreciation expense for instruments used for sales demonstrations is recorded as a component of sales, general and administrative expense. Depreciation expense for instruments placed at customer sites pursuant to reagent rental agreements is recorded as a component of cost of sales. Depreciation expense for instruments used in our laboratory and research is recorded as a component of research and development expense. The Company retains title to these instruments and depreciates them over five years.

Long-lived Assets

Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.

Warranty Reserve

Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a sixty days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.

Warranty reserve activity for the three and nine months ended September 30, 2019 and 2018 is as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Beginning balance
$
196

$
199

 
$
215

$
192

Provisions
77

128

 
147

394

Warranty incurred
(51
)
(138
)
 
(140
)
(397
)
Ending balance
$
222

$
189

 
$
222

$
189



Convertible Notes

The Company issued convertible notes in 2018 that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.

Revenue Recognition

The Company recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.


11


We determine revenue recognition through the following steps:

•
Identification of the contract with a customer

•
Identification of the performance obligations in the contract

•
Determination of the transaction price

•
Allocation of the transaction price to the performance obligations

•
Recognition of revenue as we satisfy a performance obligation

Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized and the term between invoicing and when payment is due is not typically significant.

Service revenue is derived from the sale of extended service agreements which are generally non-cancellable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine relative standalone selling prices based on the price charged to customers for each individual performance obligation.

Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the three and nine months ended September 30, 2019.

Cost of Sales

Cost of sales includes cost of materials, direct labor, equity-based compensation, facility and other manufacturing overhead costs for consumable tests and instruments sold to customers. Cost of sales for instruments also includes depreciation on revenue generating instruments that have been placed with our customers under a reagent rental agreement. Cost of sales includes repair and maintenance cost for instruments covered by a service agreement or instruments covered by a reagent rental agreement. Cost of sales also includes warranty related expenses.

Shipping and Handling

Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the condensed consolidated statements of operations and comprehensive loss. Most such billable shipping and handling costs are in connection with consumable test kits. Unlike test kits, for instruments the Company typically pays for shipping and handling.

Leases

The Company accounts for leases in accordance with ASC 842, Leases, which was adopted on January 1, 2019. We determine if an arrangement is or contains a lease and the type of lease at inception. The Company classifies leases as finance leases (lessee) or sales-type leases (lessor) when there is either a transfer of ownership of the underlying asset by the end of the lease term, the lease contains an option to purchase the asset that we are reasonably certain will be exercised, the lease term is for the major part of the remaining economic life of the asset, the present value of the lease payments and any residual value guarantee equals or substantially exceeds all the fair value of the asset, or the asset is of such a specialized nature that it will have no alternative use to the lessor at the end of the lease term. Payments contingent on future events (i.e. based on usage) are considered variable and

12


excluded from lease payments for the purposes of classification and initial measurement. Several of our leases include options to renew or extend the term upon mutual agreement of the parties and others include one-year extensions exercisable by the lessee. None of our leases contain residual value guarantees, restrictions, or covenants.

To determine whether a contract contains a lease, the Company uses its judgment in assessing whether the lessor retains a material amount of economic benefit from an underlying asset, whether explicitly or implicitly identified, which party holds control over the direction and use of the asset, and whether any substantive substitution rights over the asset exist.

Lessee

Operating leases are included in right-of-use (“ROU”) assets and operating lease liabilities within our condensed consolidated balance sheets. These assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and their related liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Typically, we use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. We use the implicit rate when readily determinable. ROU assets are net of lease payments made and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term, which may include options to extend or terminate the lease when it is reasonably certain that we will exercise the option. As of adoption of ASC 842 and as of September 30, 2019, the Company was not party to finance lease arrangements.

Our leases consist primarily of leased office, factory, and laboratory space in the United States and office space and automobiles in Europe, have between two and six-year terms, and typically contain penalizing, early-termination provisions.

Lessor

The Company leases instruments to customers under “reagent rental” agreements, whereby the customer agrees to purchase consumable products over a stated term, typically five years or less, for a volume-based price that includes an embedded rental for the instruments. When collectibility is probable, that amount is recognized as income at lease commencement for sales-type leases and on a straight-line basis over the term for operating leases, which typically include a termination without cause or penalty provision given a short notice period.

Consideration is allocated between lease and non-lease components based on stand-alone selling price in accordance with ASC 606, Revenue from Contracts with Customers.

Net investment in sales-type leases are included within our condensed consolidated balance sheets as a component of other current assets and other non-current assets, which include the present value of lease payments not yet received and the present value of the residual asset, which is determined using the information available at commencement, including the lease term and estimated useful life and expected fair value of the instrument.

Equity-Based Compensation

The Company may award stock options, restricted stock units (“RSUs”), performance-based options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method) except for performance-based options. Performance-based stock options vest based on the achievement of performance targets. Compensation costs associated with performance-based option awards are recognized over the requisite service period based on probability of achievement. Performance-based stock options require management to make assumptions regarding the likelihood of achieving performance targets.

The Company estimates the fair value of service based and performance based stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

13



•
Volatility: The expected volatility is based on the historical volatility of the Company's stock price over the most recent period commensurate with the expected term of the stock option award.

•
Expected term: The estimated expected term for employee awards is based on the calculation published by the SEC in SAB110 for use when there is not a sufficient history of employee exercise patterns. For consultant awards, the estimated expected term is the same as the life of the award.

•
Risk-free interest rate: The risk-free interest rate is based on published U.S. Treasury rates for a term commensurate with the expected term.

•
Dividend yield: The dividend yield is estimated as zero as the Company has not paid dividends in the past and does not have any plans to pay any dividends in the foreseeable future.

The Company records the fair value of RSUs or stock grants based on published closing market price on the day before the grant date.

The Company accounts for forfeitures as they occur rather than on an estimated basis.
Deferred Tax Assets

Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not certain of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.

Foreign Currency Translation and Foreign Currency Transactions

Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive loss.

The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.

Earnings Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Potentially dilutive common shares consist of shares issuable from stock options and unvested RSUs. Potentially dilutive common shares would also include common shares that would be outstanding if notes convertible at the balance sheet date were converted. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.

Earnings per share are restated when certain transactions or events, including rights offerings determined to have bonus elements, have occurred.


14


NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Standards that were recently adopted

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases, which together with subsequent amendments is included in ASC 842. ASC 842 requires a lessee to recognize a liability to make lease payments and an asset with respect to its right to use the underlying asset for the lease term. ASC 842 also addresses accounting and reporting by lessors, which is not significantly different from accounting and reporting under the prior standard, and further provides for qualitative and quantitative disclosures. We adopted ASC 842 on January 1, 2019 using the optional transition method allowed by ASU 2018-11. This optional transition method allowed the Company to apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. For contracts where we are the lessee, we recorded lease liabilities and right of use assets for contracts in effect on January 1, 2019 based on the facts and circumstances as of that date. The Company elected not to reassess whether any expired or existing contracts are or contain leases, not to reassess the lease classification for any expired or existing leases, not to reassess initial direct costs for any existing leases, and not to separate the lease components from the non-lease components for all classes of underlying assets. No cumulative-effect adjustment was recorded to the opening balance of retained earnings. We recognized right of use assets and lessee lease liabilities of $0.6 million with respect to operating leases where we are the lessee. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The adoption of ASC 842 did not have a material effect on our consolidated financial position, results of operations or cash flows.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718); Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to ASC 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. The Company adopted ASU 2018-07 on January 1, 2019, which had no impact to our consolidated financial statements as all share-based awards granted to nonemployees are fully vested.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) that the FASB refers to as having been stranded in AOCI. The Company adopted ASU 2018-02 on January 1, 2019, which had no impact to our consolidated financial statements as no amounts were reclassified from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act.

In March 2017, the FASB issued ASU 2017-08, Receivable - Nonrefundable Fees and Other Costs (Topic 310-20); Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted ASU 2017-08 on January 1, 2019, which had no impact to our consolidated financial statements as we do not carry callable securities held at a premium.

Standards not yet adopted

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820); Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. This ASU is effective for us on January 1, 2020, with early adoption permitted. We are currently assessing the impact this will have on our consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which was subsequently clarified and amended by ASU 2019-05, ASU 2019-04 and ASU 2018-19. ASU 2016-13 amends the guidance on measuring credit losses on financial assets

15


(including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this will have a significant impact on our consolidated financial statements.

NOTE 3. CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.

The Company has financial institutions for banking operations that hold 10% or more of the Company’s cash and cash equivalents. As of September 30, 2019, two of the Company's financial institutions held 71% and 26% of the Company’s cash and cash equivalents, respectively. As of December 31, 2018, two of the Company's financial institutions held 46% and 43% of the Company’s cash and cash equivalents, respectively.

The Company grants credit to domestic and international customers. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company had one customer that accounted for 14% of the Company’s net accounts receivable balance as of September 30, 2019, and one customer that accounted for 10% of the Company's net accounts receivable balance as of December 31, 2018.

Customers who represented 10% or more of the Company’s total revenue for the three and nine months ended September 30, 2019 and 2018 were as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Company A
*
20%
 
*
*
Company B
*
18%
 
*
*
Company C
*
17%
 
*
*

* Less than 10% for the period indicated


16


NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30, 2019
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
69,750

$
—

$
—

$
69,750

Total cash and cash equivalents
$
69,750

$
—

$
—

$
69,750

Investments:
 
 
 
 
Certificates of deposit
—

4,183

—

4,183

U.S. Treasury securities
12,001

—

—

12,001

U.S. Agency securities
—

1,505

—

1,505

Asset-backed securities
—

1,107

—

1,107

Corporate notes and bonds
—

10,182

—

10,182

Total investments
12,001

16,977

—

28,978

Total assets measured at fair value
$
81,751

$
16,977

$
—

$
98,728


 
December 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
38,444

$
—

$
—

$
38,444

Commercial paper
—

1,493

—

1,493

Total cash and cash equivalents
38,444

1,493

—

39,937

Investments:
 
 
 
 
Certificates of deposit
—

10,787

—

10,787

U.S. Treasury securities
22,120

—

—

22,120

U.S. Agency securities
—

7,980

—

7,980

Commercial paper
—

17,025

—

17,025

Asset-backed securities
—

11,998

—

11,998

Corporate notes and bonds
—

30,308

—

30,308

Total investments
22,120

78,098

—

100,218

Total assets measured at fair value
$
60,564

$
79,591

$
—

$
140,155




17


Highly liquid investments with an original maturity of three months or less at time of purchase are included in cash and cash equivalents on the condensed consolidated balance sheet.

Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.

Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the nine months ended September 30, 2019.

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Senior Notes due 2023 (“Notes”). In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million, as described in Note 10, Convertible Notes. At September 30, 2019 and December 31, 2018, the fair value of the Notes was $142.5 million and $121.4 million, respectively. The fair value of the Notes is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.
NOTE 5. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30, 2019
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
4,163

$
21

$
(1
)
$
4,183

U.S. Treasury securities
11,975

26

—

12,001

U.S. Agency securities
1,505

—

—

1,505

Asset-backed securities
1,107

—

—

1,107

Corporate notes and bonds
10,170

12

—

10,182

Total
$
28,920

$
59

$
(1
)
$
28,978


 
December 31, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
10,787

$
—

$
—

$
10,787

U.S. Treasury securities
22,185

1

(66
)
22,120

U.S. Agency securities
8,024

1

(45
)
7,980

Commercial paper
17,025

—

—

17,025

Asset-backed securities
12,007

—

(9
)
11,998

Corporate notes and bonds
30,361

—

(53
)
30,308

Total
$
100,389

$
2

$
(173
)
$
100,218




18


The following table summarizes the maturities of the Company’s available-for-sale securities at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30, 2019
December 31, 2018
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
28,920

$
28,978

$
83,030

$
82,893

Due in 1-3 years
—

—

17,359

17,325


$
28,920

$
28,978

$
100,389

$
100,218



There were no sales of marketable securities for the three months ended September 30, 2019 and 2018. Proceeds from sales of marketable securities (including principal paydowns) for the for the nine months ended September 30, 2019 and 2018 were $13.4 million and $3.0 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no material realized gains from sales of marketable securities for the three and nine months ended September 30, 2019 and 2018. No material balances were reclassified out of accumulated other comprehensive loss for the three and nine months ended September 30, 2019 and 2018.

The Company monitors investments for other-than-temporary impairment. It was determined that unrealized gains and losses as of September 30, 2019 and December 31, 2018 are temporary in nature because the change in market value for those securities has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.
NOTE 6. INVENTORY

Inventories consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30,
December 31,
 
2019
2018
Raw materials
$
5,088

$
4,064

Work in process
1,604

495

Finished goods
1,189

3,187


$
7,881

$
7,746



NOTE 7. PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30,
December 31,
 
2019
2018
Computer equipment
$
2,726

$
2,700

Technical equipment
3,949

3,868

Facilities
4,016

4,037

Instruments
7,747

5,318

Capital projects in progress
206

91

Total property and equipment
$
18,644

$
16,014

Accumulated depreciation
(10,078
)
(8,711
)
Property and equipment, net
$
8,566

$
7,303




19


Depreciation expense for the three months ended September 30, 2019 and 2018 was $0.6 million and $0.7 million, respectively, and $1.7 million for each of the nine months ended September 30, 2019 and 2018.

The underlying gross assets under operating leases where the Company is the lessor is $1.3 million at September 30, 2019. The underlying accumulated depreciation under operating leases where the Company is the lessor is $0.2 million at September 30, 2019.

NOTE 8. LICENSE AGREEMENTS AND GRANTS

National Institute of Health Grant

In February 2015, the National Institute of Health awarded Denver Health and the Company a five-year, $5.0 million grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The grant is paid to the Company incrementally through sub-awards. The cumulative amount awarded to date under these subawards is $1.3 million. The amount invoiced for the three months ended September 30, 2019 and 2018 was $42,000 and $69,000, respectively, and for each of the nine months ended September 30, 2019 and 2018 was $0.2 million.

Arizona Commerce Authority

In August 2012, the Company entered into a Grant Agreement (the “Grant Agreement”) with the Arizona Commerce Authority, an agency of the State of Arizona (the “Authority”), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona. Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of $1.0 million, which was recognized in January 2018 as an offset to expense after the achievement of all grant requirements.

NOTE 9. DEFERRED REVENUE AND REMAINING PERFORMANCE OBLIGATIONS

Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred revenue consists of amounts received for commitments not yet fulfilled. If we anticipate revenue will not be earned within the following twelve months, the amount is reported as other non-current liabilities. A summary of the balances as of September 30, 2019 and December 31, 2018 follows (in thousands):
 
September 30,
December 31,
 
2019
2018
Products and services not yet delivered
$
250

$
217



We recognized $0.2 million and $0.3 million of revenues that were included in the beginning contract liabilities balances during the three and nine months ended September 30, 2019, respectively. We recognized $30,000 and $65,000 of revenues that were included in the contract liabilities balances during the three and nine months ended September 30, 2018, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.
Transaction Price Allocated to Remaining Performance Obligations
As of September 30, 2019, $2.5 million of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed service contracts that begin as warranty periods expire. These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically on a straight-line basis.
The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

20


NOTE 10. CONVERTIBLE NOTES

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Senior Convertible Notes due 2023. In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes are the Company's senior unsecured obligations and mature on March 15, 2023 (the “Maturity Date”), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.

The $171.5 million of proceeds received from the issuance of the Notes were allocated between long-term debt (the “liability component”) of $116.6 million and contributed capital (the “equity component”) of $54.9 million. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of $171.5 million, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

The Company incurred approximately $5.0 million of issuance costs related to the issuance of the Notes, of which $3.4 million and $1.6 million were recorded to long-term debt and contributed capital, respectively. The $3.4 million of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the five-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is 11.52%.

The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of $1,000 principal amount at any time prior to December 15, 2022, but only in the following circumstances:

•
if the Company’s stock price exceeds 130% of the conversion price for 20 of the last 30 trading days of any calendar quarter after June 30, 2018;

•
during the 5 business day period after any 5 consecutive trading day period in which the Notes’ trading price is less than 98% of the product of the common stock price times the conversion rate; or

•
the occurrence of certain corporate events, such as a change of control, merger or liquidation.

At any time on or after December 15, 2022, a holder may convert its Notes in multiples of $1,000 principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.

The Notes at September 30, 2019 and December 31, 2018 consisted of the following (in thousands):
 
September 30,
December 31,
 
2019
2018
Outstanding principal
$
171,500

$
171,500

Unamortized debt discount
(41,490
)
(48,430
)
Unamortized debt issuance
(2,566
)
(2,996
)
Net carrying amount of the liability component
127,444

120,074



21



The Company recorded $1.1 million for contractual coupon interest for each of the three months ended September 30, 2019 and 2018, and $3.2 million and $2.2 million for the nine months ended September 30, 2019 and 2018, respectively. The Company also recorded $0.1 million for amortization of debt issuance for each of the three months ended September 30, 2019 and 2018, and $0.4 million and $0.3 million for the nine months ended September 30, 2019 and 2018, respectively. Amortization of the debt discount for the three months ended September 30, 2019 and 2018 was $2.4 million and $2.1 million, respectively, and for the nine months ended September 30, 2019 and 2018 was $6.9 million and $4.3 million, respectively. As of September 30, 2019, no Notes were convertible pursuant to their terms.

In connection with the Notes issuance, the Company entered into a prepaid forward stock repurchase transaction (“Prepaid Forward”) with a financial institution (“Forward Counterparty”). Pursuant to the Prepaid Forward, the Company used approximately $45.1 million of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company’s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.

NOTE 11. EARNINGS PER SHARE

Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company’s losses.
The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect for the three and nine months ended September 30, 2019 and 2018 (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Shares issuable upon the release of restricted stock awards
20

66

 
20

66

Shares issuable upon exercise of stock options
10,159

8,182

 
10,159

8,182

 
10,179

8,248

 
10,179

8,248



Potentially dilutive common shares would also include common shares that would be outstanding if Notes convertible at the balance sheet date were converted. As discussed in Note 10, Convertible Notes, the Company issued $171.5 million of Notes due 2023. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes. As of September 30, 2019, no Notes were convertible pursuant to their terms. The number of shares issuable upon conversion of the Notes is 5.5 million shares.

22


In connection with the Notes, the Company entered into a prepaid forward stock repurchase transaction. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company.
NOTE 12. EMPLOYEE EQUITY-BASED COMPENSATION

The following table summarizes option activity under all plans during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2019
8,090,636

$
12.22

Granted
2,883,596

14.47

Forfeited
(420,098
)
20.74

Exercised
(327,215
)
14.91

Expired
(67,574
)
23.41

Options Outstanding September 30, 2019
10,159,345

$
12.34



The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

 
Three Months Ended
 
September 30,
September 30,
 
2019
2018
Expected term (in years)
6.46

5.53

Volatility
59
%
58
%
Expected dividends
—

—

Risk free interest rates
1.47
%
2.75
%
Weighted average fair value
$
9.66

$
11.48



The following table shows summary information for outstanding options and options that are exercisable (vested) as of September 30, 2019:

 
Options
Outstanding
Options
Exercisable
Number of options
10,159,345

6,137,856

Weighted average remaining contractual term (in years)
6.14

4.32

Weighted average exercise price
$
12.34

$
9.03

Weighted average fair value
$
8.01

$
6.06

Aggregate intrinsic value (in thousands)
$
76,923

$
65,271




23


The following table summarizes RSU and restricted stock award activity during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2019
76,000

$
18.70

Granted
11,000

20.32

Forfeited
(60,500
)
19.74

Vested/released
(7,000
)
19.47

Outstanding September 30, 2019
19,500

16.13



Equity-based compensation expense is summarized below (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Cost of sales
$
65

$
68

 
$
172

$
172

Research and development
897

1,476

 
3,226

3,926

Sales, general and administrative
2,169

1,921

 
6,011

8,378

 
$
3,131

$
3,465

 
$
9,409

$
12,476



For each of the three months ended September 30, 2019 and 2018, $0.1 million of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments). During the nine months ended September 30, 2019 and 2018, $0.3 million and $0.4 million, respectively, of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments).

As of September 30, 2019, unrecognized equity-based compensation expense related to unvested stock options and unvested RSUs was $27.1 million and $0.2 million, respectively. This is expected to be recognized over the years 2019 through 2024.

Included in the above-noted stock option grants and stock compensation expense are performance-based stock options which vest only upon the achievement of certain targets. Performance-based options are generally granted at-the-money, contingently vest over a period of 1 to 2 years, depending on the nature of the performance goal, and have contractual lives of 10 years. These options were valued in the same manner as the time-based options, with the assumption that performance goals will be achieved. The inputs for expected volatility, expected dividends, and risk-free rate used in estimating those options’ fair value are the same as the time-based options issued under the plan. The expected term for performance-based options granted in 2018 is 5 to 6 years. However, the Company only recognizes stock compensation expense to the extent that the targets are determined to be probable of being achieved, which triggers the vesting of the performance options. In 2018, the Company granted 225,000 performance based-options to certain employees, of which 125,000 were outstanding as of September 30, 2019. The Company recognized $0.1 million of stock compensation expense for the nine months ended September 30, 2019 for performance-based stock options.

NOTE 13. INCOME TAXES

For the three months ended September 30, 2019, the Company recorded an income tax benefit amount of $0.2 million to reverse the foreign income tax expense recorded in prior quarters as the Company no longer expects to pay current year income taxes in any of the foreign jurisdictions. For the nine months ended September 30, 2019, the Company did not carry an income tax provision amount as the Company does not recognize tax benefits from current year tax losses in the U.S. and other foreign jurisdictions. The Company’s tax expense for the three and nine

24


months ended September 30, 2019 differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of $20.7 million and $63.0 million, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At September 30, 2019, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards and a deferred tax liability related to amortization of the Notes. The Company provided a valuation allowance against its net deferred tax assets as future realization of such assets is not more likely than not to occur.

The Company accounts for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, Income Taxes. For the three and nine months ended September 30, 2019, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax positions within the next 12 months.

NOTE 14. COMMITMENTS

Clinical Trial & Study Agreements

The Company has entered into master agreements with clinical trial and study sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expenses for start-up costs and work performed for these trials and studies is recorded as research and development or sales, general and administrative expenses on the Company's condensed consolidated statements of operations and comprehensive loss. No commitments were recorded in connection with indemnifying these sites for losses.

NOTE 15. LEASES

The following presents supplemental information related to our leases in which we are the lessee for the three and nine months ended September 30, 2019 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
 
2019
Cash paid for amounts included in lease liabilities
 
 
 
Operating cash flows from operating leases
$
168

 
$
333

ROU assets obtained in exchange for lease obligations
 
 
 
Operating leases
$
3,639

 
$
3,639

Lease Cost
 
 
 
Operating leases
$
213

 
$
378

Short-term leases
$
103

 
$
697



The weighted average remaining lease term on our operating leases is 5.6 years. The weighted average discount rate on those leases is 7.1%. Rent expense including common area charges was $0.3 million and $1.0 million for the three and nine months ended September 30, 2018, respectively.


25


The following presents maturities of operating lease liabilities in which we are the lessee as of September 30, 2019 (in thousands):
Remainder of 2019
$
180

2020
637

2021
687

2022
818

2023
913

Thereafter
1,583

Total lease payments
4,818

Less imputed interest
(939
)
 
$
3,879



The net investment in sales-type leases, where we are the lessor, is a component of other current assets and other non-current assets in our condensed consolidated balance sheet. As of September 30, 2019, the total net investment in these leases was $0.6 million. The following presents maturities of lease receivables under sales-type leases as of September 30, 2019 (in thousands):
Remainder of 2019
$
62

2020
197

2021
139

2022
106

2023
53

Thereafter
13

Total undiscounted cash flows
570

Less imputed interest
(3
)
Present value of lease payments
$
567



NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION

The Company operates as one operating segment. Sales to customers outside the United States represented 23% and 14% for the three months ended September 30, 2019 and 2018, respectively, and 26% and 22% for the nine months ended September 30, 2019 and 2018, respectively.

As of September 30, 2019 and December 31, 2018, balances due from foreign customers, in U.S. dollars, were $1.5 million and $0.9 million, respectively.

The following presents total net sales by geographic territory for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Domestic
$
1,757

$
1,172

 
$
4,308

$
2,988

Foreign
514

183

 
1,519

860

 
$
2,271

$
1,355

 
$
5,827

$
3,848




26


The following presents total net sales by line of business for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Accelerate Pheno™ revenue
$
2,221

$
1,325

 
$
5,702

$
3,760

Other revenue
50

30

 
125

88

 
$
2,271

$
1,355

 
$
5,827

$
3,848


The following presents total net sales by products and services for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Products
$
2,143

$
1,331

 
$
5,531

$
3,798

Services
128

24

 
296

50

 
$
2,271

$
1,355

 
$
5,827

$
3,848



Lease income included in net sales was $0.2 million for each of the three months ended September 30, 2019 and 2018, respectively, and $0.6 million and $0.4 million for the nine months ended September 30, 2019 and 2018, respectively, which does not represent revenues recognized from contracts with customers.

The following presents property and equipment, net by geographic territory (in thousands):
 
September 30,
December 31,
 
2019
2018
Domestic
$
7,726

$
6,309

Foreign
840

994

 
$
8,566

$
7,303



NOTE 17. RELATED PARTY TRANSACTIONS

As discussed in Note 10, Convertible Notes the Company issued Notes in March 2018. As part of this issuance, an entity controlled by one member of the Company's board of directors purchased an aggregate of $30.0 million of the Notes. In May 2019, this affiliate purchased an additional $10.0 million of Notes on the open market. The affiliated entity is a Qualified Institutional Buyer which purchased and holds an aggregate of $40.0 million of the Notes at September 30, 2019.

On August 20, 2019, the Company and an entity affiliated with the Chief Operating Officer of the Company entered into a securities purchase agreement (the “Purchase Agreement”) for the issuance and sale by the Company of an aggregate of 55,586 shares of the Company’s common stock (the “Shares”) in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The Shares were sold at a purchase price (determined in accordance with Nasdaq rules relating to the “market value” of the shares) of $17.99 per share, which was equal to the consolidated closing bid price reported by Nasdaq immediately preceding the time the Company entered into the Purchase Agreement. The $1.0 million of proceeds were recorded to contributed capital.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations


27


Introductory Note

Except as otherwise indicated by the context, references in this Quarterly Report on Form 10-Q (this “Form 10-Q”) to the “Company,” “Accelerate,” “we,” “us” or “our” are references to the combined business of Accelerate Diagnostics, Inc.

Forward-Looking Statements

This Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company intends that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements, which can be identified by the use of words such as “may,” “will,” “expect,” “anticipate,” “estimate,” or “continue,” or variations thereon or comparable terminology, include the plans and objectives of management for future operations, including plans and objectives relating to the products and future economic performance of the Company. In addition, all statements other than statements of historical facts that address activities, events, or developments the Company expects, believes, or anticipates will or may occur in the future, and other such matters, are forward-looking statements.

The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties. These forward-looking statements are based on assumptions that the Company will retain key management personnel, the Company will be successful in the commercialization of the Accelerate Pheno™ system, the Company will obtain sufficient capital to commercialize the Accelerate Pheno™ system and continue development of complementary products, the Company will be able to protect its intellectual property, the Company’s ability to respond to technological change, the Company will accurately anticipate market demand for the Company’s products and there will be no material adverse change in the Company’s operations or business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the results contemplated in forward-looking statements will be realized. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) summarizes the significant factors affecting our results of operations, liquidity, capital resources and contractual obligations. The following discussion and analysis should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and related notes included elsewhere herein. Certain information contained in the discussion and analysis set forth below and elsewhere in this report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. The Company’s future operating results may be affected by various trends and factors which are beyond the Company’s control. These include, among other factors, general public perception of issues and solutions, and other uncertain business conditions that may affect the Company’s business. The Company cautions the reader that a number of important factors discussed herein, and in other reports filed with the SEC including but not limited to the risks in the section entitled “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2018 and in the Company's subsequent filings with the SEC, could affect the Company’s actual results and cause actual results to differ materially from those discussed in forward-looking statements.

All amounts in the MD&A have been rounded to the nearest thousand unless otherwise indicated.

Overview

Accelerate Diagnostics, Inc. (“Accelerate”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Microbiology laboratories are in need of new tools to address what the U.S. Centers for Disease Control and Prevention (the “CDC”) calls one of the most serious healthcare threats of our time, antibiotic resistance. A significant contributing factor to the rise of resistance is the overuse and misuse of antibiotics, which is exacerbated by a lack of timely diagnostic results. The delay of identification and antibiotic susceptibility results is often due to the reliance by microbiology laboratories on traditional culture-based tests that often take two to three days to complete. Our technology

28


platform is built to address these challenges by delivering significantly faster testing of infectious pathogens in various patient sample types.

Our first system to address these challenges is the Accelerate Pheno™ system. The Accelerate Pheno™ system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antimicrobial. The Accelerate PhenoTest™ BC Kit, which is the first test kit for the system, provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. This information is used to rapidly modify antibiotic therapy to lessen side-effects, improve clinical outcomes, and help preserve the useful life of antibiotics.

On June 30, 2015, we declared our conformity to the European In Vitro Diagnostic Directive 98/79/EC and applied a CE Mark to the Accelerate Pheno™ system and the Accelerate PhenoTest™ BC Kit for in vitro diagnostic use. On February 23, 2017, the U.S. Food and Drug Administration (“FDA”) granted our de novo request to market our Accelerate Pheno™ system and Accelerate PhenoTest™ BC Kit.

In 2017, we began selling the Accelerate Pheno™ system in hospitals in the United States, Europe, and the Middle East. Consistent with the Company's “razor” / “razor-blade” business model, revenues to date have principally been generated from the sale of the instruments and the sale of single use consumable test kits.

Changes in Results of Operations: Three and nine months ended September 30, 2019 compared to three and nine months ended September 30, 2018

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Net sales
$
2,271

$
1,355

$
916

68
%
 
$
5,827

$
3,848

$
1,979

51
%

For the three and nine months ended September 30, 2019, total revenues increased as compared to the three and nine months ended September 30, 2018 due to increased sales of Accelerate PhenoTest™ BC Kits.

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Cost of sales
$
1,117

$
680

$
437

64
%
 
$
2,940

$
1,889

$
1,051

56
%
Gross profit
$
1,154

$
675

$
479

71
%
 
$
2,887

$
1,959

$
928

47
%

For the three and nine months ended September 30, 2019, cost of sales and gross profit increased as compared to the three and nine months ended September 30, 2018 as a result of higher sales. This increase was primarily driven by an increase in consumable inventory sales. Inventory without a cost basis was sold to customers for the three and nine months ended September 30, 2019 and 2018. Pre-launch inventory previously not capitalized and expensed in a previous period for the three months ended September 30, 2019 and 2018, was $0.1 million and $0.2 million, respectively, and $0.3 million and $0.4 million for the nine months ended September 30, 2019 and 2018, respectively.

Cost of sales included non-cash equity-based compensation of $0.1 million for each of the three months ended September 30, 2019 and 2018, and $0.2 million for each of the nine months ended September 30, 2019 and 2018.


29


 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Research and development
$
6,064

$
7,891

$
(1,827
)
(23
)%
 
$
19,145

$
20,734

$
(1,589
)
(8
)%

Research and development expenses for the three and nine months ended September 30, 2019 decreased compared to the three and nine months ended September 30, 2018. The decreases were primarily the result of decreases in employee non-cash equity-based compensation and employee related expenses, decreases in purchases of engineering supplies to support research and development and decreases in depreciation expense.

Research and development expenses included non-cash equity-based compensation of $0.9 million and$1.5 million for the three months ended September 30, 2019 and 2018, respectively, and $3.2 million and $3.9 million for the nine months ended September 30, 2019 and 2018, respectively.

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Sales, general and administrative
$
12,743

$
12,153

$
590

5
%
 
$
38,302

$
41,835

$
(3,533
)
(8
)%

Sales, general and administrative expenses for the three months ended September 30, 2019 increased as compared to the three months ended September 30, 2018. The increase was primarily the result of an increase in employee non-cash equity-based compensation, an increase in promotional events and a one-time grant receipt which offset sales, general and administrative expense for the three months ended September 30, 2018. Sales, general and administrative expenses for the nine months ended September 30, 2019 decreased as compared to the nine months ended September 30, 2018. The decrease was primarily the result of a decrease in employee non-cash equity-based compensation, along with a reduction in expenditures with third-party vendors.

Sales, general and administrative expenses included non-cash equity-based compensation of $2.2 million and $1.9 million for the three months ended September 30, 2019 and 2018, respectively, and $6.0 million and $8.4 million for the nine months ended September 30, 2019 and 2018, respectively. Non-cash equity-based compensation increased for the three months ended September 30, 2019 as compared to the three months ended September 30, 2018 due to a large stock option grant made to key management. Non-cash equity-based compensation decreased for the nine months ended September 30, 2019 as compared to the nine months ended September 30, 2018 due to a lower valuation per share for newly granted options compared to the prior period, and an increase in forfeitures which decreased expenses.

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Loss from operations
$
(17,653
)
$
(19,369
)
$
1,716

(9
)%
 
$
(54,560
)
$
(60,610
)
$
6,050

(10
)%

For the three and nine months ended September 30, 2019, our loss from operations decreased as compared to the three and nine months ended September 30, 2018. The decreases were primarily the result of a decrease in non-cash equity-based compensation, a decrease in research and development expenses, and increased sales as described above. Loss from operations included non-cash equity-based compensation of $3.1 million and $3.5 million for the three months ended September 30, 2019 and 2018, respectively, and $9.4 million and $12.5 million for the nine months ended September 30, 2019 and 2018, respectively. This loss and further losses are anticipated and was the result of our continued investments in sales and marketing, key research and development personnel, related costs associated with product development, and commercialization of the Company’s products.


30


 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Total other expense, net
$
(3,020
)
$
(2,582
)
$
(438
)
17
%
 
$
(8,410
)
$
(5,093
)
$
(3,317
)
65
%

Other expense for the three and nine months ended September 30, 2019 increased as compared to the three and nine months ended September 30, 2018. The increases were primarily the result of increased interest expense for the three and nine months ended September 30, 2019 partially offset by investment income. For the three months ended September 30, 2019 and 2018, the Company incurred interest expense associated with our convertible notes of $3.6 million and $3.4 million, respectively. These amounts were partially offset by investment income of $0.7 million and $0.9 million for the three months ended September 30, 2019 and 2018, respectively. For the nine months ended September 30, 2019 and 2018, the Company incurred interest expense associated with our convertible notes of $10.6 million and $6.7 million, respectively. These amounts were partially offset by investment income of $2.3 million and $2.0 million for the nine months ended September 30, 2019 and 2018, respectively.

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
(in thousands)
 
(in thousands)
 
2019
2018
$ Change
% Change
 
2019
2018
$ Change
% Change
Benefit (provision) for income taxes
$
239

$
(147
)
$
386

(263
)%
 
$
—

$
(432
)
$
432

NM

NM indicates percentage is not meaningful

For the three months ended September 30, 2019, the Company recorded an income tax benefit amount of $0.2 million to reverse the foreign income tax expense recorded in prior quarters as the Company no longer expects to pay current year income taxes in any of the foreign jurisdictions. For the nine months ended September 30, 2019, the Company did not carry an income tax provision amount as the Company does not recognize tax benefits from current year tax losses in the U.S. and other foreign jurisdictions.

Capital Resources and Liquidity

Our primary source of liquidity has been from sales of shares of common stock and the issuance of our convertible notes. As of September 30, 2019, the Company had $121.9 million in cash and cash equivalents and available-for-sale securities, a decrease of $44.6 million from $166.5 million at December 31, 2018. The primary reason for the decrease was due to cash used in operations during the period.

The Company is subject to lease agreements. The future minimum lease payments under these lease agreements is included in Item 1, Note 15, Leases.

As of September 30, 2019, management believes that current cash balances will be more than sufficient to fund our capital and liquidity needs for the next twelve months.

Our primary use of capital has been for the commercialization and development of the Accelerate Pheno™ system. We believe our capital requirements will continue to be met with our existing cash balance and those provided by revenue, grants, exercises of stock options and/or additional issuance of equity or debt securities. However, if capital requirements vary materially from those currently planned, we may require additional capital sooner than expected. There can be no assurance that such capital will be available in sufficient amounts or on terms acceptable to us, if at all. Additional issuances of equity or convertible debt securities will result in dilution to our current common stockholders.


31


Summary of Cash Flows

The following summarizes selected items in the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2019 and 2018:

Cash Flow Summary
(in thousands)
 
Nine Months Ended
 
 
 
September 30,
September 30,
 
Change
 
2019
2018
 
Net cash used in operating activities
$
(50,929
)
$
(53,430
)
 
$
2,501

Net cash provided by (used in) investing activities
71,464

(38,980
)
 
110,444

Net cash provided by financing activities
6,242

125,596

 
(119,354
)

Cash flows from operating activities

The net cash used in operating activities was $50.9 million and $53.4 million for the nine months ended September 30, 2019 and 2018, respectively. Net cash used in operating activities was primarily the result of net losses offset by equity-based compensation and amortization of debt discount and issuance costs. These losses are the result of continued investments in research and development, sales and marketing, along with other factors. A decrease in our net loss offset by changes in working capital resulted in a decrease in cash used in operating activities for the nine months ended September 30, 2019 compared to the prior year period.

Cash flows from investing activities

The net cash provided by investing activities was $71.5 million for the nine months ended September 30, 2019. During the nine months ended September 30, 2019, the Company had maturities and proceeds of marketable securities of $78.9 million and $13.4 million, respectively, which were offset in part by purchases of marketable securities of $20.7 million.

The net cash used by investing activities was $39.0 million for the nine months ended September 30, 2018. During the nine months ended September 30, 2018, the company purchased marketable securities of $115.6 million, offset in part by maturities of marketable securities of $74.5 million. The Company had an increase in marketable securities purchases during the nine months ended September 30, 2018 in connection with investing the proceeds from the Company's convertible notes offering.

Cash flows from financing activities

The net cash provided by financing activities was $6.2 million for the nine months ended September 30, 2019, and was primarily comprised of proceeds from exercise of options and the issuance of common stock to an entity affiliated with the Chief Operating Officer of the Company. The net cash provided by financing activities was $125.6 million for the nine months ended September 30, 2018 and was primarily from proceeds received from the Company's convertible notes offering during 2018, partially offset by the prepayment of a forward stock repurchase and debt issuance costs.

Convertible Notes

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Senior Notes (“Notes”). In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes mature on March 15, 2023, unless earlier repurchased or converted into shares of common stock subject to certain conditions. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to

32


adjustment. We will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year with interest payments beginning on September 15, 2018. Proceeds received from the issuance of the Notes was allocated between long-term debt (the “liability component”) and contributed capital (the “equity component”), within the condensed consolidated balance sheet. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. For additional information about the Notes, refer to Item 1, Note 10, Convertible Notes in this Form 10-Q.

In connection with the offering, we entered into a prepaid forward stock repurchase transaction (the “Prepaid Forward”) with a financial institution. Pursuant to the Prepaid Forward, we used approximately $45.1 million of the proceeds from the offering of the Notes to pay the prepayment amount. The aggregate number of our common stock underlying the Prepaid Forward is approximately 1,858,500 shares (based on the sale price of $24.25). The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to us the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward were treated as treasury stock on the condensed consolidated balance sheet (and not outstanding for purposes of the calculation of basic and diluted earnings per share), but remain outstanding for corporate law purposes, including for purposes of any future stockholders' votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to us.

Contractual Obligations

There have been no material changes in our reported contractual obligations, as described under “Contractual Obligations” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2018.
Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of September 30, 2019.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We evaluate our estimates on an ongoing basis, including those related to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and are not readily apparent from other sources. Actual results may differ from these estimates. Our critical accounting policies and estimates are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. Additional critical accounting policies added to Item 1, Note 1, Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies in this Form 10-Q, include the adoption of ASC 842, Leases during the nine months ended September 30, 2019.


Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

Our investment portfolio is exposed to market risk from changes in interest rates. The fair market value of fixed rate securities may be adversely impacted by fluctuations in interest rates while income earned on floating rate securities may decline as a result of decreases in interest rates. We have historically maintained a relatively short average maturity for our investment portfolio, and we believe a hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would change the fair value of our interest sensitive financial instruments by approximately $0.1 million as of September 30, 2019 and $0.5 million as of December 31, 2018.


33


Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. We attempt to ensure the safety and preservation of our invested principal funds by limiting default risk, market risk and reinvestment risk. The goals of our investment policy are preservation of capital, fulfillment of liquidity needs and fiduciary control of cash and investments. We also seek to maximize income from our investments without assuming significant risk. To achieve our goals, we maintain a portfolio of cash equivalents and investments in a variety of securities that management believes to be of high credit quality. Further information regarding our investments is included in Item 1, Note 5, Investments in this Form 10-Q.

Although the Company’s Notes are based on a fixed rate, changes in interest rates could impact the fair market value of the Notes. As of September 30, 2019, the fair market value of the Notes was $142.5 million. For additional information about the Notes, refer to Item 1, Note 10, Convertible Notes in this Form 10-Q.
Foreign Currency Risk

We operate primarily in the United States and a majority of our cost, expense and capital purchasing activities for the nine months ended September 30, 2019 were transacted in U.S. dollars. As a corporation with international and domestic operations, we are exposed to changes in foreign exchange rates. Our international revenue is predominantly in Europe and the Middle East and is denominated in Euros and United States dollars. In our international operations, we pay payroll and other expenses in local currencies. Our exposures to foreign currency risks may change over time and could have a material adverse impact on our financial results.


Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s Principal Executive Officer and Principal Financial Officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of September 30, 2019, to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period ended September 30, 2019 that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

34


PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are from time to time subject to various claims and legal actions in the ordinary course of our business. We believe that there are currently no claims or legal actions that would reasonably be expected to have a material adverse effect on our results of operations or financial condition.


Item 1A. Risk Factors

There have been no material changes to the risk factors that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On August 20, 2019, the Company and an entity affiliated with the Chief Operating Officer of the Company entered into a securities purchase agreement (the “Purchase Agreement”) for the issuance and sale by the Company of an aggregate of 55,586 shares of the Company’s common stock (the “Shares”) in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act and Rule 506 promulgated thereunder. The Shares were sold at a purchase price (determined in accordance with Nasdaq rules relating to the “market value” of the shares) of $17.99 per share, which was equal to the consolidated closing bid price reported by Nasdaq immediately preceding the time the Company entered into the Purchase Agreement.


Item 3. Defaults Upon Senior Securities

Not applicable.


Item 4. Mine Safety Disclosures

Not applicable.


Item 5. Other Information

None.


35



Item 6. Exhibits

Exhibit No.
Description
Filing Information
3.1
Incorporated by reference to Appendix B to the Registrant’s Definitive Proxy Statement on Schedule 14A filed on November 13, 2012
3.1.1
Incorporated by reference to Exhibit A to the Registrant’s Definitive Information Statement on Schedule 14C filed on July 12, 2013
3.1.2
Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on March 15, 2016
3.1.3
Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 15, 2019
3.2
Incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on August 8, 2019
10.1
Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 8, 2019
10.2
Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on August 8, 2019
10.3
Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 21, 2019
31.1
Filed herewith
31.2
Filed herewith
32
Furnished herewith
101.INS
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Filed herewith
101.SCH
 Inline XBRL Taxonomy Extension Schema Document
Filed herewith
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
Filed herewith
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
Filed herewith
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
Filed herewith
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
Filed herewith
104
Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
Filed herewith



36


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

ACCELERATE DIAGNOSTICS, INC.
November 8, 2019
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)
 
 
November 8, 2019
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


37
 EX-31.1 2 a09302019-exh311.htm EXHIBIT 31.1 Exhibit


EXHIBIT 31.1
CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lawrence Mehren, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Accelerate Diagnostics, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
November 8, 2019
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)


 EX-31.2 3 a09302019-exh312.htm EXHIBIT 31.2 Exhibit


EXHIBIT 31.2
CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steve Reichling, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Accelerate Diagnostics, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 8, 2019
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


 EX-32 4 a09302019-exh32.htm EXHIBIT 32 Exhibit


Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned officers of Accelerate Diagnostics, Inc. (the “Company”) hereby certifies that, to his knowledge, the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2019 to which this certification is attached (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 8, 2019
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)
 
 
November 8, 2019
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


 EX-101.SCH 5 axdx-20190930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2115100 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Concentration of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Concentration of Credit Risk (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Convertible Notes link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Convertible Notes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Convertible Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Deferred Revenue and Remaining Performance Obligations link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Employee Equity-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Employee Equity-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Employee Equity-Based Compensation - Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Employee Equity-Based Compensation - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Employee Equity-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2414401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Industry, Geographic and Revenue Disaggregation link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2417404 - Disclosure - Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Industry, Geographic and Revenue Disaggregation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Industry, Geographic and Revenue Disaggregation (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Investments - Schedule of Available-for-Sale Investment Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Investments - Schedule of Available-for-sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Leases - Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2416404 - Disclosure - Leases - Sales-type Lease Receivable Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - License Agreements and Grants link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - License Agreements and Grants - Arizona Commerce Authority (Details) link:presentationLink link:calculationLink link:definitionLink 2408401 - Disclosure - License Agreements and Grants - National Institute of Health Grant (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Recently Issued Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Recently Issued Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Related Party Transaction (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 axdx-20190930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 axdx-20190930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 axdx-20190930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Inventory Disclosure [Abstract] Inventory Inventory Disclosure [Text Block] Leases [Abstract] Net Investment in Lease Net Investment in Lease Remainder of 2019 Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Remainder of Fiscal Year 2020 Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Two Years 2021 Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Three Years 2022 Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Four Years 2023 Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Five Years Thereafter Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Thereafter Total undiscounted cash flows Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received Less imputed interest Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount Present value of lease payments Sales-type and Direct Financing Leases, Lease Receivable Fair Value Disclosures [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Unsecured obligations Unsecured Debt [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2.50% Convertible notes due 2023 Two Point Five Zero Convertible Notes due 2023 [Member] Two Point Five Zero Convertible Notes due 2023 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Aggregate principal amount Debt Instrument, Face Amount Interest rate Debt Instrument, Interest Rate, Stated Percentage Over-allotment option, term Over-Allotment Option, Term Over-Allotment Option, Term Over-allotment option Over-Allotment Option, Amount Over-Allotment Option, Amount Additional proceeds Proceeds from Over-Allotment Option Proceeds from Over-Allotment Option Proceeds received Proceeds from Issuance of Debt Fair value Long-term Debt, Fair Value Commitments and Contingencies Disclosure [Abstract] Commitments Commitments and Contingencies Disclosure [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventory Inventory, Net Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Income Statement [Abstract] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Costs and expenses: Costs and Expenses [Abstract] Research and development Research and Development Expense Sales, general and administrative Selling, General and Administrative Expense Total costs and expenses Costs and Expenses Loss from operations Operating Income (Loss) Other income (expense): Other Nonoperating Income (Expense) [Abstract] Interest expense Interest Expense Foreign currency exchange loss Foreign Currency Transaction Gain (Loss), before Tax Interest income Investment Income, Interest and Dividend Other expense, net Other Nonoperating Expense Total other expense, net Other Nonoperating Income (Expense) Net loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Benefit (provision) for income taxes Income Tax Expense (Benefit) Net loss Net Income (Loss) Attributable to Parent Basic and diluted net loss per share (usd per share) Earnings Per Share, Basic and Diluted Weighted average shares outstanding (shares) Weighted Average Number of Shares Outstanding, Basic Other comprehensive loss: Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Net loss Net unrealized gain (loss) on available-for-sale investments Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accounting Changes and Error Corrections [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] ASU 2016-02 Accounting Standards Update 2016-02 [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Right of use assets Operating Lease, Right-of-Use Asset Lessee lease liabilities Operating Lease, Liability Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Chief Operating Officer Chief Operating Officer [Member] Title of Individual [Axis] Title of Individual [Axis] Title of Individual [Domain] Title of Individual [Domain] Director Director [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Note holder Convertible Note Holder [Member] Convertible Note Holder [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Issuance of common stock (shares) Stock Issued During Period, Shares, New Issues Share price (usd per share) Sale of Stock, Price Per Share Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Earnings Per Share [Abstract] Conversion multiple Debt Instrument, Convertible, Conversion Principal Multiple Debt Instrument, Convertible, Conversion Principal Multiple Shares issued (shares) Debt Conversion, Converted Instrument, Shares Issued Conversion of Stock, Shares Converted Conversion of Stock, Shares Converted Aggregate number of shares (shares) Treasury Stock, Shares, Acquired Conversion ratio Debt Instrument, Convertible, Conversion Ratio Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Risks and Uncertainties [Abstract] Schedule of Customer Concentration Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Debt Disclosure [Abstract] Convertible Notes Debt Disclosure [Text Block] Statement of Financial Position [Abstract] Preferred Stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Preferred Stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred Stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common Stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Common Stock, shares authorized (shares) Common Stock, Shares Authorized Common Stock, shares issued (shares) Common Stock, Shares, Issued Common Stock, shares outstanding (shares) Common Stock, Shares, Outstanding Segment Reporting [Abstract] Industry, Geographic and Revenue Disaggregation Segment Reporting Disclosure [Text Block] Earnings Per Share Earnings Per Share [Text Block] Investments, Debt and Equity Securities [Abstract] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract] Due in less than 1 year Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost Due in 1-3 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Amortized Cost Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Amortized Cost Total Debt Securities, Available-for-sale, Amortized Cost Fair Value Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract] Due in less than 1 year Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value Due in 1-3 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Fair Value Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Fair Value Total Debt Securities, Available-for-sale Share-based Payment Arrangement [Abstract] Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected dividends Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Risk free interest rates Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Weighted average fair value (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Geographic Distribution [Axis] Geographic Distribution [Axis] Geographic Distribution [Domain] Geographic Distribution [Domain] Domestic Geographic Distribution, Domestic [Member] Foreign Geographic Distribution, Foreign [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Accelerate Pheno™ revenue Accelerate Pheno [Member] Accelerate Pheno [Member] Other revenue Other Revenue [Member] Other Revenue [Member] Products Product [Member] Services Service [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Net sales Accounting Policies [Abstract] Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Business Description and Basis of Presentation [Text Block] Schedule of Fair Value Measurement Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of Available-for-Sale Investments Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Schedule of Available-For-Sale Investment Maturities Debt Securities, Available-for-sale [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Property and equipment Property, Plant and Equipment [Member] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Shares issuable upon the release of restricted stock awards Restricted Stock Units (RSUs) [Member] Performance-based stock options Performance Shares [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Award Date [Axis] Award Date [Axis] Award Date [Domain] Award Date [Domain] Granted in 2018 Granted in 2018 [Member] Granted in 2018 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Equity-based compensation expense Share-based Payment Arrangement, Expense Unrecognized equity-based compensation cost Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized equity-based compensation cost, restricted stock units Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Contractual life Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contractual Terms Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contractual Terms Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Outstanding (shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Cash paid for amounts included in lease liabilities Cash Flow, Operating Activities, Lessee [Abstract] Operating cash flows from operating leases Operating Lease, Payments ROU assets obtained in exchange for lease obligations Lessee, Operating Lease, Description [Abstract] Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Lease Cost Lease, Cost [Abstract] Operating leases Operating Lease, Cost Short-term leases Short-term Lease, Cost Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate (%) Operating Lease, Weighted Average Discount Rate, Percent Rent expense Operating Leases, Rent Expense Research and Development [Abstract] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Project [Axis] Project [Axis] Project [Domain] Project [Domain] National Institute of Health Grant National Institute of Health Grant [Member] National Institute of Health Grant [Member] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Grant period Research and Development Arrangement, Contract to Perform for Others, Proposed Period Research and Development Arrangement, Contract to Perform for Others, Proposed Period Total grant funding Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Cumulative amount awarded Research and Development Arrangement, Contract to Perform for Others, Invoiced Research and Development Arrangement, Contract to Perform for Others, Invoiced Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Shares issuable upon exercise of stock options Share-based Payment Arrangement, Option [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive common stock instruments outstanding (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Long-lived Assets by Geographic Territory Long-lived Assets by Geographic Areas [Table Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common stock Common Stock [Member] Contributed capital Additional Paid-in Capital [Member] Accumulated deficit Retained Earnings [Member] Treasury stock Treasury Stock [Member] Accumulated other comprehensive (loss) income AOCI Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance (shares) Shares, Issued Proceeds from issuance of common stock (shares) Proceeds from issuance of common stock Stock Issued During Period, Value, New Issues Exercise of options (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Issuance of common stock under employee purchase plan (shares) Stock Issued During Period, Shares, Employee Stock Ownership Plan Repurchase of common stock under Prepaid Forward contract (shares) Ending Balance (shares) Beginning Balance, amount Stockholders' Equity Attributable to Parent Cumulative impact of accounting change Cumulative Effect of New Accounting Principle in Period of Adoption Exercise of options Stock Issued During Period, Value, Stock Options Exercised Repurchase of common stock under Prepaid Forward contract Treasury Stock, Value, Acquired, Cost Method Issuance of common stock under employee purchase plan Stock Issued During Period, Value, Employee Stock Ownership Plan Issuance of convertible note Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Equity-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Unrealized loss on available-for-sale securities Foreign currency translation adjustment Ending Balance, amount Proceeds from sales of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale Gross realized gains or losses from sales of marketable securities Marketable Securities, Realized Gain (Loss) Recently Issued Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Inputs to Calculate Estimated Fair Value of Options Awarded Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Stock Option Supplemental Information Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block] Restricted Stock Unit (RSU) Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Equity-Based Compensation Expenses Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Concentration Risk [Table] Concentration Risk [Table] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Financial institution A Financial Institution A [Member] Financial Institution A [Member] Financial institution B Financial Institution B [Member] Financial Institution B [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Cash and cash equivalents Cash and Cash Equivalents [Member] Net accounts receivable Accounts Receivable [Member] Total revenue Revenue Benchmark [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Concentration of credit risk Credit Concentration Risk [Member] Customer concentration Customer Concentration Risk [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Company A Customer A [Member] Customer A [Member] Company B Customer B [Member] Customer B [Member] Company C Customer C [Member] Customer C [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Risk concentration Concentration Risk, Percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] RSUs and RSAs Restricted Stock Units And Restricted Stock Awards [Member] Restricted Stock Units And Restricted Stock Awards [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Beginning balance (shares) Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Vested/Released (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Ending balance (shares) Weighted Average Grant Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning balance (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Forfeited (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vested/Released (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Ending balance (dollars per share) Investment [Table] Investment [Table] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Certificates of deposit Certificates of Deposit [Member] U.S. Treasury securities US Treasury and Government [Member] U.S. Agency securities US Government Agencies Debt Securities [Member] Commercial paper Commercial Paper, Not Included with Cash and Cash Equivalents [Member] Asset-backed securities Asset-backed Securities [Member] Corporate notes and bonds Corporate Debt Securities [Member] Investment [Line Items] Investment [Line Items] Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Fair Value Benefit (provision) for income taxes Pre-tax loss Cover page. Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Remainder of 2019 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total lease payments Lessee, Operating Lease, Liability, Payments, Due Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total Property, Plant and Equipment [Abstract] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Deferred Revenue Disclosure [Abstract] Deferred Revenue and Income Summary Contract with Customer, Asset and Liability [Table Text Block] Property and Equipment Property, Plant and Equipment [Table Text Block] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding, beginning balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Exercised (shares) Expired (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Outstanding, ending balance (shares) Weighted Average Exercise Price per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price [Abstract] Outstanding, beginning balance (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Granted (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Exercised (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Expired (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Outstanding, ending balance (dollars per share) Concentration of Credit Risk Concentration Risk Disclosure [Text Block] Cost of sales Cost of Sales [Member] Research and development Research and Development Expense [Member] Sales, general and administrative Selling, General and Administrative Expenses [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Long-term debt Long-term Debt [Member] Initial conversion price (usd per share) Debt Instrument, Convertible, Conversion Price Outstanding principal Long-term Debt, Gross Equity component Adjustments to Additional Paid in Capital, Other Unamortized debt issuance Debt Issuance Costs, Gross Contractual term Debt Instrument, Term Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Stock price conversion threshold, percentage Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Trading price threshold, percentage Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger Repurchase principal balance, percent Debt Instrument, Principle Repurchase Percent Debt Instrument, Principle Repurchase Percent Interest expense Interest Expense, Debt, Excluding Amortization Amortization of debt issuance costs Amortization of Debt Issuance Costs Amortization of the debt discount Amortization of Debt Discount (Premium) Net proceeds from notes to fund Prepaid Forward Debt Proceeds Used to Fund Embedded Derivative Debt Proceeds Used to Fund Embedded Derivative Unamortized debt discount Debt Instrument, Unamortized Discount Unamortized debt issuance Net carrying amount of the liability component Convertible Debt, Noncurrent Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Computer equipment Computer Equipment [Member] Technical equipment Technology Equipment [Member] Facilities Leaseholds and Leasehold Improvements [Member] Instruments Instruments [Member] Instruments [Member] Capital projects in progress Construction in Progress [Member] Assets under operating leases Assets Leased to Others [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Total property and equipment Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Depreciation Depreciation, Depletion and Amortization Schedule of Product Warranty Reserve Activity Schedule of Product Warranty Liability [Table Text Block] Deferred Revenue and Remaining Performance Obligations Revenue from Contract with Customer [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Fair value on a recurring basis Fair Value, Recurring [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Money market funds Money Market Funds [Member] Commercial paper Commercial Paper [Member] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total assets measured at fair value Assets, Fair Value Disclosure Number of operating segments Number of Operating Segments Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Geographic concentration Geographic Concentration Risk [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Trade accounts receivable Receivables, Net, Current Lease Income Lease Income Lease income Operating Leases, Income Statement, Lease Revenue Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Estimated Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Accounts Receivable Accounts Receivable [Policy Text Block] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Long-lived Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Warranty Reserve Standard Product Warranty, Policy [Policy Text Block] Convertible Notes Debt, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Leases, Lessee Lessee, Leases [Policy Text Block] Leases, Lessor Lessor, Leases [Policy Text Block] Equity-Based Compensation Share-based Payment Arrangement [Policy Text Block] Deferred Tax Assets Income Tax, Policy [Policy Text Block] Foreign Currency Translation and Foreign Currency Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Standards That Were Recently Adopted and Standards not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Beginning balance Standard Product Warranty Accrual Provisions Standard Product Warranty Accrual, Increase for Warranties Issued Warranty incurred Standard Product Warranty Accrual, Decrease for Payments Ending balance Arizona Commerce Authority Grant [Member] Arizona Commerce Authority grant Revenues Components of Inventories Schedule of Inventory, Current [Table Text Block] Assets And Liabilities Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Lease Costs Lease, Cost [Table Text Block] Maturities of Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Sales-type Lease Receivable Maturity Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block] Options Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Number of options (shares) Weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average exercise price (dollars per share) Weighted average fair value (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value Aggregate intrinsic value (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Options Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Number of options (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average exercise price (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average fair value (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Aggregate intrinsic value (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Employee Equity-Based Compensation Share-based Payment Arrangement [Text Block] License Agreements and Grants License Agreements and Grants License agreements Convertible Notes Convertible Debt [Table Text Block] Products and services not yet delivered Products and Services not Yet Delivered [Member] Products and Services not Yet Delivered [Member] Deferred revenue and income Contract with Customer, Liability, Current Revenues recognized included in contract liabilities balances Contract with Customer, Liability, Revenue Recognized Revenue expected to be recognized from remaining performance obligations Revenue, Remaining Performance Obligation, Amount Contact period Revenue, Performance Obligation, Description of Timing ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Investments Investments Inventory Prepaid expenses Prepaid Expense, Current Other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Other non-current assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Accrued interest Interest and Dividends Payable, Current Deferred revenue Current operating lease liability Operating Lease, Liability, Current Total current liabilities Liabilities, Current Non-current operating lease liability Operating Lease, Liability, Noncurrent Other non-current liabilities Other Liabilities, Noncurrent Convertible notes Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred shares Preferred Stock, Value, Issued Common stock Common Stock, Value, Outstanding Contributed capital Additional Paid in Capital, Common Stock Treasury stock Treasury Stock, Value Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders’ equity Total liabilities and stockholders’ equity Liabilities and Equity Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation Amortization of investment discount Investment Income, Net, Amortization of Discount and Premium Equity-based compensation Share-based Payment Arrangement, Noncash Expense Amortization of debt discount and issuance costs Accretion Expense Loss on disposal of property and equipment Gain (Loss) on Disposition of Assets (Increase) decrease in assets: Increase (Decrease) in Operating Assets [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid expense and other Increase (Decrease) in Prepaid Expense and Other Assets Increase (decrease) in liabilities: Increase (Decrease) in Accrued Liabilities [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities, and other Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accrued interest Increase (Decrease) in Interest Payable, Net Deferred revenue and income Increase (Decrease) in Contract with Customer, Liability Deferred compensation Increase (Decrease) in Deferred Compensation Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of equipment Payments to Acquire Productive Assets Purchase of marketable securities Payments to Acquire Marketable Securities Proceeds from sales of marketable securities Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from exercise of options Proceeds from Stock Options and Warrants Exercised Proceeds from Stock Options and Warrants Exercised Proceeds from issuance of convertible note Proceeds from Convertible Debt Prepayment of forward stock repurchase transaction Payments for Repurchase of Common Stock Payment of debt issuance costs Payments of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents, beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents, end of period Non-cash investing activities: Noncash Investing and Financing Items [Abstract] Transfer of instruments from inventory to property and equipment Inventory Transferred to Fixed Assets Inventory Transferred to Fixed Assets Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Income taxes paid Income Taxes Paid Estimated useful life of assets Property, Plant and Equipment, Useful Life Instrument warranty term Standard Product Warranty, Instruments, Term Standard Product Warranty, Instruments, Term Kits and accessories warranty term Standard Product Warranty, Kits And Accessories, Term Standard Product Warranty, Kits And Accessories, Term Lease term Lessee, Operating Lease, Term of Contract Term of lease Lessor, Operating Lease, Term of Contract Long-lived assets (excluding intangible assets) Leases Lessor, Sales-type Leases [Text Block] Leases Lessee, Operating Leases [Text Block] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] EX-101.PRE 9 axdx-20190930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 R56.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]      
Expected term (in years) 6 years 5 months 15 days 5 years 6 months 10 days  
Volatility 59.00% 58.00%  
Expected dividends 0.00% 0.00% 0.00%
Risk free interest rates 1.47% 2.75%  
Weighted average fair value (dollars per share) $ 9.66 $ 11.48 $ 9.66
XML 11 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies
NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES

Accelerate Diagnostics, Inc. (“we” or “us” or “our” or “Accelerate” or the “Company”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the SEC on March 1, 2019.

The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2019, or any future period.

All amounts are rounded to the nearest thousand dollars unless otherwise indicated.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.

Use of Estimates

The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, tax valuation accounts and equity–based compensation. Actual results could differ materially from those estimates.
Estimated Fair Value of Financial Instruments

The Company follows ASC 820, Fair Value Measurement, which has defined fair value and requires the Company to establish a framework for measuring and disclosing fair value. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

•
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•
Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

•
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, and other current liabilities approximate the related fair values due to the short-term maturities of these instruments.

The estimated fair value of the Company’s long-term debt represents a Level 2 measurement. See Note 10, Convertible Notes for further detail on the Company’s long-term debt.
Cash and Cash Equivalents

All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe, however, that the market risk arising from holding these financial instruments is minimal.

Investments

The Company invests in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificates of deposit, U.S. government and agency securities, commercial paper, asset-backed securities, and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive loss, a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive loss.

Inventory

Inventory is stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first out method. The Company estimates the recoverability of inventory by reference to internal estimates of future demands and product life cycles, including expiration. The Company periodically analyzes its inventory levels to identify inventory that may expire prior to expected sale or has a cost basis in excess of its estimated net realizable value and records a charge to expense for such inventory as appropriate.

Accounts Receivable

Accounts receivable consist of amounts due to the Company for sales to customers and are based on what we expect to collect in exchange for goods and services. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis by recording adjustments to revenue, if necessary. No allowances were recorded at September 30, 2019 and December 31, 2018.

Property and Equipment

Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one year to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less.

Property and equipment includes Accelerate Pheno™ systems (also referred to as instruments) used for sales demonstrations, instruments under rental agreements and instruments used for research and development. Depreciation expense for instruments used for sales demonstrations is recorded as a component of sales, general and administrative expense. Depreciation expense for instruments placed at customer sites pursuant to reagent rental agreements is recorded as a component of cost of sales. Depreciation expense for instruments used in our laboratory and research is recorded as a component of research and development expense. The Company retains title to these instruments and depreciates them over five years.

Long-lived Assets

Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.

Warranty Reserve

Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a sixty days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.

Warranty reserve activity for the three and nine months ended September 30, 2019 and 2018 is as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Beginning balance
$
196

$
199

 
$
215

$
192

Provisions
77

128

 
147

394

Warranty incurred
(51
)
(138
)
 
(140
)
(397
)
Ending balance
$
222

$
189

 
$
222

$
189



Convertible Notes

The Company issued convertible notes in 2018 that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.

Revenue Recognition

The Company recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.

We determine revenue recognition through the following steps:

•
Identification of the contract with a customer

•
Identification of the performance obligations in the contract

•
Determination of the transaction price

•
Allocation of the transaction price to the performance obligations

•
Recognition of revenue as we satisfy a performance obligation

Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized and the term between invoicing and when payment is due is not typically significant.

Service revenue is derived from the sale of extended service agreements which are generally non-cancellable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine relative standalone selling prices based on the price charged to customers for each individual performance obligation.

Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the three and nine months ended September 30, 2019.

Cost of Sales

Cost of sales includes cost of materials, direct labor, equity-based compensation, facility and other manufacturing overhead costs for consumable tests and instruments sold to customers. Cost of sales for instruments also includes depreciation on revenue generating instruments that have been placed with our customers under a reagent rental agreement. Cost of sales includes repair and maintenance cost for instruments covered by a service agreement or instruments covered by a reagent rental agreement. Cost of sales also includes warranty related expenses.

Shipping and Handling

Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the condensed consolidated statements of operations and comprehensive loss. Most such billable shipping and handling costs are in connection with consumable test kits. Unlike test kits, for instruments the Company typically pays for shipping and handling.

Leases

The Company accounts for leases in accordance with ASC 842, Leases, which was adopted on January 1, 2019. We determine if an arrangement is or contains a lease and the type of lease at inception. The Company classifies leases as finance leases (lessee) or sales-type leases (lessor) when there is either a transfer of ownership of the underlying asset by the end of the lease term, the lease contains an option to purchase the asset that we are reasonably certain will be exercised, the lease term is for the major part of the remaining economic life of the asset, the present value of the lease payments and any residual value guarantee equals or substantially exceeds all the fair value of the asset, or the asset is of such a specialized nature that it will have no alternative use to the lessor at the end of the lease term. Payments contingent on future events (i.e. based on usage) are considered variable and
excluded from lease payments for the purposes of classification and initial measurement. Several of our leases include options to renew or extend the term upon mutual agreement of the parties and others include one-year extensions exercisable by the lessee. None of our leases contain residual value guarantees, restrictions, or covenants.

To determine whether a contract contains a lease, the Company uses its judgment in assessing whether the lessor retains a material amount of economic benefit from an underlying asset, whether explicitly or implicitly identified, which party holds control over the direction and use of the asset, and whether any substantive substitution rights over the asset exist.

Lessee

Operating leases are included in right-of-use (“ROU”) assets and operating lease liabilities within our condensed consolidated balance sheets. These assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and their related liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Typically, we use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. We use the implicit rate when readily determinable. ROU assets are net of lease payments made and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term, which may include options to extend or terminate the lease when it is reasonably certain that we will exercise the option. As of adoption of ASC 842 and as of September 30, 2019, the Company was not party to finance lease arrangements.

Our leases consist primarily of leased office, factory, and laboratory space in the United States and office space and automobiles in Europe, have between two and six-year terms, and typically contain penalizing, early-termination provisions.

Lessor

The Company leases instruments to customers under “reagent rental” agreements, whereby the customer agrees to purchase consumable products over a stated term, typically five years or less, for a volume-based price that includes an embedded rental for the instruments. When collectibility is probable, that amount is recognized as income at lease commencement for sales-type leases and on a straight-line basis over the term for operating leases, which typically include a termination without cause or penalty provision given a short notice period.

Consideration is allocated between lease and non-lease components based on stand-alone selling price in accordance with ASC 606, Revenue from Contracts with Customers.

Net investment in sales-type leases are included within our condensed consolidated balance sheets as a component of other current assets and other non-current assets, which include the present value of lease payments not yet received and the present value of the residual asset, which is determined using the information available at commencement, including the lease term and estimated useful life and expected fair value of the instrument.

Equity-Based Compensation

The Company may award stock options, restricted stock units (“RSUs”), performance-based options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method) except for performance-based options. Performance-based stock options vest based on the achievement of performance targets. Compensation costs associated with performance-based option awards are recognized over the requisite service period based on probability of achievement. Performance-based stock options require management to make assumptions regarding the likelihood of achieving performance targets.

The Company estimates the fair value of service based and performance based stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

•
Volatility: The expected volatility is based on the historical volatility of the Company's stock price over the most recent period commensurate with the expected term of the stock option award.

•
Expected term: The estimated expected term for employee awards is based on the calculation published by the SEC in SAB110 for use when there is not a sufficient history of employee exercise patterns. For consultant awards, the estimated expected term is the same as the life of the award.

•
Risk-free interest rate: The risk-free interest rate is based on published U.S. Treasury rates for a term commensurate with the expected term.

•
Dividend yield: The dividend yield is estimated as zero as the Company has not paid dividends in the past and does not have any plans to pay any dividends in the foreseeable future.

The Company records the fair value of RSUs or stock grants based on published closing market price on the day before the grant date.

The Company accounts for forfeitures as they occur rather than on an estimated basis.
Deferred Tax Assets

Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not certain of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.

Foreign Currency Translation and Foreign Currency Transactions

Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive loss.

The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.

Earnings Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Potentially dilutive common shares consist of shares issuable from stock options and unvested RSUs. Potentially dilutive common shares would also include common shares that would be outstanding if notes convertible at the balance sheet date were converted. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.

Earnings per share are restated when certain transactions or events, including rights offerings determined to have bonus elements, have occurred.
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Preferred Stock, par value (usd per share) $ 0.001 $ 0.001
Preferred Stock, shares authorized (shares) 5,000,000 5,000,000
Preferred Stock, shares outstanding (shares) 0 0
Common Stock, par value (usd per share) $ 0.001 $ 0.001
Common Stock, shares authorized (shares) 85,000,000 75,000,000
Common Stock, shares issued (shares) 54,641,187 54,231,876
Common Stock, shares outstanding (shares) 54,641,187 54,231,876
XML 13 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Notes - Schedule of Convertible Notes (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Debt Disclosure [Abstract]    
Outstanding principal $ 171,500 $ 171,500
Unamortized debt discount (41,490) (48,430)
Unamortized debt issuance (2,566) (2,996)
Net carrying amount of the liability component $ 127,444 $ 120,074
XML 14 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Equity-Based Compensation
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Employee Equity-Based Compensation
NOTE 12. EMPLOYEE EQUITY-BASED COMPENSATION

The following table summarizes option activity under all plans during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2019
8,090,636

$
12.22

Granted
2,883,596

14.47

Forfeited
(420,098
)
20.74

Exercised
(327,215
)
14.91

Expired
(67,574
)
23.41

Options Outstanding September 30, 2019
10,159,345

$
12.34



The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

 
Three Months Ended
 
September 30,
September 30,
 
2019
2018
Expected term (in years)
6.46

5.53

Volatility
59
%
58
%
Expected dividends
—

—

Risk free interest rates
1.47
%
2.75
%
Weighted average fair value
$
9.66

$
11.48



The following table shows summary information for outstanding options and options that are exercisable (vested) as of September 30, 2019:

 
Options
Outstanding
Options
Exercisable
Number of options
10,159,345

6,137,856

Weighted average remaining contractual term (in years)
6.14

4.32

Weighted average exercise price
$
12.34

$
9.03

Weighted average fair value
$
8.01

$
6.06

Aggregate intrinsic value (in thousands)
$
76,923

$
65,271



The following table summarizes RSU and restricted stock award activity during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2019
76,000

$
18.70

Granted
11,000

20.32

Forfeited
(60,500
)
19.74

Vested/released
(7,000
)
19.47

Outstanding September 30, 2019
19,500

16.13



Equity-based compensation expense is summarized below (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Cost of sales
$
65

$
68

 
$
172

$
172

Research and development
897

1,476

 
3,226

3,926

Sales, general and administrative
2,169

1,921

 
6,011

8,378

 
$
3,131

$
3,465

 
$
9,409

$
12,476



For each of the three months ended September 30, 2019 and 2018, $0.1 million of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments). During the nine months ended September 30, 2019 and 2018, $0.3 million and $0.4 million, respectively, of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments).

As of September 30, 2019, unrecognized equity-based compensation expense related to unvested stock options and unvested RSUs was $27.1 million and $0.2 million, respectively. This is expected to be recognized over the years 2019 through 2024.

Included in the above-noted stock option grants and stock compensation expense are performance-based stock options which vest only upon the achievement of certain targets. Performance-based options are generally granted at-the-money, contingently vest over a period of 1 to 2 years, depending on the nature of the performance goal, and have contractual lives of 10 years. These options were valued in the same manner as the time-based options, with the assumption that performance goals will be achieved. The inputs for expected volatility, expected dividends, and risk-free rate used in estimating those options’ fair value are the same as the time-based options issued under the plan. The expected term for performance-based options granted in 2018 is 5 to 6 years. However, the Company only recognizes stock compensation expense to the extent that the targets are determined to be probable of being achieved, which triggers the vesting of the performance options. In 2018, the Company granted 225,000 performance based-options to certain employees, of which 125,000 were outstanding as of September 30, 2019. The Company recognized $0.1 million of stock compensation expense for the nine months ended September 30, 2019 for performance-based stock options.
XML 15 R14.htm IDEA: XBRL DOCUMENT v3.19.3
License Agreements and Grants
 9 Months Ended
Sep. 30, 2019
Research and Development [Abstract]  
License Agreements and Grants
NOTE 8. LICENSE AGREEMENTS AND GRANTS

National Institute of Health Grant

In February 2015, the National Institute of Health awarded Denver Health and the Company a five-year, $5.0 million grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The grant is paid to the Company incrementally through sub-awards. The cumulative amount awarded to date under these subawards is $1.3 million. The amount invoiced for the three months ended September 30, 2019 and 2018 was $42,000 and $69,000, respectively, and for each of the nine months ended September 30, 2019 and 2018 was $0.2 million.

Arizona Commerce Authority

In August 2012, the Company entered into a Grant Agreement (the “Grant Agreement”) with the Arizona Commerce Authority, an agency of the State of Arizona (the “Authority”), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona. Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of $1.0 million, which was recognized in January 2018 as an offset to expense after the achievement of all grant requirements.
XML 16 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments
 9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30, 2019
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
69,750

$
—

$
—

$
69,750

Total cash and cash equivalents
$
69,750

$
—

$
—

$
69,750

Investments:
 
 
 
 
Certificates of deposit
—

4,183

—

4,183

U.S. Treasury securities
12,001

—

—

12,001

U.S. Agency securities
—

1,505

—

1,505

Asset-backed securities
—

1,107

—

1,107

Corporate notes and bonds
—

10,182

—

10,182

Total investments
12,001

16,977

—

28,978

Total assets measured at fair value
$
81,751

$
16,977

$
—

$
98,728


 
December 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
38,444

$
—

$
—

$
38,444

Commercial paper
—

1,493

—

1,493

Total cash and cash equivalents
38,444

1,493

—

39,937

Investments:
 
 
 
 
Certificates of deposit
—

10,787

—

10,787

U.S. Treasury securities
22,120

—

—

22,120

U.S. Agency securities
—

7,980

—

7,980

Commercial paper
—

17,025

—

17,025

Asset-backed securities
—

11,998

—

11,998

Corporate notes and bonds
—

30,308

—

30,308

Total investments
22,120

78,098

—

100,218

Total assets measured at fair value
$
60,564

$
79,591

$
—

$
140,155



Highly liquid investments with an original maturity of three months or less at time of purchase are included in cash and cash equivalents on the condensed consolidated balance sheet.

Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.

Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the nine months ended September 30, 2019.

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Senior Notes due 2023 (“Notes”). In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million, as described in Note 10, Convertible Notes. At September 30, 2019 and December 31, 2018, the fair value of the Notes was $142.5 million and $121.4 million, respectively. The fair value of the Notes is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.
XML 17 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share
The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect for the three and nine months ended September 30, 2019 and 2018 (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Shares issuable upon the release of restricted stock awards
20

66

 
20

66

Shares issuable upon exercise of stock options
10,159

8,182

 
10,159

8,182

 
10,179

8,248

 
10,179

8,248
XML 18 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Property, Plant and Equipment [Line Items]      
Instrument warranty term     1 year
Kits and accessories warranty term     60 days
Term of lease 5 years   5 years
Expected dividends 0.00% 0.00% 0.00%
Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life of assets     1 year
Lease term 2 years   2 years
Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life of assets     7 years
Lease term 6 years   6 years
Instruments      
Property, Plant and Equipment [Line Items]      
Estimated useful life of assets     5 years
XML 19 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Concentration of Credit Risk (Tables)
 9 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]  
Schedule of Customer Concentration
Customers who represented 10% or more of the Company’s total revenue for the three and nine months ended September 30, 2019 and 2018 were as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Company A
*
20%
 
*
*
Company B
*
18%
 
*
*
Company C
*
17%
 
*
*

* Less than 10% for the period indicated
XML 20 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Industry, Geographic and Revenue Disaggregation
 9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Industry, Geographic and Revenue Disaggregation
NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION

The Company operates as one operating segment. Sales to customers outside the United States represented 23% and 14% for the three months ended September 30, 2019 and 2018, respectively, and 26% and 22% for the nine months ended September 30, 2019 and 2018, respectively.

As of September 30, 2019 and December 31, 2018, balances due from foreign customers, in U.S. dollars, were $1.5 million and $0.9 million, respectively.

The following presents total net sales by geographic territory for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Domestic
$
1,757

$
1,172

 
$
4,308

$
2,988

Foreign
514

183

 
1,519

860

 
$
2,271

$
1,355

 
$
5,827

$
3,848



The following presents total net sales by line of business for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Accelerate Pheno™ revenue
$
2,221

$
1,325

 
$
5,702

$
3,760

Other revenue
50

30

 
125

88

 
$
2,271

$
1,355

 
$
5,827

$
3,848


The following presents total net sales by products and services for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2019
2018
 
2019
2018
Products
$
2,143

$
1,331

 
$
5,531

$
3,798

Services
128

24

 
296

50

 
$
2,271

$
1,355

 
$
5,827

$
3,848



Lease income included in net sales was $0.2 million for each of the three months ended September 30, 2019 and 2018, respectively, and $0.6 million and $0.4 million for the nine months ended September 30, 2019 and 2018, respectively, which does not represent revenues recognized from contracts with customers.

The following presents property and equipment, net by geographic territory (in thousands):
 
September 30,
December 31,
 
2019
2018
Domestic
$
7,726

$
6,309

Foreign
840

994

 
$
8,566

$
7,303
JSON 21 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "axdx-093019x10q.htm": { "axisCustom": 0, "axisStandard": 26, "contextCount": 258, "dts": { "calculationLink": { "local": [ "axdx-20190930_cal.xml" ] }, "definitionLink": { "local": [ "axdx-20190930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "axdx-093019x10q.htm" ] }, "labelLink": { "local": [ "axdx-20190930_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "axdx-20190930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "axdx-20190930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 507, "entityCount": 1, "hidden": { "http://acceleratediagnostics.com/20190930": 1, "http://fasb.org/us-gaap/2019-01-31": 29, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 35 }, "keyCustom": 21, "keyStandard": 361, "memberCustom": 14, "memberStandard": 47, "nsprefix": "axdx", "nsuri": "http://acceleratediagnostics.com/20190930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://acceleratediagnostics.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Fair Value of Financial Instruments", "role": "http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Investments", "role": "http://acceleratediagnostics.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Inventory", "role": "http://acceleratediagnostics.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Property and Equipment", "role": "http://acceleratediagnostics.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:LicenseAgreement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - License Agreements and Grants", "role": "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrants", "shortName": "License Agreements and Grants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:LicenseAgreement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Deferred Revenue and Remaining Performance Obligations", "role": "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligations", "shortName": "Deferred Revenue and Remaining Performance Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - Convertible Notes", "role": "http://acceleratediagnostics.com/role/ConvertibleNotes", "shortName": "Convertible Notes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Earnings Per Share", "role": "http://acceleratediagnostics.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - Employee Equity-Based Compensation", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation", "shortName": "Employee Equity-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - Income Taxes", "role": "http://acceleratediagnostics.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET", "role": "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - Commitments", "role": "http://acceleratediagnostics.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorSalesTypeLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - Leases", "role": "http://acceleratediagnostics.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorSalesTypeLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Industry, Geographic and Revenue Disaggregation", "role": "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregation", "shortName": "Industry, Geographic and Revenue Disaggregation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - Related Party Transactions", "role": "http://acceleratediagnostics.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies)", "role": "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies", "shortName": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2301302 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables)", "role": "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesTables", "shortName": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Concentration of Credit Risk (Tables)", "role": "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables", "shortName": "Concentration of Credit Risk (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Investments (Tables)", "role": "http://acceleratediagnostics.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Inventory (Tables)", "role": "http://acceleratediagnostics.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical)", "role": "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - Property and Equipment (Tables)", "role": "http://acceleratediagnostics.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Tables)", "role": "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsTables", "shortName": "Deferred Revenue and Remaining Performance Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310301 - Disclosure - Convertible Notes (Tables)", "role": "http://acceleratediagnostics.com/role/ConvertibleNotesTables", "shortName": "Convertible Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Earnings Per Share (Tables)", "role": "http://acceleratediagnostics.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - Employee Equity-Based Compensation (Tables)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables", "shortName": "Employee Equity-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316301 - Disclosure - Leases (Tables)", "role": "http://acceleratediagnostics.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317301 - Disclosure - Industry, Geographic and Revenue Disaggregation (Tables)", "role": "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationTables", "shortName": "Industry, Geographic and Revenue Disaggregation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StandardProductWarrantyPolicy", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:StandardProductWarrantyInstrumentsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401403 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "shortName": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:StandardProductWarrantyPolicy", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:StandardProductWarrantyInstrumentsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401404 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details)", "role": "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails", "shortName": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - Recently Issued Accounting Pronouncements (Details)", "role": "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails", "shortName": "Recently Issued Accounting Pronouncements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "I2019Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "role": "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD_srt_MajorCustomersAxis_axdx_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - Concentration of Credit Risk (Details)", "role": "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "shortName": "Concentration of Credit Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD_srt_MajorCustomersAxis_axdx_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details)", "role": "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "shortName": "Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q1Mar27", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:OverAllotmentOptionTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value of Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3_us-gaap_DebtInstrumentAxis_axdx_TwoPointFiveZeroConvertibleNotesdue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_UnsecuredDebtMember", "decimals": "-5", "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Investments - Schedule of Available-for-sale Securities (Details)", "role": "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails", "shortName": "Investments - Schedule of Available-for-sale Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - Investments - Schedule of Available-for-Sale Investment Maturities (Details)", "role": "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails", "shortName": "Investments - Schedule of Available-for-Sale Investment Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - Investments - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/InvestmentsNarrativeDetails", "shortName": "Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "lang": null, "name": "us-gaap:MarketableSecuritiesRealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Inventory (Details)", "role": "http://acceleratediagnostics.com/role/InventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Property and Equipment (Details)", "role": "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails", "shortName": "Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2018Q4", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "axdx:LicenseAgreement", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2015Q1Feb1-28_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_axdx_NationalInstituteofHealthGrantMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408401 - Disclosure - License Agreements and Grants - National Institute of Health Grant (Details)", "role": "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails", "shortName": "License Agreements and Grants - National Institute of Health Grant (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "axdx:LicenseAgreement", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2015Q1Feb1-28_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_axdx_NationalInstituteofHealthGrantMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "axdx:LicenseAgreement", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q1Jan1-31_srt_ProductOrServiceAxis_us-gaap_GrantMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - License Agreements and Grants - Arizona Commerce Authority (Details)", "role": "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails", "shortName": "License Agreements and Grants - Arizona Commerce Authority (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "axdx:LicenseAgreement", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q1Jan1-31_srt_ProductOrServiceAxis_us-gaap_GrantMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Details)", "role": "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails", "shortName": "Deferred Revenue and Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q1Mar27", "decimals": null, "first": true, "lang": "en-US", "name": "axdx:OverAllotmentOptionTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410402 - Disclosure - Convertible Notes - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "shortName": "Convertible Notes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q2Apr4", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410403 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)", "role": "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails", "shortName": "Convertible Notes - Schedule of Convertible Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details)", "role": "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails", "shortName": "Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "D2018Q2Apr4", "decimals": "-2", "first": true, "lang": null, "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD_us-gaap_DebtInstrumentAxis_axdx_TwoPointFiveZeroConvertibleNotesdue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_UnsecuredDebtMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2018Q4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - Employee Equity-Based Compensation - Stock Option Activity (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails", "shortName": "Employee Equity-Based Compensation - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413403 - Disclosure - Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails", "shortName": "Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413404 - Disclosure - Employee Equity-Based Compensation - Stock Option Supplemental Information (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails", "shortName": "Employee Equity-Based Compensation - Stock Option Supplemental Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2018Q4_us-gaap_AwardTypeAxis_axdx_RestrictedStockUnitsAndRestrictedStockAwardsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413405 - Disclosure - Employee Equity-Based Compensation - Restricted Stock Activity (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails", "shortName": "Employee Equity-Based Compensation - Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2018Q4_us-gaap_AwardTypeAxis_axdx_RestrictedStockUnitsAndRestrictedStockAwardsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413406 - Disclosure - Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "shortName": "Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Employee Equity-Based Compensation - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "shortName": "Employee Equity-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember", "decimals": "-5", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414401 - Disclosure - Income Taxes (Details)", "role": "http://acceleratediagnostics.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "axdx:AssetsAndLiabilitiesLesseeTableTextBlock", "us-gaap:LessorSalesTypeLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416402 - Disclosure - Leases - Assets and Liabilities (Details)", "role": "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails", "shortName": "Leases - Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "axdx:AssetsAndLiabilitiesLesseeTableTextBlock", "us-gaap:LessorSalesTypeLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416403 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "role": "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetInvestmentInLease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416404 - Disclosure - Leases - Sales-type Lease Receivable Maturity (Details)", "role": "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails", "shortName": "Leases - Sales-type Lease Receivable Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetInvestmentInLease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417402 - Disclosure - Industry, Geographic and Revenue Disaggregation - Narrative (Details)", "role": "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails", "shortName": "Industry, Geographic and Revenue Disaggregation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417403 - Disclosure - Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details)", "role": "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "shortName": "Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3QTD_srt_ProductOrServiceAxis_axdx_AcceleratePhenoMember", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417404 - Disclosure - Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details)", "role": "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "shortName": "Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FI2019Q3_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "I2019Q3Aug19", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418401 - Disclosure - Related Party Transaction (Details)", "role": "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails", "shortName": "Related Party Transaction (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "I2019Q3Aug19", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies", "role": "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies", "shortName": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - Recently Issued Accounting Pronouncements", "role": "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncements", "shortName": "Recently Issued Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Concentration of Credit Risk", "role": "http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk", "shortName": "Concentration of Credit Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9999": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "axdx-093019x10q.htm", "contextRef": "I2018Q1Jan1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "Uncategorized Items - axdx-093019x10q.htm", "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "shortName": "Uncategorized Items - axdx-093019x10q.htm", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 70, "tag": { "axdx_AcceleratePhenoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accelerate Pheno [Member]", "label": "Accelerate Pheno [Member]", "terseLabel": "Accelerate Pheno\u2122 revenue" } } }, "localname": "AcceleratePhenoMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "axdx_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Assets And Liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "axdx_ConvertibleNoteHolderMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Note Holder [Member]", "label": "Convertible Note Holder [Member]", "terseLabel": "Note holder" } } }, "localname": "ConvertibleNoteHolderMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "axdx_CustomerAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]", "terseLabel": "Company A" } } }, "localname": "CustomerAMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "axdx_CustomerBMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]", "terseLabel": "Company B" } } }, "localname": "CustomerBMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "axdx_CustomerCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer C [Member]", "label": "Customer C [Member]", "terseLabel": "Company C" } } }, "localname": "CustomerCMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "axdx_DebtInstrumentConvertibleConversionPrincipalMultiple": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Conversion Principal Multiple", "label": "Debt Instrument, Convertible, Conversion Principal Multiple", "terseLabel": "Conversion multiple" } } }, "localname": "DebtInstrumentConvertibleConversionPrincipalMultiple", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "axdx_DebtInstrumentConvertibleThresholdPercentageofNotesTradingPriceTrigger": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger", "label": "Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger", "terseLabel": "Trading price threshold, percentage" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageofNotesTradingPriceTrigger", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "axdx_DebtInstrumentPrincipleRepurchasePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Principle Repurchase Percent", "label": "Debt Instrument, Principle Repurchase Percent", "terseLabel": "Repurchase principal balance, percent" } } }, "localname": "DebtInstrumentPrincipleRepurchasePercent", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "axdx_DebtProceedsUsedtoFundEmbeddedDerivative": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Proceeds Used to Fund Embedded Derivative", "label": "Debt Proceeds Used to Fund Embedded Derivative", "terseLabel": "Net proceeds from notes to fund Prepaid Forward" } } }, "localname": "DebtProceedsUsedtoFundEmbeddedDerivative", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "axdx_DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterOneThroughThreeYearsAmortizedCost": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Amortized Cost", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Amortized Cost", "terseLabel": "Due in 1-3 years" } } }, "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterOneThroughThreeYearsAmortizedCost", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "axdx_DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterOneThroughThreeYearsFairValue": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Fair Value", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Three Years, Fair Value", "terseLabel": "Due in 1-3 years" } } }, "localname": "DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterOneThroughThreeYearsFairValue", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "axdx_FinancialInstitutionAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial Institution A [Member]", "label": "Financial Institution A [Member]", "terseLabel": "Financial institution A" } } }, "localname": "FinancialInstitutionAMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "axdx_FinancialInstitutionBMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial Institution B [Member]", "label": "Financial Institution B [Member]", "terseLabel": "Financial institution B" } } }, "localname": "FinancialInstitutionBMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "axdx_Grantedin2018Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Granted in 2018 [Member]", "label": "Granted in 2018 [Member]", "terseLabel": "Granted in 2018" } } }, "localname": "Grantedin2018Member", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "axdx_InstrumentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "axdx_InventoryTransferredtoFixedAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Inventory Transferred to Fixed Assets", "label": "Inventory Transferred to Fixed Assets", "terseLabel": "Transfer of instruments from inventory to property and equipment" } } }, "localname": "InventoryTransferredtoFixedAssets", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "axdx_LicenseAgreement": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "License agreements", "label": "License Agreements and Grants", "terseLabel": "License Agreements and Grants" } } }, "localname": "LicenseAgreement", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrants" ], "xbrltype": "textBlockItemType" }, "axdx_NationalInstituteofHealthGrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "National Institute of Health Grant [Member]", "label": "National Institute of Health Grant [Member]", "terseLabel": "National Institute of Health Grant" } } }, "localname": "NationalInstituteofHealthGrantMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "domainItemType" }, "axdx_OtherRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Revenue [Member]", "label": "Other Revenue [Member]", "terseLabel": "Other revenue" } } }, "localname": "OtherRevenueMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "axdx_OverAllotmentOptionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Over-Allotment Option, Amount", "label": "Over-Allotment Option, Amount", "terseLabel": "Over-allotment option" } } }, "localname": "OverAllotmentOptionAmount", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "axdx_OverAllotmentOptionTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Over-Allotment Option, Term", "label": "Over-Allotment Option, Term", "terseLabel": "Over-allotment option, term" } } }, "localname": "OverAllotmentOptionTerm", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "durationItemType" }, "axdx_ProceedsfromOverAllotmentOption": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from Over-Allotment Option", "label": "Proceeds from Over-Allotment Option", "terseLabel": "Additional proceeds" } } }, "localname": "ProceedsfromOverAllotmentOption", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "axdx_ProceedsfromStockOptionsandWarrantsExercised": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from Stock Options and Warrants Exercised", "label": "Proceeds from Stock Options and Warrants Exercised", "terseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsfromStockOptionsandWarrantsExercised", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "axdx_ProductsandServicesnotYetDeliveredMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Products and Services not Yet Delivered [Member]", "label": "Products and Services not Yet Delivered [Member]", "terseLabel": "Products and services not yet delivered" } } }, "localname": "ProductsandServicesnotYetDeliveredMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails" ], "xbrltype": "domainItemType" }, "axdx_ResearchandDevelopmentArrangementContracttoPerformforOthersInvoiced": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Research and Development Arrangement, Contract to Perform for Others, Invoiced", "label": "Research and Development Arrangement, Contract to Perform for Others, Invoiced", "terseLabel": "Cumulative amount awarded" } } }, "localname": "ResearchandDevelopmentArrangementContracttoPerformforOthersInvoiced", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "monetaryItemType" }, "axdx_ResearchandDevelopmentArrangementContracttoPerformforOthersProposedPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Research and Development Arrangement, Contract to Perform for Others, Proposed Period", "label": "Research and Development Arrangement, Contract to Perform for Others, Proposed Period", "terseLabel": "Grant period" } } }, "localname": "ResearchandDevelopmentArrangementContracttoPerformforOthersProposedPeriod", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "durationItemType" }, "axdx_RestrictedStockUnitsAndRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock Units And Restricted Stock Awards [Member]", "label": "Restricted Stock Units And Restricted Stock Awards [Member]", "terseLabel": "RSUs and RSAs" } } }, "localname": "RestrictedStockUnitsAndRestrictedStockAwardsMember", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "axdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsContractualTerms": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contractual Terms", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contractual Terms", "terseLabel": "Contractual life" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsContractualTerms", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "axdx_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value", "terseLabel": "Weighted average fair value (dollars per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails" ], "xbrltype": "perShareItemType" }, "axdx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value (dollars per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "perShareItemType" }, "axdx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value", "terseLabel": "Weighted average fair value (dollars per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageFairValue", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "perShareItemType" }, "axdx_StandardProductWarrantyInstrumentsTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Standard Product Warranty, Instruments, Term", "label": "Standard Product Warranty, Instruments, Term", "terseLabel": "Instrument warranty term" } } }, "localname": "StandardProductWarrantyInstrumentsTerm", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "axdx_StandardProductWarrantyKitsAndAccessoriesTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Standard Product Warranty, Kits And Accessories, Term", "label": "Standard Product Warranty, Kits And Accessories, Term", "terseLabel": "Kits and accessories warranty term" } } }, "localname": "StandardProductWarrantyKitsAndAccessoriesTerm", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "axdx_TwoPointFiveZeroConvertibleNotesdue2023Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Point Five Zero Convertible Notes due 2023 [Member]", "label": "Two Point Five Zero Convertible Notes due 2023 [Member]", "terseLabel": "2.50% Convertible notes due 2023" } } }, "localname": "TwoPointFiveZeroConvertibleNotesdue2023Member", "nsuri": "http://acceleratediagnostics.com/20190930", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r412" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r413" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r415" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r410" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "invest_InvestmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment [Line Items]", "terseLabel": "Investment [Line Items]" } } }, "localname": "InvestmentLineItems", "nsuri": "http://xbrl.sec.gov/invest/2013-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "stringItemType" }, "invest_InvestmentTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment [Table]", "terseLabel": "Investment [Table]" } } }, "localname": "InvestmentTable", "nsuri": "http://xbrl.sec.gov/invest/2013-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "stringItemType" }, "srt_ChiefOperatingOfficerMember": { "auth_ref": [ "r147", "r345" ], "lang": { "en-US": { "role": { "label": "Chief Operating Officer [Member]", "terseLabel": "Chief Operating Officer" } } }, "localname": "ChiefOperatingOfficerMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r49", "r104" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r147" ], "lang": { "en-US": { "role": { "label": "Director [Member]", "terseLabel": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r145", "r226", "r230", "r399" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r143", "r226", "r229", "r397", "r398" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r147", "r345" ], "lang": { "en-US": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "ASU 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Net accounts receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r194", "r195" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r32", "r190" ], "calculation": { "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r54", "r55", "r56" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive loss:" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r53", "r56", "r57", "r288" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Contributed capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Contributed capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r107" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r211", "r217", "r283" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature", "terseLabel": "Issuance of convertible note" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Equity component" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r236", "r238", "r270", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Equity-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r238", "r265", "r269" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Equity-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r74", "r91", "r312" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of the debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r68", "r91", "r314" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive common stock instruments outstanding (shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r163", "r232" ], "lang": { "en-US": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r139", "r374", "r388" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r48" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r293" ], "calculation": { "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets measured at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsLeasedToOthersMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Long lived, depreciable property, plant or equipment held for lease to others under contractual agreements meeting the criteria for operating lease classification.", "label": "Assets Leased to Others [Member]", "terseLabel": "Assets under operating leases" } } }, "localname": "AssetsLeasedToOthersMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r159" ], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r160" ], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r157", "r174" ], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Total" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r162" ], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost", "terseLabel": "Due in less than 1 year" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r161", "r162", "r383" ], "calculation": { "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value", "terseLabel": "Due in less than 1 year" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r155", "r158", "r174" ], "calculation": { "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Fair Value", "totalLabel": "Total" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r239", "r267" ], "lang": { "en-US": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r239", "r267" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r291", "r292" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r106", "r132" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": { "auth_ref": [ "r356", "r357", "r358" ], "lang": { "en-US": { "role": { "documentation": "Information by project.", "label": "Project [Axis]", "terseLabel": "Project [Axis]" } } }, "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r29", "r93" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r8", "r94", "r100" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r86", "r93", "r99" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r86", "r308" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash Flow, Operating Activities, Lessee [Abstract]", "terseLabel": "Cash paid for amounts included in lease liabilities" } } }, "localname": "CashFlowOperatingActivitiesLesseeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r385" ], "lang": { "en-US": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r204" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": { "auth_ref": [ "r232", "r298" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.", "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r42", "r197", "r379", "r393" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r196", "r198" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, par value (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized (shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, shares issued (shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r211" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, shares outstanding (shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r15" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "terseLabel": "Common stock" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r59", "r61", "r62" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r126", "r127", "r302", "r303" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r126", "r127", "r302", "r303", "r401" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r126", "r127", "r302", "r303", "r401" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r126", "r127", "r302", "r303" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Risk concentration" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r123", "r126", "r127", "r128", "r302", "r304" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r126", "r127", "r302", "r303" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r100", "r287", "r289", "r290" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Capital projects in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "terseLabel": "Deferred Revenue and Income Summary" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r220", "r221", "r227" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue and income" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r228" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "verboseLabel": "Revenues recognized included in contract liabilities balances" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r96", "r97", "r98" ], "lang": { "en-US": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of Stock, Shares Converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "terseLabel": "Convertible notes", "totalLabel": "Net carrying amount of the liability component" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r232", "r235", "r400" ], "lang": { "en-US": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate notes and bonds" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r71" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r69" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Credit Concentration Risk [Member]", "terseLabel": "Concentration of credit risk" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Cumulative impact of accounting change" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer concentration" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r96", "r98" ], "lang": { "en-US": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Shares issued (shares)" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r210" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r11", "r12", "r13", "r375", "r376", "r387" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r13", "r207", "r376", "r387" ], "calculation": { "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails": { "order": 3.0, "parentTag": "us-gaap_ConvertibleDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Outstanding principal" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r208" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Initial conversion price (usd per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r39", "r212", "r213", "r215" ], "lang": { "en-US": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Stock price conversion threshold, percentage" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r313", "r315" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails", "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r38", "r209", "r313" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r38" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r105", "r212", "r214", "r215", "r216", "r312", "r313", "r315", "r386" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Contractual term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r312", "r315" ], "calculation": { "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails": { "order": 1.0, "parentTag": "us-gaap_ConvertibleDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r100", "r205" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r164" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table Text Block]", "terseLabel": "Schedule of Available-For-Sale Investment Maturities" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r314" ], "calculation": { "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails": { "order": 2.0, "parentTag": "us-gaap_ConvertibleDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "negatedTerseLabel": "Unamortized debt issuance", "verboseLabel": "Unamortized debt issuance" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Revenue Disclosure [Abstract]" } } }, "localname": "DeferredRevenueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r91", "r188" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r91", "r137" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Employee Equity-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r239", "r267" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Equity-Based Compensation Expenses" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net loss per share (usd per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r100", "r114", "r115", "r116" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r308" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r266" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized equity-based compensation cost, restricted stock units" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r266" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized equity-based compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Shares issuable upon exercise of stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r293", "r294", "r295", "r300" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r293", "r294", "r295", "r299", "r300" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Schedule of Fair Value Measurement" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r232", "r233", "r235", "r294", "r351" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r293", "r294", "r296", "r297", "r301" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r232", "r233", "r235", "r294", "r352" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r232", "r233", "r235", "r294", "r353" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "verboseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r232", "r233", "r235", "r294", "r354" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "verboseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Estimated Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r298", "r301" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair value on a recurring basis" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r166", "r167", "r168", "r169", "r170", "r175", "r176", "r177", "r178" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r305", "r306", "r307" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign currency exchange loss" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r100", "r307", "r310" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation and Foreign Currency Transactions" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r91" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedTerseLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r125" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic concentration" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r171" ], "lang": { "en-US": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicDistributionDomesticMember": { "auth_ref": [ "r172" ], "lang": { "en-US": { "role": { "documentation": "Allocation of business activity identified as domestic.", "label": "Geographic Distribution, Domestic [Member]", "terseLabel": "Domestic" } } }, "localname": "GeographicDistributionDomesticMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicDistributionForeignMember": { "auth_ref": [ "r173" ], "lang": { "en-US": { "role": { "documentation": "Allocation of business activity identified as foreign.", "label": "Geographic Distribution, Foreign [Member]", "terseLabel": "Foreign" } } }, "localname": "GeographicDistributionForeignMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r100", "r187" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Long-lived Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrantMember": { "auth_ref": [ "r229" ], "lang": { "en-US": { "role": { "documentation": "Award of money not required to be repaid.", "label": "Grant [Member]", "terseLabel": "Arizona Commerce Authority" } } }, "localname": "GrantMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r70" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r66", "r108", "r372", "r380", "r396" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Pre-tax loss", "totalLabel": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r192" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r286" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r102", "r138", "r284" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit (provision) for income taxes", "negatedTerseLabel": "Benefit (provision) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r63", "r100", "r278", "r279", "r280", "r281", "r282", "r285", "r408" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Deferred Tax Assets" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r88", "r95" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Accrued Liabilities [Abstract]", "terseLabel": "Increase (decrease) in liabilities:" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue and income" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredCompensation": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.", "label": "Increase (Decrease) in Deferred Compensation", "terseLabel": "Deferred compensation" } } }, "localname": "IncreaseDecreaseInDeferredCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "(Increase) decrease in assets:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued liabilities, and other" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaid expense and other" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InterestAndDividendsPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest and Dividends Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestAndDividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r64", "r136", "r311", "r314", "r382" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r85", "r87", "r95" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r23", "r183" ], "calculation": { "http://acceleratediagnostics.com/role/InventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r45", "r180" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://acceleratediagnostics.com/role/InventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r7", "r46", "r100", "r118", "r181", "r182" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r25", "r183" ], "calculation": { "http://acceleratediagnostics.com/role/InventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r24", "r183" ], "calculation": { "http://acceleratediagnostics.com/role/InventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterestAndDividend": { "auth_ref": [ "r73" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Interest and Dividend", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterestAndDividend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": { "auth_ref": [ "r74" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.", "label": "Investment Income, Net, Amortization of Discount and Premium", "negatedTerseLabel": "Amortization of investment discount" } } }, "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r403", "r404", "r405", "r406" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r403", "r404", "r405", "r406" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Investments": { "auth_ref": [ "r394" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "terseLabel": "Investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r164", "r373", "r384", "r407" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r329" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease Costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseIncome": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.", "label": "Lease Income", "terseLabel": "Lease Income" } } }, "localname": "LeaseIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "auth_ref": [ "r189" ], "lang": { "en-US": { "role": { "documentation": "Assets held by a lessee under a capital lease and any addition or improvement to assets held under a lease arrangement (including addition or improvement to assets held by lessee under an operating lease arrangement).", "label": "Leaseholds and Leasehold Improvements [Member]", "terseLabel": "Facilities" } } }, "localname": "LeaseholdsAndLeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases, Lessee" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDescriptionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Operating Lease, Description [Abstract]", "terseLabel": "ROU assets obtained in exchange for lease obligations" } } }, "localname": "LesseeOperatingLeaseDescriptionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturities of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r330" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "Remainder of 2019" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r330" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r334", "r338", "r339", "r342" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Leases, Lessor" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "verboseLabel": "Term of lease" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorSalesTypeLeasesTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of lessor's sales-type leases.", "label": "Lessor, Sales-type Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LessorSalesTypeLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r35" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r377", "r390" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r144" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Long-lived Assets by Geographic Territory" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r40", "r206" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Realized Gain (Loss)", "terseLabel": "Gross realized gains or losses from sales of marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r86", "r89", "r92" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r58", "r60", "r67", "r92", "r115", "r381", "r395" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r333" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease.", "label": "Net Investment in Lease", "verboseLabel": "Net Investment in Lease" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r107", "r109" ], "lang": { "en-US": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Standards That Were Recently Adopted and Standards not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.", "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]", "terseLabel": "Restricted Stock Unit (RSU) Activity" } } }, "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r323", "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r319" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total", "verboseLabel": "Lessee lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails", "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r319" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r319" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current operating lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r320", "r325" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "verboseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r318" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r328", "r331" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate (%)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r327", "r331" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesIncomeStatementLeaseRevenue": { "auth_ref": [ "r316" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.", "label": "Operating Leases, Income Statement, Lease Revenue", "terseLabel": "Lease income" } } }, "localname": "OperatingLeasesIncomeStatementLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r51", "r52", "r54" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax", "terseLabel": "Net unrealized gain (loss) on available-for-sale investments", "verboseLabel": "Unrealized loss on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r50", "r309" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r41" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r75" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedTerseLabel": "Other expense, net" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r75" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Total other expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r83" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Prepayment of forward stock repurchase transaction" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r84" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r156" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedTerseLabel": "Purchase of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r80" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedTerseLabel": "Purchases of equipment" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance-based stock options" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred Stock, par value (usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, shares authorized (shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, shares outstanding (shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred shares" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r185" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r82" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible note" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r81" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds received" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r78", "r79", "r156" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale", "terseLabel": "Proceeds from sales of marketable securities", "verboseLabel": "Proceeds from sales of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://acceleratediagnostics.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Maturities of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r229" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Products" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProjectMember": { "auth_ref": [ "r361" ], "lang": { "en-US": { "role": { "documentation": "Planned program of work.", "label": "Project [Domain]", "terseLabel": "Project [Domain]" } } }, "localname": "ProjectMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r32", "r191" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r31", "r189" ], "calculation": { "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r9", "r10", "r191", "r392" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net", "verboseLabel": "Long-lived assets (excluding intangible assets)" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r30", "r100", "r191" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r9", "r191" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r9", "r189" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life of assets" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r16", "r22", "r391", "r402" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Trade accounts receivable" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r350" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r234", "r344", "r346" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r234", "r344", "r346", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r350" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Research and Development [Abstract]" } } }, "localname": "ResearchAndDevelopmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": { "auth_ref": [ "r275", "r277" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.", "label": "Research and Development Arrangement, Contract to Perform for Others, Compensation Earned", "terseLabel": "Total grant funding" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails", "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r274", "r409" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Shares issuable upon the release of restricted stock awards" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r217", "r389" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r225", "r226" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r101", "r231" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r231" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Deferred Revenue and Remaining Performance Obligations" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.", "label": "Revenue, Performance Obligation, Description of Timing", "terseLabel": "Contact period" } } }, "localname": "RevenuePerformanceObligationDescriptionOfTiming", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r224" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue expected to be recognized from remaining performance obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r65", "r134", "r135", "r142" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "verboseLabel": "Arizona Commerce Authority grant" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r326", "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Share price (usd per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Total revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": { "auth_ref": [ "r335", "r341" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable", "terseLabel": "Present value of lease payments" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]", "terseLabel": "Sales-type Lease Receivable Maturity" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received", "totalLabel": "Total undiscounted cash flows" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 5.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Five Years", "terseLabel": "2023" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Four Years", "terseLabel": "2022" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of the fiscal year following latest fiscal year. Excludes interim and annual period when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Remainder of Fiscal Year", "terseLabel": "Remainder of 2019" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 6.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases after fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Thereafter", "terseLabel": "Thereafter" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Three Years", "terseLabel": "2021" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r335" ], "calculation": { "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Two Years", "terseLabel": "2020" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount": { "auth_ref": [ "r335" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undiscounted lease receivable in excess of discounted receivable for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount", "negatedTerseLabel": "Less imputed interest" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.", "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]", "terseLabel": "Schedule of Available-for-Sale Investments" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r238", "r264", "r269" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r7", "r26", "r27", "r28" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Components of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Reserve Activity" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r32", "r191" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails", "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r103", "r344", "r346", "r347", "r348", "r349" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": { "auth_ref": [ "r276", "r277" ], "lang": { "en-US": { "role": { "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.", "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]", "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]" } } }, "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails", "http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r133", "r139", "r140", "r141", "r186" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r239", "r267" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r244", "r256", "r257" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]", "terseLabel": "Stock Option Supplemental Information" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r259" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Inputs to Calculate Estimated Fair Value of Options Awarded" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r123", "r126", "r127", "r128", "r302", "r304" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedule of Customer Concentration" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r146" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Industry, Geographic and Revenue Disaggregation" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails", "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r72", "r179" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Sales, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r77" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Sales, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r229" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Services" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r90" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Equity-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]", "terseLabel": "Options Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r240" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r252" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (dollars per share)", "periodStartLabel": "Beginning balance (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested/Released (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested/Released (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r261" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividends" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails", "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rates" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r245", "r247" ], "lang": { "en-US": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Ending balance (shares)", "periodStartLabel": "Beginning balance (shares)", "terseLabel": "Outstanding (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Options Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of options (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r251" ], "lang": { "en-US": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedTerseLabel": "Expired (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r267" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate intrinsic value (in thousands)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r246", "r267" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (shares)", "periodStartLabel": "Outstanding, beginning balance (shares)", "terseLabel": "Number of options (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, ending balance (dollars per share)", "periodStartLabel": "Outstanding, beginning balance (dollars per share)", "terseLabel": "Weighted average exercise price (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r237", "r241" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "verboseLabel": "Exercised (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "verboseLabel": "Forfeited (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r100", "r239", "r242" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Equity-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r260", "r268" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r267" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate intrinsic value (in thousands)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r324", "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term leases" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r202" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Warranty incurred" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Provisions" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r100", "r201" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Warranty Reserve" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r44", "r211" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r14", "r15", "r211", "r217", "r272" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan", "terseLabel": "Issuance of common stock under employee purchase plan (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r211", "r217" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock (shares)", "verboseLabel": "Proceeds from issuance of common stock (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r15", "r211", "r217", "r249" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (shares)", "verboseLabel": "Exercise of options (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r14", "r15", "r211", "r217", "r272" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Employee Stock Ownership Plan", "terseLabel": "Issuance of common stock under employee purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r211", "r217" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r44", "r211", "r217" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r19", "r20", "r153" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance, amount", "periodStartLabel": "Beginning Balance, amount", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet", "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals.", "label": "Technology Equipment [Member]", "terseLabel": "Technical equipment" } } }, "localname": "TechnologyEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r148", "r149", "r150", "r151", "r152", "r154" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r355" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r43", "r218" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r15", "r211", "r217" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedTerseLabel": "Repurchase of common stock under Prepaid Forward contract (shares)", "terseLabel": "Aggregate number of shares (shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r43", "r218", "r219" ], "calculation": { "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury stock" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r211", "r217", "r218" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Repurchase of common stock under Prepaid Forward contract" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": { "auth_ref": [ "r232", "r378" ], "lang": { "en-US": { "role": { "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).", "label": "US Government Agencies Debt Securities [Member]", "terseLabel": "U.S. Agency securities" } } }, "localname": "USGovernmentAgenciesDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r232", "r378", "r400" ], "lang": { "en-US": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. Treasury securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails", "http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Unsecured obligations" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails", "http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails", "http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r119", "r120", "r121", "r122", "r129", "r130", "r131" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r111", "r113" ], "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding (shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e4975-111524" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5212-111524" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5093-111524" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r198": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130554-203045" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e34017-109320" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "30", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902458&loc=d3e39896-112707" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919306-209978" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919352-209981" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919391-209981" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919398-209981" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL117410129-209981" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL117410129-209981" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919379-209981" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "14", "Topic": "842", "URI": "http://asc.fasb.org/section&trid=77888298" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888252" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(a)(32))", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=82851474&loc=d3e511914-122862" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=82851474&loc=d3e511914-122862" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=82851474&loc=d3e511914-122862" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6806780-109447" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r373": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6)(a)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803" }, "r384": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e604059-122996" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(2)(i))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C(1)(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r407": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r411": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r412": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r413": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r414": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r415": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" } }, "version": "2.1" } XML 22 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Investments - Schedule of Available-for-sale Securities (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Investment [Line Items]    
Total $ 28,920 $ 100,389
Gross Unrealized Gains 59 2
Gross Unrealized Losses (1) (173)
Fair Value 28,978 100,218
Certificates of deposit    
Investment [Line Items]    
Total 4,163 10,787
Gross Unrealized Gains 21 0
Gross Unrealized Losses (1) 0
Fair Value 4,183 10,787
U.S. Treasury securities    
Investment [Line Items]    
Total 11,975 22,185
Gross Unrealized Gains 26 1
Gross Unrealized Losses 0 (66)
Fair Value 12,001 22,120
U.S. Agency securities    
Investment [Line Items]    
Total 1,505 8,024
Gross Unrealized Gains 0 1
Gross Unrealized Losses 0 (45)
Fair Value 1,505 7,980
Commercial paper    
Investment [Line Items]    
Total   17,025
Gross Unrealized Gains   0
Gross Unrealized Losses   0
Fair Value   17,025
Asset-backed securities    
Investment [Line Items]    
Total 1,107 12,007
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 (9)
Fair Value 1,107 11,998
Corporate notes and bonds    
Investment [Line Items]    
Total 10,170 30,361
Gross Unrealized Gains 12 0
Gross Unrealized Losses 0 (53)
Fair Value $ 10,182 $ 30,308
XML 23 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Property, Plant and Equipment [Line Items]          
Total property and equipment $ 18,644   $ 18,644   $ 16,014
Accumulated depreciation (10,078)   (10,078)   (8,711)
Property and equipment, net 8,566   8,566   7,303
Depreciation 600 $ 700 1,700 $ 1,700  
Computer equipment          
Property, Plant and Equipment [Line Items]          
Total property and equipment 2,726   2,726   2,700
Technical equipment          
Property, Plant and Equipment [Line Items]          
Total property and equipment 3,949   3,949   3,868
Facilities          
Property, Plant and Equipment [Line Items]          
Total property and equipment 4,016   4,016   4,037
Instruments          
Property, Plant and Equipment [Line Items]          
Total property and equipment 7,747   7,747   5,318
Capital projects in progress          
Property, Plant and Equipment [Line Items]          
Total property and equipment 206   206   $ 91
Assets under operating leases          
Property, Plant and Equipment [Line Items]          
Accumulated depreciation (200)   (200)    
Property and equipment, net $ 1,300   $ 1,300    
XML 24 R68.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transaction (Details) - USD ($)
 9 Months Ended
Aug. 20, 2019
Sep. 30, 2019
Sep. 30, 2018
Aug. 19, 2019
May 31, 2019
Mar. 31, 2018
Related Party Transaction [Line Items]            
Share price (usd per share)       $ 17.99    
Proceeds from issuance of common stock $ 1,000,000.0 $ 1,363,000 $ 447,000      
Director | Note holder            
Related Party Transaction [Line Items]            
Aggregate principal amount   $ 40,000,000.0     $ 10,000,000.0 $ 30,000,000.0
Chief Operating Officer            
Related Party Transaction [Line Items]            
Issuance of common stock (shares) 55,586          
XML 25 R64.htm IDEA: XBRL DOCUMENT v3.19.3
Leases - Sales-type Lease Receivable Maturity (Details)
$ in Thousands
Sep. 30, 2019
USD ($)
Leases [Abstract]  
Net Investment in Lease $ 600
Remainder of 2019 62
2020 197
2021 139
2022 106
2023 53
Thereafter 13
Total undiscounted cash flows 570
Less imputed interest (3)
Present value of lease payments $ 567
XML 26 R60.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Equity-Based Compensation - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Equity-based compensation expense $ 3,131 $ 3,465 $ 9,409 $ 12,476  
Unrecognized equity-based compensation cost 27,100   27,100    
Shares issuable upon the release of restricted stock awards          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Unrecognized equity-based compensation cost, restricted stock units $ 200   200    
Performance-based stock options          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Equity-based compensation expense     $ 100    
Contractual life     10 years    
Granted (shares)         225,000
Outstanding (shares) 125,000   125,000    
Performance-based stock options | Minimum          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Vesting period     1 year    
Performance-based stock options | Minimum | Granted in 2018          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Vesting period     5 years    
Performance-based stock options | Maximum          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Vesting period     2 years    
Performance-based stock options | Maximum | Granted in 2018          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Vesting period     6 years    
Property and equipment          
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Equity-based compensation expense $ 100 $ 100 $ 300 $ 400  
ZIP 27 0001628280-19-013835-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-19-013835-xbrl.zip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

K MIKGD]ZXP7U ?*6@)-#O6VR;KT5DEBLL0(H()YFJ7*LZETEASAI%V?<15S8[M M*7!^*7&CQK!Y(0N2Y[)@LSGNG0A6;2WZ>KTDRFDWMM0&9^/KNMQ1F3$R-FB2 ME@F?43X.D)H1C\\8KCG#,\W*=PWN[;5YK5.$GVSX=F'BM$O--3)(66:T-J/$F3'B[.;( M,4'H]$#U31YU;#DWBYQO]J_-'O&(MW4VOO3J*7-S]X&Y ZB$)Q7C6KJ4!^.] MS*YA;D_Y6)*:PRK&5?%E86UYX51^/BI*'67(]IC9Q_>A$;- ],BQ5P"5GTXN M/3+2JQ<;]R8W_<[TD6,W"D9E[J=Z?'TRNNNGQ:3KT4=*CADAQX(]G(PSG>)3 M2^J9W#0>U%1V9O-;87OCO0!Y64^ M602?6*/EW[?9+!%X$YU<95'XQTEX;4;P(1Q\"^]SFZJZS1[?X10$!EO2$Q3X M+@V@^85*SX>$4N@#'Y6ILP.]PXFO)&9]1O990R]_?7(&OO0^!?;@>G5^=AF< M76Y^D].B]:^, >Y<%GEZS#!X65(8K4P*<[9D9R=YL]V;Z[KO4]*&:V&Q[.S< M9E;\_RFG7$.7NE!+)2AE7 K)M&;4$RZ"8ZFP-LK'P_@LOUPZI\Z)HT_/Y)DZ ME9\SV(FH.(]VR&'-AJZ&#)?0U\$;C&6O$-9 #S@,==YBI[ M_AY[/G1.B^C.@>\<1S_XWN4Q7&59=XN0LR0NNMT%Q4]GOX^X@C!@# *?0@*H MT-SS;96)ZT&@F5+$W1!7R.#JUS Q!I.%TX,MZ<=Y;S2^;,36M,DD'-SG<6E] MSE"H4F-?%M,^7Z)\-"C*+N?#:'R.\ ' PH %2GJ<>HP)"#!" M"I( ^1)+NB$^L<'G;S:0&!N19RO=+=3,!X/I[Q:I@]1>YIH[\LJX/=.ME%_B M_(\#@-_*9<<'(1X#+(R[QGT4!(K"@'B^RSRC)UR"@8<@V1!^Q,#/B+DB,V9S M";W/6=J+^J,L.@#1MGI-[0V(36"KU= 21IH3QJ'6OJ(2 4DQ#HA05!#?'I>Z M@3,09H5S:KV!\\N_!%\Z3V O11+1..!4<(BL94 "[JO 5SZ "'& J7Z!)_ I MNC'V5RF+R@U8!R",E("^=IF6&MD#&Q@G*H"<,\R5Q# P+CFFAZ#H7. R$F#/ M7MM'*0+&$1)&*GF*,9=0Q#=%E32PLB:38V/N:78 B%J]DH>!*.8+Y%/S?V9O M:-=:$".W A< %W-&H7R!9_E[4CGH[R(FT/ V/08Q)3#)4.7.II9&QZP8U_S'4 8<#A"]S#7^,D,K+M M.C(BK1*,V']LK5[3P\"61@$02ADSW]Z0%&C#:1PCK%E A89:;8@M.JV*.R_K MK4Z3<=%!]9:^O876ZB4]#&AYOB(,*J4\#*AV%<> !Y0;RQ7Z@*'GG/Y0A18S M8BOX?AM?Q8>00%J]B)C5@NF%IHFUZ M7_=+BVG6K#MHIF+H52:Y&.X38J^1@:\E]CJSJXP%/7/L:$J@LO.TY"966T 8K5T$\ 936DD.18DT_ 8$]2755'KV_AF)C:,+C3?"W)>08YV3 M_9\%KEXZ2+,/TQ,E-R>75"KX%'R1EX'CG\I?SLXO+D_5Q;'A/=78P2[MFK$Z M/_.#LXO MV5[%^>?3GTS>7\_Y^K)3T:6!L[%7X+@\M7NW-A06OX0)TYQFX[R M,.GGQ_:\]VA8C*N)G7Y8A$W?:S(_X!TJKES[B)X7UU^Z*^LOW64W:RQI6M:V MS2>^:>KWE;>IKK[J\!5V'V_I1LH+(Q_*[2(.!L>'-WT_ZDUF#^MFWZ'\*9E? MYVCPUX9!=8M4MRJ55>$=4^R'[#OZ^'L2COIQ47O1SUO?Y_M6U4<5 VW!I*?MIH,WR'^6U93-.S/]ACU;^&@_D(X=8R/ L7;ZNS M_H]-;OM91>8ELUP[:_7RXV?GML=30 ",&)J=?2$H=H70@FO)*-">AWD@-0.< M,HQ=X$VWQX_RDYLP''ZP&)%)W_X3S B"Q5FF3WZY;_M34I/CL08;Y/'E2WR MH[Q?W1]_@A^VQ^.EV^,%.A:8K]H:WP0AU\[/;BIKZO9<=XRUXXQ5N0J>N\SN MY'*))W%9GQ?X$@K(5( 9)R1HBK'X;Z0!QF+L&*T^VVIJ@0 M/Q9NDXKJ+?71OF/)G=T*1GQ B:1,&H.(^@IR)C7EF"K )='NG#FT'$O-R&8( MP#&">P&FP_"C[,V]T?2$0WM!52\R^OQJL.!>T;79J]&840OX3LSX3AGN8MH/ ME&:0&@X4&F$()>(:&Q&NQ%.^^_*PIOE95-1?<]6@-#]F!.VU<73 ,'0!F]WG MC @ FA+D!CX%"G&78"2@[VJ?!LK%F\*P(45PS#L;?;=L]*1(LP5G<>^Y5>6B M&5OY@'M**\R8YU,2&(X"DE)7>XPA'4A29U65*V>8:FM"W3WF'.Z#474 6"*@ MZNU)3 +&H4NI@*ZG%&=<8.5S%W/!GXFE9B2S>^P2M@]8.@P#_7,6#<.X[T3? MAU&21R\-H>R;0<0JU]-Y@T6@"'/5QH0EYI6 "577"#!?1_Y+G+GA/ZZ,&Q&^@O> M6>4[8Y6/]\/V'I5RO)3QME"LUP+^$S/^4YX'$00:""4I%,::BEZ^C9\Q0CQEY%<>CG=#=I\KRSUDZ M-&._+ZMO;>'MT)84'#M)5!QDP)>S&?MAZ@;0Q9CY+J52"B&)Y 'PI0^( AZ8 M]_W':_EY$":%3/K!=#FWF4S@QY3M10#X +#ESBX'\Z%@@8":4B:H3S'7.O # M(8%4C&H,7XBMII(+IX[9?8N^RS_#%OL8>16HO36V?R] "_A,5_L,>E=2# M&&M!M4<$YRZ%TO,$]8R 1W-^_/AJD.3F4Q3F4;G4Y]>_YU%IMM>URU-B_9%]GR4*MP9^5&@? T$!ZF"BDJ )8>]EQ"A21: M^URJ^E#K]M(#Q#U&C6[CVIS0[0S"=DS?,?U&3,]GQ252L0 HP][<4Y3S0# 2 ML, 3S%[/)(.Y .]"IF\HL<+I,6*-Y@3WC.DW.O!HRP;.ELXU^G0JO=-/IY>G MP84CSWSGXO)<_;^_G'_R@R\/IQUM$)-P?]KDRS7C&Y]8$_SV^^GEWW?1+IV> M:O]"D3,]F6D0AU?QH+R=YZ7',[WJBK3UW*:]782]*FF5TYW&P_!^\3;CUXMS MO)5!M1.Q&0CXS-_1 2,(*8DD\RA06KJ0$>!3296+.69SIL^$TI_'A-[^OF>T M-UOD.OBW!/Z5LG(DA>8!T%SXG"+ C+;2[VO#OZG]UEUX9[X#VH!$#$XQAQCRI,/=\7&AK'%W/(()[+"TQ6 M]]-L<;>O?01_E=+"[(>CI9.9GT_?AK;/SQ_FMY'5#LB\^Q]P"C;L65%>;W 'L448H8D9!P MXG),F0;"9W.INXT UI1=CQH5YNV7V3MMU_O1=60 T7>RZ&N4C+I3])XP8:6> MG5+SFX*,!L9TMN?F^:X(F, 8:"/U^=PQ>LJ\T#[VKW%QJT:YF5643:VJ^ZW; M]W2_CTTX:%"*65&C!-ICUO! KC(@1)QK@H ?*!@HSCW9$"B;T0W&"=EK4.Z5 MF3]-^Z73;0'.P.X+>(@ O?3DO?T\2 $B.#MXE;I$$DQ<$$!,!64>"###&'M: M"TCUW %/CW=@O)JN(*A)GZ"UIRKL-SA?L!VCK00[E *+QR=AM#3"WO*:-XC( M[$A4SV5$>#R@08 H]+%$Q N$5EAH8ROY:O6+/U8*B;A' ?4\H0, J"N@-,:[CP!AKNMSZ,]O'*PWXU]A M$R$^)G0O[C+9;81M;HNW7[+MN*T]OSNZI?9V"V0@AK-JLH!+Y?J,8)^YE!E[ MV@VHYQM#Q?=<)%3]3M>*8?(*PN]U[.J=$(E[AT0T.YX4"$P940H0HY>Y1Z02 M2L% !Z:[U'@^J/8<)#9T3.E^GYN^9U:P2I-R^';36)(6+U8#N\IC9,9C@;%K M/<-AT#12[0&/^H)1S_PFH2=)759INH1^=%6\@K"'R#TFI,F#@W9"L.\JMM@L M*>)!JC0 @BGDE7?W0A6XQI)P!240NW.U+,_!5D,E+ @< WG<7C^]$+\\SM[@R(XB2WLOCESOJ7! XR_QS M(A%E+N3(\ZAKV%4I;%Q93@-/$.K/A2DKRRF3OJHNYGKJ^GL>?TCB@9EZ-HH> MF!8\8=JT?)1Q63XNY-0--5?GM6X16)4K5CC7@/H^]P,/4,_%'M8<^0&C+-#< M!=[+@%6C# X66.UT69^>GW([/BF(F8X-K,7NGR?3K<>;K,>>63<71=K[XS8= M&#LRGYSE5=[84MR_],2IUZ!Y6X"_ZW-MIP9H_%:BZ+D);]QKQYS'#N#L]!@#8_YSA$[9PPE%QFV:F:[_T M=XV%&SGIJ,@+\YNM5@QS>Q_,130LHKNK*',P.':LJU;V]J/>Y%-8?LH/TY&A M=.8A,X1\*;7'?1O YDA@PA51 F J$(1SQ<4/Q_1UG:#_/; M2LG<[N?<#@%0E6/%N80@"'R%H0$4"83DPL>(N\+W$,'SU>KK 6K#\.A> NH@ M["$;,$EM?P.*SA;J;*&#M87XS!CJ37ABSA+Z%A>W#B7'C,!CR-UICSC/1Q,[ MJ6HBF4C 1& :HVE3XWQQ0#4 MG@):U]3366+,%.3Y;(6W5D5 FSP.L#.^M@@L,LM)^YY0$'%-*-<4(L2Q= 7F MFBM! J9JBNF> ZR&JJ&[2KK=,<*2(HNO1H61[+UP&!?AH-N)\)CYV(SYH*=1 M0#P<"%]3Y4&!)<0NT=K#*O!K[E8Q$[+/# >?P[A_FJCQ"E=XVE9=1:%^2B['[OE>VIN_;"*M\2,MQCWC&C7!"GL4:V@%-)87B0PW(89 M]LA3WIHNX#:"IT]YR?ARK,GSU>:Q]1*"-6&>_'B@"'3A+-SJ2M?G08 9]3B5 MB'(@M "(VD[&^/ W0F!#TOPP$=A.S^"%$Y6]WNAN- BM)]"/KN->_-)SOG?. MY%K)E96[Q87Q 7" F*>0X4JE/4F1T1+2@Y#;(YJ?65 MY?;'J_TR/9&;M3"?+3\L1.!C#%]ET_QN,/)AH[ER?IH;2(E=IH7F/G49,#:. M9(1Z7A 0A.<=VXW0_ R=LQ::,3C&I$-S._R.YJ^<>-!&:7F"2R^]&V;1;93D M\=?(&:3YOFY^6,FW;)9FD#XSSK[U]P-)9< \KKB/C'6H)&6*UUT[-%W6\I0, M55W4T\2LP)0 FW_G- !=$\ MT$0RY -D;[@(MH#1AA4-)(<'TG:Z.-LZ1B!?6(6^Y5.E#^K$4PYF%RB!@+F* MNYQ1)BAWB;W9AD/D:0]@ZYGIPC-#V-M@^ P3MW%_;X7]3 M_$.WL\'JN1GP& !HZ;&.K)M%6CLUHB>V^2DJ1F>GN:X6\@!-#?TVU4=<&!UP1 MX6LAH.F_Y ,F?1?4V<3]QBYKWH@SEOJWX[;]H;;*AMUD.2*!P$"@$#J:\ # MB@0/C#7L^8HOO05@76YKZ P:3H\1VYZ)T"9N*[7]^\)>I/GP>?EW93B#.(E. M)ON_(0+_^11KP&"M,N1>9"_K''\2)WWS6]EC_4D\Q=OB*;1OD!=1Y(0]&\P- MDWM;/UX>P.H4J06K>4T>E4?&?V]CI,PZ<6EEVX^* _8>#!.=7&51^,=)>&U&\"$ M][?99 7"4KCDA.I ,R:\P(=422FQKV2 ",3$\ZB ]COAHZ5[P7I,C=#F%Z2. M(5=1>S.,OW"H$Y]E(JC&C?:K1C0:"3KI_FT\J"LCG\2@5? J^R,O \4_E+V?G%Y>GZN+8.3U3\WC?BQFK\S,_.+L(?,?\=''^Z=0W MD_?WQ*.^K&1ZNV:WM'''^+$*6[346Y\W_S8B;[WHF'A#*-LO/G),:HH? B3 M5X;[R)1^&%M%7U;G,UFLJF$*P=@,+>T+IQ<-!I/6\N G^[MY96_Z>\U\+N,[ MHSW/HF_.E_0NG-MT=Q=F-W$R'EXX*M+I!^/P0OG)M[A?W)K>9JTG5IBA]B < MYM&'Z0\_/;6WCAX"( ^10$B.%L='QN\@[G_^=#1G$$[>OZ1I65M;GMC"X;]I MG.JM=L2RUTRHSDF?#?S$.=%Y]/'R-C-&\J^FX39W B-+^B](,W9$;0=1SXPB M6$73@^38MSC;:OOD?K3]NEN! Q=@!TOA U^!3J"_TDWK;P\%F\KJ%J9^81:< M!])QQ+X3ON.(9W!$ZTLN7Y[JK?.+HL+)P\%&]S=M5"3VTNWBKY?A?L$M*V^: MV<90\(BYLV)/H:''!5%N@.VV!"*A)-)W-7)=#5@P=V;-E^AKE(PBG:5WY?DD MYAE_C8M;-EYH K2H&6GG()HT)!#B'E>CN,QIMB-'B,&SV3;/<8;6\/ M;.PDS.Y*&!=4:M2P/38Z0%022*%&@DC)? B%YU&/!EN2,$:5_[T1"4./.6KR MO(K=DS =H[68T5#EJ#E&L::8>4 1JIDK$1%(<,$!U)*JN4OO&U/ES3 :/N:O MLS7_,+>!++A\"+K/JKS;O:1&-^]7G_*M*\\+>G[,DYKJ_ M1R(M-[\XX+.KGS7QI=!,^1Q3*8 4D@&F'%V?"'F0Y9V6<^O?TG3?KD7)\J^ MQKTHOS!KOLW()#R&<._=F8.%(YIMQ'0Y"WP54.8"1:G4@B@?<^ 3@:6![=S6 ML&?!L;'X'>.-'IO01C"V1U&\53+[T+BP"9YSR@"()? 4I]*$]B95[BBO& M$:6(OU0I-.-ZHV-!]IX/#Q:.E?W"&&,/0 FTRVR(2$KE4X2 AR!2+O'A2Y5" M,W"$QYSO]S4$;3D0I(F@ZR]9FN?.,$NO7WS\[T:1YM8>X3/F/G?&?20(-)8! M@2Z4E!MO0;H>UR#@1 !,V-P)/N7*?BX7=LLN0:/7[[3S#)Y#QZ&8'0_/@#U? MT>6!DC;%CP32A #?"WS*-,7H>3ALSA?8QA%2[4/AFT?+VF+V[R&7"2!FMA9# ME&,?*@1\BA4PFL#>QX",Y:6 R^8.R%XI[9NR]3EO- #45CX[:!PB4KD,!$!/ M!CH0QNJ DGC !QAH#*0]*4C/'::[4MHW9>2+1D]R;B<.VYDQV(6\4;<@![H@ MW2)TJ.@6I*%$=.OC1PORS>,C9:/O0WN\6_YA!VH0VH+_/9CKOL_OD&AY,'-M MV-*';1361Q^_1'D49KW;4CSWHZ_1(!W:\S6[E%O5_8: S^J"/ JD)Q@F@6MS M;A[7T)52>IA#AKFH*+[%,^OYL@8.Q*MQF'H = ]9H'J!U:;=#AB0$L]J@ M0$@)I<:,,&K^$,]7P,5:,2Q=)63-[MKG0;*QE(![S,5A[Z/M"H3VD1+B8QJV 2>@0Q MCP%#<8RH!R%!@ NL"%:(S56M;: ?&DIF@6,7[[?-LEFHIZ7NPX7=0G#LW$1) ME(6#THD(^W=Q$N>%/?;Y:[2GEU^NXKU*B9Y"6FM%S/^@2R%2W+ =YI0++B6! M9,XVNX@& S.C7\9+:CA0/EK05_ ;(#IV"6Z0"7="_N\JU%Q0N9 >080]B065 M% DH(9:4NJZ60@9$SM^HN"G4FCON QU#NB]0V^MP6)-7/NXJJ_%9,1 W7C;& MF@1:0.J[BEN[RE. $JU<;][*?XE4;V@[/C_& +WBG8Z=U-\>%!&8U0/Y0 JM M-)82NU3Y1&*?^"YB*. 4>W#NAKZ72/UFH$C@,<=->I[M-^9W.DDPOA^T-Y?& MW;*:.)";@2<BLPD]S[7$J!.:<0N +3RC) HZ0E("CN0Q#F6 WC#QAW7RK MS@$_YF +]:;/1T$["P0[!MB4 ?#,ND+(WH$=!%BZC 8N]SPO( ( 9M2<-K]N MP "-N2P(' .RA>TU>\0 70*DX_SG<#Z=)=>YE(&Q9YE/A4^148.(:D\+JHA& M6@>;<'YS)P>ZQX1TJJ]3?8TS0.6@[( 9X\] W34ZCT)(N ZX+S2F/H;4=?W- M5%\S#,#0,65;V..Q+PS0G0?8@IK ;M[=>8 =C;MYMZ#FMYW1O$_V>(_K++US MTF$TOISYX$X!_&&%18;9+!HGN0N)%IZ&"%!@"WTU%RCP@4N$YGSNE(_S\:HF M-Z=)+[V+['*_.""7F_F;SY9'YMQCUF@N=2559X!]"5F;P/2/'8"? )C/R@*( M"ERH!(,$ QJXU -"2R(H0AJ8EKD-X^L!^'D!M;4 +(YQL^[%S@.X/4JHM9&T M?>-< BH'^U"%M$0^9(&D$KB>1Q@' 4(" $%\N;'J>48\8!W.I>28LE 0PK=\4@S9!"1!(.* \"[D$48.D!Y'D>@W/1K+553\, 9N"8P0[ 723K M$+W> Y[W(<^\0'1$,:*.HI MXOO2!T@&U.7S!^6O!F!CY;SX&-,F:_IV!H!O[@JU)8.PJPS&*G%6#;!&,-"4 M^CZ51(F <2)\0I6G&:%SEX.M)>$;.F8$'%/>Y&:OG>&P_4<@GAU!!5P(E/F_ MW:M! X,[JH3K;&!? 1)Q)JS8RM1B0'&C )"%*NL=7FM@U/ M5EI-%OHR"Y-\_)9?PCBQF3HO,DP8U=\JWWRYT^O<*+8;O'[8H&:S[4.:$->7 M+G:ET4+,PYPI'U,/:,F5 ?N*>HAXNG$EU3"J,7Z5(WQW ]7[F3L9I]#W-*RQBE6K)[$ J3PJC:X! M@DH;R@"^*P#E0BC(Y=S-FJ?)5[-\]K#4<0'C=$'M0:KQU]@8#@ON_6[JQDVV M#Z=$"X\#PN@.&'4U\@+5* 9(U +!+%;$SK;!&2-94P$:#)A]Y8@ MZU(@.\Y$E8-#7 ]@ZQ\ S]44,62,*\+L10@N0AKS.:-J8TG=U*VM1P.ID M]19A5CF>@TJ/1C9C M7+\Z*5PZ=I+HQ?8Q.ZWPL\6,5Y7"OJ^0CP(J*$.^IP*70,%4X LDYJ-' MY>J?I4DZW83T"O5/K3A-9S<\[8/&_0K8<\ KQ5:8,FIFJ3R?2E\)Y5(1($*5 M$%!Y<]5^SX#]YC[$OZ,L[8?YK358.8+HIS;@OK6^1Y?9V,<8,$?NS(Z$1"E- M7,]'G+I>X!&&J:8:<>O_LY(T%BZ5!)._'6\J%4LT7SQ&#JF M_#4O^-D/ENB20 ?-\F+&\I %W)-0NBZPEV@C*6S>/_ 8#A3C>OZPH@VT8,.E M./R8-'MLT4&P?,<2RUA"P%G]BX> [VI/4X]YE$LFM<^-5@2*PD H,']TY 9: ML.FSZ(Z!:+2(>O]9HIV'Q>S"D4'=@ASH@G2+T*&B6Y!M'"O3SLCC6524.TJ= MJ[+4?GK&6!%^?_$UF#N:%4 S%PGK;@?!#I 5+G&<_(%D(IY2@L;.9%J[L;* MV?&N.DOOE'E_G(S,',\?;B08;VD8][NTJQQ\+[+0F$UQ$F;WIT5TEQL[T]J3 M65K>9SNMK'J5Z","Q\QMTLK+B.-#2)8!1R#%U72@D!MQ3'+M* M\ #7E/^_)JRW$$&$QX(VN;EG9V#=10%WG6W)C&TU\CDB/@@@\2D3DFNF*0E\ M)8" R@=OKHV:/KT<'0OW\$XX.0A8L]EM$(((SZ<>81H+ZGM<0NQZ6'O0A5HQ MR=]<&S4-:WKL@L,SLMH9C6MXXEZ41-=QX?PPS-*O<6[H^J.%0I-^U,U844)320GHL#2;!@+B6NO\!;6@>4C>U=AW[W; MI8&MTB]M]8=VCF-7,"RL9'<1"5S"&/=\9=A5"*Y(P*GY/S5_!?-E?\_2(AN6 M\FYUHTBG.]JD.R">^39 EMLIP!1@G+?8!$J&(! X MVP^QU[F=%Q>'X.%WIY^.K@;1&U0(-;$2_['-)=CAFB@$Z>RL;4 P]GSB(D84 M51[C4E/BLKI;O3C% M$PP:%U8K35W!I$2("P4)9KX?N',&\BI6WT+&#AV#1B]0Z5A]+_)]G2CK1!F" MHB+*[+'N@@!7TX!JGWL4:"69<6H@%U+-726^AM72]BQF)\HZ5C\45D=@=K:$ MAR70OJW DYBJP/@GBGC&;B'$2=_IQX-1$?7MX3#C?1O#*'/RVS!;<*C] MZQ4/OI49O"-)00PJ!8^>IL#>\P]VMLAT?O2$?5>H\H%8(<,]X MA4Q0)0./0 TD5U)[$C%W[BR;Y_-176"[(3XBW7Z40XM/=W+B%>4$GLD)'@34 MZ%JC9UU% T6DD1@<:3] @'D,S!5P;J1OYT))C<@)^ XV>?7-XG;]L966UXXG\MXPG&)0[- MW,*;:.P-YTXZ*O+"N,QF*(=6H+J*I=DLI\)IP'R.,?0#1BDA7"*@N,M5(-R MNG/WODQ76XX7^VQT=Q5EY]FOT^T 37R]P;Y\_]G M[UV;VT;.1.&_@O*>[)FIHB=]O\S4;E4WT$AT=D9V+,VF]OVR!9&0A0P%,@!I M6_GU;W<#($%1LFZ@!)*H2CPB2 #=3S_W*Z%=&EF]I,_C1=.6PS 4(%*A$"X[ MC(81T-9^B0QDKEA,":9W($:Z1%,J7V5 ]9NAZ9N&[/8A<#OL^R#V?4Q[/=8S M/LI]'X'#R7_Z6L'S8C:=_-),-QW/KN=%>I7F9?8E];D9/^]SFDY?R..0@7"T M&Q].?P#"HT&U_1#/?+UX)A7DF"O>]R-P.1!,CPBF-4GJ".O&CY=@^J0I M# RA/PR!07G,U=?'RQ &@GDFP;1248^PAGD_"*9CUV6/C=1E7J3VB?]*)\'G M),N#'YS5^F-@\3;YDF33Y&*:OK?X\;ZT6!-D^9>T7%RG^6)H6WV+JEN)L88) M("*BJ&" ,A!K' ,8F=BJQR"&="N+SGN,P[;#>$WDJCF$>%:?+MQ3;H]S)F.VU9TKM8\U&C+EL+I,@9GS6F/L9-V3^TFBV"I?59@\:M(\_%-L"B2O)SZ:5-!LD*V MEQ+^(T>R[QO]<]1JB$^5C+3D "-**8F44-(P(PGE2J+M85_?H__Z5,+Z4,[= MF50K4/GD?'U".S"<'E5S"#LM3GHD1PHPJL.(*:H8$%(+ M0S6*.9!$F.C-R&$'H;E.:RP.A1H./6QW\),L.6T-'F(QBHP5;H!@&G,I.8-Q M3)! / 28;M67O*9PZUC5A9U.O]L;56%?0=K/)5#50$1K33=HXO1X4][F,^\)"!ASR/ MAPB(UYU.!(@Y-SKB1E <669"$0(42VMB2;6=D_XT'K*3A%N(=N?G&GC(T<1V M!^8Y,,_G,$^\9IXTQ!I'ANH((TH(EII;@U;%'"%&D=K*PWJR M9](AI(B;#14*$)&$1TB#E3X8@6L^WQM)%]U M*.XA\Q#O$_OSPB65K*[[?UO+F&9Y^KYIJ8' GV[O"MA=M98Z3BT.%-65++>* MU,+_XO':U.W5WY]JU+]%GJ5ID(Q=;XPDO[&O#_+9(BV#QN*ZN%YF>9*/[;/L2^P%GWG^T]8NF\W?WO7VCMX]"2J0/0@6(KJ "[F%>_[? MJZ)YPCSYG+Z_*-+DC_?)I5W!S\GT:W)3VO?\^:JH(9!X+E8J1F,C$4*&ABZ# M2H58(BQEK(4*$53NGF0#="^ A_/-9Y/=UN$.-78-GUK/ !#L>E4_M6%8;F5_-)G9L@.E%_.?UP=GX2GHV" MD]-P&]\/8L?AA]/(G)Z9*+!_G7WX]22RFX\.9N?\^3Y22S[+OOXNB'+ \65[-EF>23"RHWB-8A@G$ZG];>^4[W[;%\Y;C[?L?#S[-K*Q]/T:_!I=IUL.5VN MD^)SEE?+2Y:+67.A4KG\E:_99'%E?VV!7.M6]IBGR;Q,?V[^^.6V)O5N%0A< M!;CYN_O#A-4K./G3+^^VE,KZ]=_YZGO?[?*)O6HO^5II-^PU\Q2VN%(W#=9. M+@KL_[K-T;A7_B[0(,!@-$!B0_7%'O8MT MX;='!>=W'@!S-V#$T(*T!D:8E%>!(\HRN"QFU\%LGCH-/?\<.'?@%U\3-;0C M'7HQ=CXN&?20/H9>C'W/-68 YA2289&4GU/$A[HI3?TPH <^DCUG5ZZUC_[ M*6#751H^EE>D%J'&V30-\EKRNJON[[%33)CT-+WRN^C$29<5Q_UGS8\4G/WDV:K%HH/99:N/ M:##)RK'=U8N;Y>R17O$HZTZNB3!B3 D$PP@Q1+6KO$81U0+P& &DY%93QI,5 M=%<)J.T#^' 9U3!7^>1CD5YGR^M=LGX"7J5WZ'X8A,>,TQRPM8G.Y _IMIG3?N/T09D7YI_+;''S_B*I M'J]IP=':M, @QM+$,A:Q%4.66H54$( (A)Q:^;15"N'G(FL'Q[ %QEU*&CDB MX""TPB- +-)J+,,-(9%@0&A,N0 20\-%',9:*@71EI'Q:,3JSMQ (\*[;%@V MV!NO:F],THNUI>&=1EE9+I-\G%JD*8=A!K=HD[5LCQ!S'5NV&FM-(ZX4"^-0 M8!Z"* )@NX>9&H^+U#W3?'.4F>Z2W?,1[C0$VS_'[3$C(:>M+M'0: @1"F-. M0R0?=F_>4ZN2:ZJ! 4$L>13&0U%"J:(A<7V86$R6YVFI&^Y:J+--%"5\E*X?R+OM7[07;WT\\$ZWD%8 XD5&$",3:HA@7 MD98Q8Q!SHN(0;"5[/1G/=M'9OTN]H_^11LD&N*9%'Q#B1@&,FJ %08XRX5LI(24E(MX8Z;5-B ^4L?7DUSW?X>U!6Q\HL]67U^B%<$RULI1 M(R5"Z)@:$PD#XA!&VU/2MNFS!FZ47J9%D4[J,)'*)WYF3>5)W*G@@<.XI$-$ M4K*>_D$9CXFARD"-*#%<(QUJ95@H9!@*\P@#^9E(VIET0?#X3.;C\(@WN!;\ MT#C$?W0>\6F67&33H0YS7[VNPP'U_( .2D%=N<7GR/$?D-3#]6(-VM0UP<@M?Q$%#L :T2 KA.RN$\ M-DS% D4AIU%H))8AAHP(C",N0M8%CNW Q8VZ'$EPG*ID;Z5 L4PG;=UQU)FO M8I^4E,=1,EY7P*%0A9HR186"%&DI0V((HX!#Q260CXA757;@)CE;\[ ^DE_7 M)_(JN7=H!&&7#7[VW!EYW'A.8:LCA5"8019BS:EP0HH#P(26"@E R".\=2_! M\QW,ANY2;]IS)#\T@\:+LLPUJ$W+0TT ?Y!V^3H2)I#B6B*")8-4("@))2*. MI$!A1$W\"&WSI 9F3;:GZ>)5A!$<63EZ="KG(:#G0]@I6GD&H3 B5AA$!E$! M0F&M<>Y2Q@U1,@RW>AT]$SN[JR*57:)D_[U8>VW8-&&7H$B_I/FR"L!FOO?$ ML6E[#Y"DE1@KDE11R'E$I*O>H,I0S5D8 FVDXH2'^!&I$Z%=@GO1W[/%5;@L M[3[3HE'Q;G8:DWV5CAY[X2C;.PQ]2*>!J.6E-4CAR&!,":"156]@S% );CZ-4U^H(A[*4*V*DL9@)QA1;D"%(=(<8XC^Q^& MN(B1W/(YOX@B=I#J@$<$][?A;;\HXDTG5[[V%+ZJZ776Z12^7<"EK\/V]GVO MQY%;_G%9C*^LS5&ZSEI=-=,Z.(;P#\7+[O+YH%T MQ/!0UW"@9DPQLXN=U*9[:?&AW)54V3O-\"&J1FMGGC5F@,:,$K@W88POUL\2G>?^6+!R<;SY%^_)UY _$HU>: M8#7D!KT%MK9*MY_J*M1V;.YCU4@ZMDGSF=1@]N+@)?J@S?GZ\,W0YZ)&;I"W7I"VD B$C M%#.K-0(8"\*U(3@28408B[<*D^Y)83AIH-YA4L_W:!J.".O2G]$_W?&@$?0A M;QL!9&WIA%089K$G)( B'"L90AH3'44(:DBWO, OPM#NDVRP59I$?Y-L^NN3 M.X0\FLLL3_+QD$=SK'L]1@?T:ESI[-)5!EW/W)-FXS^.3<8]).)8N\Z/&@$C M1! *:8A#):@V7!E F"8J_JXS[Z0&]X?+T /[S,%ZIT[F$69#_>G!HF5KEFD4 M6@2T)KYD.J(*(,4B$;M2M4@B&85;"?_/04Y<'I*^U"!,<1HB/ CF]XV9%8$VOY,+'J MP]J>&,_*Q:X3$0].IY-K"P-PA)"62 "74!Q)920.8QA'(8Z@B;=SO6H:_W#I MU+C&[1NZ4]@; ?+L\]X+R7-PV/R0R&)PK199Z\29R)0IEX>KA ATJYRG0G. M0[:5W_0T=.Y.5HVD?,W,VJ-,(MFGA,:[,D?>0 -]\W9,#Y$Z;B6**0XX0UA% M#%&KMJH0$<,(53'7L0);E?WW)(K%#>1?)Y61C5"W1?Y==$W:.TNI]WC:&K<+ MN9L(S94F"E-(D;!&% XEC2E',-R>B_8B/.W.B8;HB.XBC[YGF-JU^;2;I+6K M*NT0NL[0?4G6&P!RC YS'S>W#'"J7V"N;Q,Q][-D'X;7R7YYS0HDD4:6!;O M=+8C=0KR5GX^9B:."<:<&4F%9A) 1NW/L';5R73+PJH@^N'2U/#\9,'Y(7<2 MSOW?_'.9?;'BR)I@G])R463C13IQ7ZA\LGFA]!2H#->^K]! M!(V,*:"*+C[/)]O2/\73IP-26J)64W6G?/C9BO,MFL0?K9^L#RK:JUW&H MC?T_(*'4E*!8<_L9(AP)S(D46[;'FZ-L=\G/> 3!0:3:]U,SZU@$A?>)G5%P MD7[.\MQ%>F:7P=SCV!#P?1)'$'#-$8"F$*LXHL8:<:'+BF:&X!#06!N@S%;Z M0I?&VHDG<-)%4(B-$.LT877(<#@DA$=K]UNHJ8H!)A!03)G44FO@_HQP3 7A MW8K .Q">=X+P2(PLW1XUPA^2Q?4=<9?:JP\(NB<<++8'.YDM7>703OJM=0&, M_[/+7?:<49&UW+"!(NH=IRKG;-J*RUV &CDF@D M<:=S11XZZ;>4P ,E'@PEMDI%) D1=HX=#C@-%=!12$B,(8#/OF?FZKK_M[6<:9:G[QOO, )_NHV'+HV_M>2Q/9NT MJ*YD^<1^\K]X_"9NX^+]6^C?(L_2-$C&;FQYDM\XR]M5'9?!8N9PU;ZF]$/- MNC0>H*JNZ"G%RZJMI=JIEA]Z6YMDF;:>32^+YY?@>7;L\(/\W;L.K5O M56%H?C6?U+D)HA/UE],/9^GO)OKQ,'?^>YXL M)YD5&WT7@S]D>;"XFBU=YY9R=1BM=6XH\*M%M9;0WD@-I;8Z#$&E_%9S L;I M=%I_^Q_OP#O_V;YRW'R^8^'GV;65RZ?IU^#3[#K9ZM5XG12?L[Q:7K)2O[O?2U.]@I,_ M_?)N2].L7_^=K[[WW2Z?^*;NIK?J-\I>,R2ZQ96ZZ3%[:FDN^,U>ORH#8TGQ M+B?:41[N6S23W?UQGZ5S:W!96W"4A9_E['WBZ:Q;(2]NO[QA23RB*ZRWK.4H(/4\*P3Z2U+O_/'>=M2ZM MQ)U=6B(J%\72NSSKUHV6JO+%K+AQ#M-Y,9O;;=[X:*\+],[=+U]01K#7P:*] MB 4AP-933T/%74MA1"@6- ICJ8!4D0P%B!4Q?+/SZTES\@U^%.ED,8NS;^E$ ME67:<<>7K7:O"-%#2'@<**$_E-!*?[?BPQ("9AQC3"G&DO%80!%BHY@*V

  •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end XML 29 R27.htm IDEA: XBRL DOCUMENT v3.19.3
    Fair Value of Financial Instruments (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Fair Value Disclosures [Abstract]  
    Schedule of Fair Value Measurement
    The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30, 2019
     
    Quoted Prices
    in Active
    Markets for
    Identical
    Assets
    (Level 1)
    Significant
    Other
    Observable Inputs
    (Level 2)
    Significant
    Unobservable
    Inputs
    (Level 3)
    Total
    Assets:
     
     
     
     
    Cash and cash equivalents:
     
     
     
     
    Money market funds
    $
    69,750

    $
    —

    $
    —

    $
    69,750

    Total cash and cash equivalents
    $
    69,750

    $
    —

    $
    —

    $
    69,750

    Investments:
     
     
     
     
    Certificates of deposit
    —

    4,183

    —

    4,183

    U.S. Treasury securities
    12,001

    —

    —

    12,001

    U.S. Agency securities
    —

    1,505

    —

    1,505

    Asset-backed securities
    —

    1,107

    —

    1,107

    Corporate notes and bonds
    —

    10,182

    —

    10,182

    Total investments
    12,001

    16,977

    —

    28,978

    Total assets measured at fair value
    $
    81,751

    $
    16,977

    $
    —

    $
    98,728


     
    December 31, 2018
     
    Quoted Prices
    in Active
    Markets for
    Identical
    Assets
    (Level 1)
    Significant
    Other
    Observable Inputs
    (Level 2)
    Significant
    Unobservable
    Inputs
    (Level 3)
    Total
    Assets:
     
     
     
     
    Cash and cash equivalents:
     
     
     
     
    Money market funds
    $
    38,444

    $
    —

    $
    —

    $
    38,444

    Commercial paper
    —

    1,493

    —

    1,493

    Total cash and cash equivalents
    38,444

    1,493

    —

    39,937

    Investments:
     
     
     
     
    Certificates of deposit
    —

    10,787

    —

    10,787

    U.S. Treasury securities
    22,120

    —

    —

    22,120

    U.S. Agency securities
    —

    7,980

    —

    7,980

    Commercial paper
    —

    17,025

    —

    17,025

    Asset-backed securities
    —

    11,998

    —

    11,998

    Corporate notes and bonds
    —

    30,308

    —

    30,308

    Total investments
    22,120

    78,098

    —

    100,218

    Total assets measured at fair value
    $
    60,564

    $
    79,591

    $
    —

    $
    140,155

    XML 30 R23.htm IDEA: XBRL DOCUMENT v3.19.3
    Related Party Transactions
    		 9 Months Ended
    Sep. 30, 2019
    Related Party Transactions [Abstract]  
    Related Party Transactions
    NOTE 17. RELATED PARTY TRANSACTIONS

    As discussed in Note 10, Convertible Notes the Company issued Notes in March 2018. As part of this issuance, an entity controlled by one member of the Company's board of directors purchased an aggregate of $30.0 million of the Notes. In May 2019, this affiliate purchased an additional $10.0 million of Notes on the open market. The affiliated entity is a Qualified Institutional Buyer which purchased and holds an aggregate of $40.0 million of the Notes at September 30, 2019.

    On August 20, 2019, the Company and an entity affiliated with the Chief Operating Officer of the Company entered into a securities purchase agreement (the “Purchase Agreement”) for the issuance and sale by the Company of an aggregate of 55,586 shares of the Company’s common stock (the “Shares”) in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The Shares were sold at a purchase price (determined in accordance with Nasdaq rules relating to the “market value” of the shares) of $17.99 per share, which was equal to the consolidated closing bid price reported by Nasdaq immediately preceding the time the Company entered into the Purchase Agreement. The $1.0 million of proceeds were recorded to contributed capital.
    XML 31 R42.htm IDEA: XBRL DOCUMENT v3.19.3
    Fair Value of Financial Instruments - Narrative (Details) - USD ($)
    Apr. 04, 2018
    Mar. 27, 2018
    Sep. 30, 2019
    Dec. 31, 2018
    Debt Instrument [Line Items]        
    Over-allotment option, term   13 days    
    Over-allotment option   $ 22,500,000    
    Additional proceeds $ 21,500,000      
    Unsecured obligations | 2.50% Convertible notes due 2023        
    Debt Instrument [Line Items]        
    Aggregate principal amount 171,500,000 $ 150,000,000.0    
    Interest rate   2.50%    
    Proceeds received $ 171,500,000      
    Fair value     $ 142,500,000 $ 121,400,000
    XML 32 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 33 R46.htm IDEA: XBRL DOCUMENT v3.19.3
    Inventory (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Dec. 31, 2018
    Inventory Disclosure [Abstract]    
    Raw materials $ 5,088 $ 4,064
    Work in process 1,604 495
    Finished goods 1,189 3,187
    Inventory $ 7,881 $ 7,746
    EXCEL 34 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 35 R65.htm IDEA: XBRL DOCUMENT v3.19.3
    Industry, Geographic and Revenue Disaggregation - Narrative (Details)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    USD ($)
    Sep. 30, 2018
    USD ($)
    Sep. 30, 2019
    USD ($)
    segment
    Sep. 30, 2018
    USD ($)
    Dec. 31, 2018
    USD ($)
    Segment Reporting [Abstract]          
    Number of operating segments | segment     1    
    Segment Reporting Information [Line Items]          
    Trade accounts receivable $ 2,642   $ 2,642   $ 1,860
    Lease Income $ 200   $ 600    
    Lease income   $ 200   $ 400  
    Geographic concentration | Foreign | Total revenue          
    Segment Reporting Information [Line Items]          
    Risk concentration 23.00% 14.00% 26.00% 22.00%  
    Geographic concentration | Foreign | Net accounts receivable          
    Segment Reporting Information [Line Items]          
    Trade accounts receivable $ 1,500   $ 1,500   $ 900
    XML 36 R61.htm IDEA: XBRL DOCUMENT v3.19.3
    Income Taxes (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Income Tax Disclosure [Abstract]        
    Benefit (provision) for income taxes $ 239,000 $ (147,000) $ 0 $ (432,000)
    Pre-tax loss $ (20,673,000) $ (21,951,000) $ (62,970,000) $ (65,703,000)
    XML 37 R57.htm IDEA: XBRL DOCUMENT v3.19.3
    Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) - USD ($)
    $ / shares in Units, $ in Thousands
    		 9 Months Ended
    Sep. 30, 2019
    Dec. 31, 2018
    Options Outstanding    
    Number of options (shares) 10,159,345 8,090,636
    Weighted average remaining contractual term (in years) 6 years 1 month 20 days  
    Weighted average exercise price (dollars per share) $ 12.34 $ 12.22
    Weighted average fair value (dollars per share) $ 8.01  
    Aggregate intrinsic value (in thousands) $ 76,923  
    Options Exercisable    
    Number of options (shares) 6,137,856  
    Weighted average remaining contractual term (in years) 4 years 3 months 25 days  
    Weighted average exercise price (dollars per share) $ 9.03  
    Weighted average fair value (dollars per share) $ 6.06  
    Aggregate intrinsic value (in thousands) $ 65,271  
    XML 38 R6.htm IDEA: XBRL DOCUMENT v3.19.3
    CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
    $ in Thousands
    Total
    Common stock
    Contributed capital
    Accumulated deficit
    Treasury stock
    Accumulated other comprehensive (loss) income
    Beginning Balance (shares) at Dec. 31, 2017   55,674,000        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Exercise of options (shares)   360,000        
    Issuance of common stock under employee purchase plan (shares)   22,000        
    Repurchase of common stock under Prepaid Forward contract (shares)   (1,859,000)        
    Ending Balance (shares) at Sep. 30, 2018   54,197,000        
    Beginning Balance, amount at Dec. 31, 2017   $ 56 $ 360,620 $ (241,972) $ 0 $ 0
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Proceeds from issuance of common stock $ 447          
    Exercise of options     3,710      
    Repurchase of common stock under Prepaid Forward contract   (2)     (45,067)  
    Issuance of common stock under employee purchase plan     447      
    Issuance of convertible note     53,283      
    Equity-based compensation     12,674      
    Net loss (66,135)     (66,135)    
    Unrealized loss on available-for-sale securities (54)         (54)
    Foreign currency translation adjustment (105)         (105)
    Ending Balance, amount at Sep. 30, 2018 77,406 $ 54 430,734 (308,156) (45,067) (159)
    Beginning Balance (shares) at Jun. 30, 2018   54,091,000        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Exercise of options (shares)   98,000        
    Issuance of common stock under employee purchase plan (shares)   8,000        
    Ending Balance (shares) at Sep. 30, 2018   54,197,000        
    Beginning Balance, amount at Jun. 30, 2018   $ 54 426,091 (286,058) (45,067) (134)
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Exercise of options     954      
    Issuance of common stock under employee purchase plan     171      
    Equity-based compensation     3,518      
    Net loss (22,098)     (22,098)    
    Unrealized loss on available-for-sale securities 1         1
    Foreign currency translation adjustment (26)         (26)
    Ending Balance, amount at Sep. 30, 2018 $ 77,406 $ 54 430,734 (308,156) (45,067) (159)
    Beginning Balance (shares) at Dec. 31, 2018   54,232,000        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Proceeds from issuance of common stock (shares)   56,000        
    Exercise of options (shares) 327,215 334,000        
    Issuance of common stock under employee purchase plan (shares)   19,000        
    Ending Balance (shares) at Sep. 30, 2019   54,641,000        
    Beginning Balance, amount at Dec. 31, 2018 $ 57,375 $ 54 432,885 (330,348) (45,067) (149)
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Proceeds from issuance of common stock 1,363          
    Exercise of options   1 4,879      
    Issuance of common stock under employee purchase plan     362      
    Equity-based compensation     9,483      
    Net loss (62,970)     (62,970)    
    Unrealized loss on available-for-sale securities 229         229
    Foreign currency translation adjustment (139)         (139)
    Ending Balance, amount at Sep. 30, 2019 10,220 $ 55 448,609 (393,318) (45,067) (59)
    Beginning Balance (shares) at Jun. 30, 2019   54,512,000        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Proceeds from issuance of common stock (shares)   56,000        
    Proceeds from issuance of common stock     1,000      
    Exercise of options (shares)   66,000        
    Issuance of common stock under employee purchase plan (shares)   7,000        
    Ending Balance (shares) at Sep. 30, 2019   54,641,000        
    Beginning Balance, amount at Jun. 30, 2019   $ 55 443,857 (372,884) (45,067) 44
    Increase (Decrease) in Stockholders' Equity [Roll Forward]            
    Exercise of options     510      
    Issuance of common stock under employee purchase plan     112      
    Equity-based compensation     3,130      
    Net loss (20,434)     (20,434)    
    Unrealized loss on available-for-sale securities 10         10
    Foreign currency translation adjustment (113)         (113)
    Ending Balance, amount at Sep. 30, 2019 $ 10,220 $ 55 $ 448,609 $ (393,318) $ (45,067) $ (59)
    XML 39 R2.htm IDEA: XBRL DOCUMENT v3.19.3
    CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Dec. 31, 2018
    Current assets:    
    Cash and cash equivalents $ 92,938 $ 66,260
    Investments 28,978 100,218
    Trade accounts receivable 2,642 1,860
    Inventory 7,881 7,746
    Prepaid expenses 1,163 980
    Other current assets 793 576
    Total current assets 134,395 177,640
    Property and equipment, net 8,566 7,303
    Right of use assets 3,834  
    Other non-current assets 483 322
    Total assets 147,278 185,265
    Current liabilities:    
    Accounts payable 2,281 1,322
    Accrued liabilities 2,985 4,962
    Accrued interest 191 1,262
    Deferred revenue 250 217
    Current operating lease liability 421  
    Total current liabilities 6,128 7,763
    Non-current operating lease liability 3,458  
    Other non-current liabilities 28 53
    Convertible notes 127,444 120,074
    Total liabilities 137,058 127,890
    Commitments and contingencies
    Stockholders’ equity:    
    Preferred shares 0 0
    Common stock 55 54
    Contributed capital 448,609 432,885
    Treasury stock (45,067) (45,067)
    Accumulated deficit (393,318) (330,348)
    Accumulated other comprehensive loss (59) (149)
    Total stockholders’ equity 10,220 57,375
    Total liabilities and stockholders’ equity $ 147,278 $ 185,265
    XML 40 R53.htm IDEA: XBRL DOCUMENT v3.19.3
    Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) - shares
    shares in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
    Antidilutive common stock instruments outstanding (shares) 10,179 8,248 10,179 8,248
    Shares issuable upon the release of restricted stock awards        
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
    Antidilutive common stock instruments outstanding (shares) 20 66 20 66
    Shares issuable upon exercise of stock options        
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
    Antidilutive common stock instruments outstanding (shares) 10,159 8,182 10,159 8,182
    XML 41 R15.htm IDEA: XBRL DOCUMENT v3.19.3
    Deferred Revenue and Remaining Performance Obligations
    		 9 Months Ended
    Sep. 30, 2019
    Deferred Revenue Disclosure [Abstract]  
    Deferred Revenue and Remaining Performance Obligations
    NOTE 9. DEFERRED REVENUE AND REMAINING PERFORMANCE OBLIGATIONS

    Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred revenue consists of amounts received for commitments not yet fulfilled. If we anticipate revenue will not be earned within the following twelve months, the amount is reported as other non-current liabilities. A summary of the balances as of September 30, 2019 and December 31, 2018 follows (in thousands):
     
    September 30,
    December 31,
     
    2019
    2018
    Products and services not yet delivered
    $
    250

    $
    217



    We recognized $0.2 million and $0.3 million of revenues that were included in the beginning contract liabilities balances during the three and nine months ended September 30, 2019, respectively. We recognized $30,000 and $65,000 of revenues that were included in the contract liabilities balances during the three and nine months ended September 30, 2018, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.
    Transaction Price Allocated to Remaining Performance Obligations
    As of September 30, 2019, $2.5 million of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed service contracts that begin as warranty periods expire. These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically on a straight-line basis.
    The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
    XML 42 R11.htm IDEA: XBRL DOCUMENT v3.19.3
    Investments
    		 9 Months Ended
    Sep. 30, 2019
    Investments, Debt and Equity Securities [Abstract]  
    Investments
    NOTE 5. INVESTMENTS

    The following tables summarize the Company’s available-for-sale investments at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30, 2019
     
    Amortized
    Cost
    Gross
    Unrealized
    Gains
    Gross
    Unrealized
    Losses
    Fair Value
    Certificates of deposit
    $
    4,163

    $
    21

    $
    (1
    )
    $
    4,183

    U.S. Treasury securities
    11,975

    26

    —

    12,001

    U.S. Agency securities
    1,505

    —

    —

    1,505

    Asset-backed securities
    1,107

    —

    —

    1,107

    Corporate notes and bonds
    10,170

    12

    —

    10,182

    Total
    $
    28,920

    $
    59

    $
    (1
    )
    $
    28,978


     
    December 31, 2018
     
    Amortized
    Cost
    Gross
    Unrealized
    Gains
    Gross
    Unrealized
    Losses
    Fair Value
    Certificates of deposit
    $
    10,787

    $
    —

    $
    —

    $
    10,787

    U.S. Treasury securities
    22,185

    1

    (66
    )
    22,120

    U.S. Agency securities
    8,024

    1

    (45
    )
    7,980

    Commercial paper
    17,025

    —

    —

    17,025

    Asset-backed securities
    12,007

    —

    (9
    )
    11,998

    Corporate notes and bonds
    30,361

    —

    (53
    )
    30,308

    Total
    $
    100,389

    $
    2

    $
    (173
    )
    $
    100,218



    The following table summarizes the maturities of the Company’s available-for-sale securities at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30, 2019
    December 31, 2018
     
    Amortized
    Cost
    Fair Value
    Amortized
    Cost
    Fair Value
    Due in less than 1 year
    $
    28,920

    $
    28,978

    $
    83,030

    $
    82,893

    Due in 1-3 years
    —

    —

    17,359

    17,325


    $
    28,920

    $
    28,978

    $
    100,389

    $
    100,218



    There were no sales of marketable securities for the three months ended September 30, 2019 and 2018. Proceeds from sales of marketable securities (including principal paydowns) for the for the nine months ended September 30, 2019 and 2018 were $13.4 million and $3.0 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no material realized gains from sales of marketable securities for the three and nine months ended September 30, 2019 and 2018. No material balances were reclassified out of accumulated other comprehensive loss for the three and nine months ended September 30, 2019 and 2018.

    The Company monitors investments for other-than-temporary impairment. It was determined that unrealized gains and losses as of September 30, 2019 and December 31, 2018 are temporary in nature because the change in market value for those securities has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.
    XML 44 R19.htm IDEA: XBRL DOCUMENT v3.19.3
    Income Taxes
    		 9 Months Ended
    Sep. 30, 2019
    Income Tax Disclosure [Abstract]  
    Income Taxes
    NOTE 13. INCOME TAXES

    For the three months ended September 30, 2019, the Company recorded an income tax benefit amount of $0.2 million to reverse the foreign income tax expense recorded in prior quarters as the Company no longer expects to pay current year income taxes in any of the foreign jurisdictions. For the nine months ended September 30, 2019, the Company did not carry an income tax provision amount as the Company does not recognize tax benefits from current year tax losses in the U.S. and other foreign jurisdictions. The Company’s tax expense for the three and nine
    months ended September 30, 2019 differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of $20.7 million and $63.0 million, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At September 30, 2019, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards and a deferred tax liability related to amortization of the Notes. The Company provided a valuation allowance against its net deferred tax assets as future realization of such assets is not more likely than not to occur.

    The Company accounts for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, Income Taxes. For the three and nine months ended September 30, 2019, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax positions within the next 12 months.
    XML 45 R32.htm IDEA: XBRL DOCUMENT v3.19.3
    Convertible Notes (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Debt Disclosure [Abstract]  
    Convertible Notes
    The Notes at September 30, 2019 and December 31, 2018 consisted of the following (in thousands):
     
    September 30,
    December 31,
     
    2019
    2018
    Outstanding principal
    $
    171,500

    $
    171,500

    Unamortized debt discount
    (41,490
    )
    (48,430
    )
    Unamortized debt issuance
    (2,566
    )
    (2,996
    )
    Net carrying amount of the liability component
    127,444

    120,074
    XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.3
    Industry, Geographic and Revenue Disaggregation (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Segment Reporting [Abstract]  
    Disaggregation of Revenue
    The following presents total net sales by geographic territory for the three and nine months ended September 30, 2019 and 2018 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
    2018
     
    2019
    2018
    Domestic
    $
    1,757

    $
    1,172

     
    $
    4,308

    $
    2,988

    Foreign
    514

    183

     
    1,519

    860

     
    $
    2,271

    $
    1,355

     
    $
    5,827

    $
    3,848



    The following presents total net sales by line of business for the three and nine months ended September 30, 2019 and 2018 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
    2018
     
    2019
    2018
    Accelerate Pheno™ revenue
    $
    2,221

    $
    1,325

     
    $
    5,702

    $
    3,760

    Other revenue
    50

    30

     
    125

    88

     
    $
    2,271

    $
    1,355

     
    $
    5,827

    $
    3,848


    The following presents total net sales by products and services for the three and nine months ended September 30, 2019 and 2018 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
    2018
     
    2019
    2018
    Products
    $
    2,143

    $
    1,331

     
    $
    5,531

    $
    3,798

    Services
    128

    24

     
    296

    50

     
    $
    2,271

    $
    1,355

     
    $
    5,827

    $
    3,848
    Long-lived Assets by Geographic Territory
    The following presents property and equipment, net by geographic territory (in thousands):
     
    September 30,
    December 31,
     
    2019
    2018
    Domestic
    $
    7,726

    $
    6,309

    Foreign
    840

    994

     
    $
    8,566

    $
    7,303
    XML 48 R29.htm IDEA: XBRL DOCUMENT v3.19.3
    Inventory (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Inventory Disclosure [Abstract]  
    Components of Inventories
    Inventories consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30,
    December 31,
     
    2019
    2018
    Raw materials
    $
    5,088

    $
    4,064

    Work in process
    1,604

    495

    Finished goods
    1,189

    3,187


    $
    7,881

    $
    7,746
    XML 49 R25.htm IDEA: XBRL DOCUMENT v3.19.3
    Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Accounting Policies [Abstract]  
    Schedule of Product Warranty Reserve Activity
    Warranty reserve activity for the three and nine months ended September 30, 2019 and 2018 is as follows (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
    September 30,
     
    September 30,
    September 30,
     
    2019
    2018
     
    2019
    2018
    Beginning balance
    $
    196

    $
    199

     
    $
    215

    $
    192

    Provisions
    77

    128

     
    147

    394

    Warranty incurred
    (51
    )
    (138
    )
     
    (140
    )
    (397
    )
    Ending balance
    $
    222

    $
    189

     
    $
    222

    $
    189
    XML 50 R21.htm IDEA: XBRL DOCUMENT v3.19.3
    Leases
    		 9 Months Ended
    Sep. 30, 2019
    Leases [Abstract]  
    Leases
    NOTE 15. LEASES

    The following presents supplemental information related to our leases in which we are the lessee for the three and nine months ended September 30, 2019 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
     
    2019
    Cash paid for amounts included in lease liabilities
     
     
     
    Operating cash flows from operating leases
    $
    168

     
    $
    333

    ROU assets obtained in exchange for lease obligations
     
     
     
    Operating leases
    $
    3,639

     
    $
    3,639

    Lease Cost
     
     
     
    Operating leases
    $
    213

     
    $
    378

    Short-term leases
    $
    103

     
    $
    697



    The weighted average remaining lease term on our operating leases is 5.6 years. The weighted average discount rate on those leases is 7.1%. Rent expense including common area charges was $0.3 million and $1.0 million for the three and nine months ended September 30, 2018, respectively.

    The following presents maturities of operating lease liabilities in which we are the lessee as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    180

    2020
    637

    2021
    687

    2022
    818

    2023
    913

    Thereafter
    1,583

    Total lease payments
    4,818

    Less imputed interest
    (939
    )
     
    $
    3,879



    The net investment in sales-type leases, where we are the lessor, is a component of other current assets and other non-current assets in our condensed consolidated balance sheet. As of September 30, 2019, the total net investment in these leases was $0.6 million. The following presents maturities of lease receivables under sales-type leases as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    62

    2020
    197

    2021
    139

    2022
    106

    2023
    53

    Thereafter
    13

    Total undiscounted cash flows
    570

    Less imputed interest
    (3
    )
    Present value of lease payments
    $
    567
    Leases
    NOTE 15. LEASES

    The following presents supplemental information related to our leases in which we are the lessee for the three and nine months ended September 30, 2019 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
     
    2019
    Cash paid for amounts included in lease liabilities
     
     
     
    Operating cash flows from operating leases
    $
    168

     
    $
    333

    ROU assets obtained in exchange for lease obligations
     
     
     
    Operating leases
    $
    3,639

     
    $
    3,639

    Lease Cost
     
     
     
    Operating leases
    $
    213

     
    $
    378

    Short-term leases
    $
    103

     
    $
    697



    The weighted average remaining lease term on our operating leases is 5.6 years. The weighted average discount rate on those leases is 7.1%. Rent expense including common area charges was $0.3 million and $1.0 million for the three and nine months ended September 30, 2018, respectively.

    The following presents maturities of operating lease liabilities in which we are the lessee as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    180

    2020
    637

    2021
    687

    2022
    818

    2023
    913

    Thereafter
    1,583

    Total lease payments
    4,818

    Less imputed interest
    (939
    )
     
    $
    3,879



    The net investment in sales-type leases, where we are the lessor, is a component of other current assets and other non-current assets in our condensed consolidated balance sheet. As of September 30, 2019, the total net investment in these leases was $0.6 million. The following presents maturities of lease receivables under sales-type leases as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    62

    2020
    197

    2021
    139

    2022
    106

    2023
    53

    Thereafter
    13

    Total undiscounted cash flows
    570

    Less imputed interest
    (3
    )
    Present value of lease payments
    $
    567
    XML 51 R67.htm IDEA: XBRL DOCUMENT v3.19.3
    Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Dec. 31, 2018
    Segment Reporting Information [Line Items]    
    Long-lived assets (excluding intangible assets) $ 8,566 $ 7,303
    Property and equipment | Geographic concentration    
    Segment Reporting Information [Line Items]    
    Long-lived assets (excluding intangible assets) 8,566 7,303
    Property and equipment | Geographic concentration | Domestic    
    Segment Reporting Information [Line Items]    
    Long-lived assets (excluding intangible assets) 7,726 6,309
    Property and equipment | Geographic concentration | Foreign    
    Segment Reporting Information [Line Items]    
    Long-lived assets (excluding intangible assets) $ 840 $ 994
    XML 52 R63.htm IDEA: XBRL DOCUMENT v3.19.3
    Leases - Maturities of Lease Liabilities (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Jan. 01, 2019
    Leases [Abstract]    
    Remainder of 2019 $ 180  
    2020 637  
    2021 687  
    2022 818  
    2023 913  
    Thereafter 1,583  
    Total lease payments 4,818  
    Less imputed interest (939)  
    Total $ 3,879 $ 600
    XML 53 R40.htm IDEA: XBRL DOCUMENT v3.19.3
    Concentration of Credit Risk (Details)
    		 3 Months Ended 9 Months Ended 12 Months Ended
    Sep. 30, 2018
    Sep. 30, 2019
    Dec. 31, 2018
    Net accounts receivable | Customer concentration | Company A      
    Concentration Risk [Line Items]      
    Risk concentration   14.00% 10.00%
    Total revenue | Customer concentration | Company A      
    Concentration Risk [Line Items]      
    Risk concentration 20.00%    
    Total revenue | Customer concentration | Company B      
    Concentration Risk [Line Items]      
    Risk concentration 18.00%    
    Total revenue | Customer concentration | Company C      
    Concentration Risk [Line Items]      
    Risk concentration 17.00%    
    Financial institution A | Cash and cash equivalents | Concentration of credit risk      
    Concentration Risk [Line Items]      
    Risk concentration   71.00% 46.00%
    Financial institution B | Cash and cash equivalents | Concentration of credit risk      
    Concentration Risk [Line Items]      
    Risk concentration   26.00% 43.00%
    XML 54 R44.htm IDEA: XBRL DOCUMENT v3.19.3
    Investments - Schedule of Available-for-Sale Investment Maturities (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Dec. 31, 2018
    Amortized Cost    
    Due in less than 1 year $ 28,920 $ 83,030
    Due in 1-3 years 0 17,359
    Total 28,920 100,389
    Fair Value    
    Due in less than 1 year 28,978 82,893
    Due in 1-3 years 0 17,325
    Total $ 28,978 $ 100,218
    XML 55 R48.htm IDEA: XBRL DOCUMENT v3.19.3
    License Agreements and Grants - National Institute of Health Grant (Details) - National Institute of Health Grant - USD ($)
    $ in Thousands
    		 1 Months Ended 3 Months Ended 9 Months Ended 56 Months Ended
    Feb. 28, 2015
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Research and Development Arrangement, Contract to Perform for Others [Line Items]            
    Grant period 5 years          
    Total grant funding $ 5,000 $ 42 $ 69 $ 200 $ 200  
    Cumulative amount awarded           $ 1,300
    XML 56 R9999.htm IDEA: XBRL DOCUMENT v3.19.3
    Label Element Value
    Retained Earnings [Member]  
    Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (49,000)
    XML 57 R8.htm IDEA: XBRL DOCUMENT v3.19.3
    Recently Issued Accounting Pronouncements
    		 9 Months Ended
    Sep. 30, 2019
    Accounting Changes and Error Corrections [Abstract]  
    Recently Issued Accounting Pronouncements
    NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

    Standards that were recently adopted

    In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases, which together with subsequent amendments is included in ASC 842. ASC 842 requires a lessee to recognize a liability to make lease payments and an asset with respect to its right to use the underlying asset for the lease term. ASC 842 also addresses accounting and reporting by lessors, which is not significantly different from accounting and reporting under the prior standard, and further provides for qualitative and quantitative disclosures. We adopted ASC 842 on January 1, 2019 using the optional transition method allowed by ASU 2018-11. This optional transition method allowed the Company to apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. For contracts where we are the lessee, we recorded lease liabilities and right of use assets for contracts in effect on January 1, 2019 based on the facts and circumstances as of that date. The Company elected not to reassess whether any expired or existing contracts are or contain leases, not to reassess the lease classification for any expired or existing leases, not to reassess initial direct costs for any existing leases, and not to separate the lease components from the non-lease components for all classes of underlying assets. No cumulative-effect adjustment was recorded to the opening balance of retained earnings. We recognized right of use assets and lessee lease liabilities of $0.6 million with respect to operating leases where we are the lessee. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The adoption of ASC 842 did not have a material effect on our consolidated financial position, results of operations or cash flows.

    In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718); Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to ASC 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. The Company adopted ASU 2018-07 on January 1, 2019, which had no impact to our consolidated financial statements as all share-based awards granted to nonemployees are fully vested.

    In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) that the FASB refers to as having been stranded in AOCI. The Company adopted ASU 2018-02 on January 1, 2019, which had no impact to our consolidated financial statements as no amounts were reclassified from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act.

    In March 2017, the FASB issued ASU 2017-08, Receivable - Nonrefundable Fees and Other Costs (Topic 310-20); Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted ASU 2017-08 on January 1, 2019, which had no impact to our consolidated financial statements as we do not carry callable securities held at a premium.

    Standards not yet adopted

    In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820); Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. This ASU is effective for us on January 1, 2020, with early adoption permitted. We are currently assessing the impact this will have on our consolidated financial statements.

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which was subsequently clarified and amended by ASU 2019-05, ASU 2019-04 and ASU 2018-19. ASU 2016-13 amends the guidance on measuring credit losses on financial assets
    (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this will have a significant impact on our consolidated financial statements.
    XML 58 R59.htm IDEA: XBRL DOCUMENT v3.19.3
    Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
    Equity-based compensation expense $ 3,131 $ 3,465 $ 9,409 $ 12,476
    Cost of sales        
    Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
    Equity-based compensation expense 65 68 172 172
    Research and development        
    Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
    Equity-based compensation expense 897 1,476 3,226 3,926
    Sales, general and administrative        
    Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
    Equity-based compensation expense $ 2,169 $ 1,921 $ 6,011 $ 8,378
    XML 59 R55.htm IDEA: XBRL DOCUMENT v3.19.3
    Employee Equity-Based Compensation - Stock Option Activity (Details)
    		 9 Months Ended
    Sep. 30, 2019
    $ / shares
    shares
    Number of Shares  
    Outstanding, beginning balance (shares) | shares 8,090,636
    Granted (shares) | shares 2,883,596
    Forfeited (shares) | shares (420,098)
    Exercised (shares) | shares (327,215)
    Expired (shares) | shares (67,574)
    Outstanding, ending balance (shares) | shares 10,159,345
    Weighted Average Exercise Price per Share  
    Outstanding, beginning balance (dollars per share) | $ / shares $ 12.22
    Granted (dollars per share) | $ / shares 14.47
    Forfeited (dollars per share) | $ / shares 20.74
    Exercised (dollars per share) | $ / shares 14.91
    Expired (dollars per share) | $ / shares 23.41
    Outstanding, ending balance (dollars per share) | $ / shares $ 12.34
    XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 258 382 1 false 70 0 false 6 false false R1.htm 0001000 - Document - Cover Page Sheet http://acceleratediagnostics.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet CONDENSED CONSOLIDATED BALANCE SHEET Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 2101100 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Notes 7 false false R8.htm 2102100 - Disclosure - Recently Issued Accounting Pronouncements Sheet http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncements Recently Issued Accounting Pronouncements Notes 8 false false R9.htm 2103100 - Disclosure - Concentration of Credit Risk Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 9 false false R10.htm 2104100 - Disclosure - Fair Value of Financial Instruments Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 10 false false R11.htm 2105100 - Disclosure - Investments Sheet http://acceleratediagnostics.com/role/Investments Investments Notes 11 false false R12.htm 2106100 - Disclosure - Inventory Sheet http://acceleratediagnostics.com/role/Inventory Inventory Notes 12 false false R13.htm 2107100 - Disclosure - Property and Equipment Sheet http://acceleratediagnostics.com/role/PropertyAndEquipment Property and Equipment Notes 13 false false R14.htm 2108100 - Disclosure - License Agreements and Grants Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrants License Agreements and Grants Notes 14 false false R15.htm 2109100 - Disclosure - Deferred Revenue and Remaining Performance Obligations Sheet http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligations Deferred Revenue and Remaining Performance Obligations Notes 15 false false R16.htm 2110100 - Disclosure - Convertible Notes Notes http://acceleratediagnostics.com/role/ConvertibleNotes Convertible Notes Notes 16 false false R17.htm 2112100 - Disclosure - Earnings Per Share Sheet http://acceleratediagnostics.com/role/EarningsPerShare Earnings Per Share Notes 17 false false R18.htm 2113100 - Disclosure - Employee Equity-Based Compensation Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation Employee Equity-Based Compensation Notes 18 false false R19.htm 2114100 - Disclosure - Income Taxes Sheet http://acceleratediagnostics.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2115100 - Disclosure - Commitments Sheet http://acceleratediagnostics.com/role/Commitments Commitments Notes 20 false false R21.htm 2116100 - Disclosure - Leases Sheet http://acceleratediagnostics.com/role/Leases Leases Notes 21 false false R22.htm 2117100 - Disclosure - Industry, Geographic and Revenue Disaggregation Sheet http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregation Industry, Geographic and Revenue Disaggregation Notes 22 false false R23.htm 2118100 - Disclosure - Related Party Transactions Sheet http://acceleratediagnostics.com/role/RelatedPartyTransactions Related Party Transactions Notes 23 false false R24.htm 2201201 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) Policies http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies 24 false false R25.htm 2301302 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesTables Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) Tables http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies 25 false false R26.htm 2303301 - Disclosure - Concentration of Credit Risk (Tables) Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables Concentration of Credit Risk (Tables) Tables http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk 26 false false R27.htm 2304301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments 27 false false R28.htm 2305301 - Disclosure - Investments (Tables) Sheet http://acceleratediagnostics.com/role/InvestmentsTables Investments (Tables) Tables http://acceleratediagnostics.com/role/Investments 28 false false R29.htm 2306301 - Disclosure - Inventory (Tables) Sheet http://acceleratediagnostics.com/role/InventoryTables Inventory (Tables) Tables http://acceleratediagnostics.com/role/Inventory 29 false false R30.htm 2307301 - Disclosure - Property and Equipment (Tables) Sheet http://acceleratediagnostics.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://acceleratediagnostics.com/role/PropertyAndEquipment 30 false false R31.htm 2309301 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Tables) Sheet http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsTables Deferred Revenue and Remaining Performance Obligations (Tables) Tables http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligations 31 false false R32.htm 2310301 - Disclosure - Convertible Notes (Tables) Notes http://acceleratediagnostics.com/role/ConvertibleNotesTables Convertible Notes (Tables) Tables http://acceleratediagnostics.com/role/ConvertibleNotes 32 false false R33.htm 2312301 - Disclosure - Earnings Per Share (Tables) Sheet http://acceleratediagnostics.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://acceleratediagnostics.com/role/EarningsPerShare 33 false false R34.htm 2313301 - Disclosure - Employee Equity-Based Compensation (Tables) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables Employee Equity-Based Compensation (Tables) Tables http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation 34 false false R35.htm 2316301 - Disclosure - Leases (Tables) Sheet http://acceleratediagnostics.com/role/LeasesTables Leases (Tables) Tables http://acceleratediagnostics.com/role/Leases 35 false false R36.htm 2317301 - Disclosure - Industry, Geographic and Revenue Disaggregation (Tables) Sheet http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationTables Industry, Geographic and Revenue Disaggregation (Tables) Tables http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregation 36 false false R37.htm 2401403 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesNarrativeDetails Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Narrative (Details) Details http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesTables 37 false false R38.htm 2401404 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) Details 38 false false R39.htm 2402401 - Disclosure - Recently Issued Accounting Pronouncements (Details) Sheet http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncementsDetails Recently Issued Accounting Pronouncements (Details) Details http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncements 39 false false R40.htm 2403402 - Disclosure - Concentration of Credit Risk (Details) Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails Concentration of Credit Risk (Details) Details http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables 40 false false R41.htm 2404402 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) Details 41 false false R42.htm 2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails Fair Value of Financial Instruments - Narrative (Details) Details 42 false false R43.htm 2405402 - Disclosure - Investments - Schedule of Available-for-sale Securities (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails Investments - Schedule of Available-for-sale Securities (Details) Details 43 false false R44.htm 2405403 - Disclosure - Investments - Schedule of Available-for-Sale Investment Maturities (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails Investments - Schedule of Available-for-Sale Investment Maturities (Details) Details 44 false false R45.htm 2405404 - Disclosure - Investments - Narrative (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 45 false false R46.htm 2406402 - Disclosure - Inventory (Details) Sheet http://acceleratediagnostics.com/role/InventoryDetails Inventory (Details) Details http://acceleratediagnostics.com/role/InventoryTables 46 false false R47.htm 2407402 - Disclosure - Property and Equipment (Details) Sheet http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://acceleratediagnostics.com/role/PropertyAndEquipmentTables 47 false false R48.htm 2408401 - Disclosure - License Agreements and Grants - National Institute of Health Grant (Details) Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails License Agreements and Grants - National Institute of Health Grant (Details) Details 48 false false R49.htm 2408402 - Disclosure - License Agreements and Grants - Arizona Commerce Authority (Details) Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityDetails License Agreements and Grants - Arizona Commerce Authority (Details) Details 49 false false R50.htm 2409402 - Disclosure - Deferred Revenue and Remaining Performance Obligations (Details) Sheet http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsDetails Deferred Revenue and Remaining Performance Obligations (Details) Details http://acceleratediagnostics.com/role/DeferredRevenueAndRemainingPerformanceObligationsTables 50 false false R51.htm 2410402 - Disclosure - Convertible Notes - Narrative (Details) Notes http://acceleratediagnostics.com/role/ConvertibleNotesNarrativeDetails Convertible Notes - Narrative (Details) Details 51 false false R52.htm 2410403 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details) Notes http://acceleratediagnostics.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails Convertible Notes - Schedule of Convertible Notes (Details) Details 52 false false R53.htm 2412402 - Disclosure - Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) Sheet http://acceleratediagnostics.com/role/EarningsPerShareScheduleOfPotentiallyIssuableCommonSharesNotIncludedInComputationOfDilutedNetLossPerShareDetails Earnings Per Share - Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share (Details) Details 53 false false R54.htm 2412403 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://acceleratediagnostics.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 54 false false R55.htm 2413402 - Disclosure - Employee Equity-Based Compensation - Stock Option Activity (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails Employee Equity-Based Compensation - Stock Option Activity (Details) Details 55 false false R56.htm 2413403 - Disclosure - Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) Details 56 false false R57.htm 2413404 - Disclosure - Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) Details 57 false false R58.htm 2413405 - Disclosure - Employee Equity-Based Compensation - Restricted Stock Activity (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails Employee Equity-Based Compensation - Restricted Stock Activity (Details) Details 58 false false R59.htm 2413406 - Disclosure - Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) Details 59 false false R60.htm 2413407 - Disclosure - Employee Equity-Based Compensation - Narrative (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationNarrativeDetails Employee Equity-Based Compensation - Narrative (Details) Details 60 false false R61.htm 2414401 - Disclosure - Income Taxes (Details) Sheet http://acceleratediagnostics.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://acceleratediagnostics.com/role/IncomeTaxes 61 false false R62.htm 2416402 - Disclosure - Leases - Assets and Liabilities (Details) Sheet http://acceleratediagnostics.com/role/LeasesAssetsAndLiabilitiesDetails Leases - Assets and Liabilities (Details) Details 62 false false R63.htm 2416403 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://acceleratediagnostics.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 63 false false R64.htm 2416404 - Disclosure - Leases - Sales-type Lease Receivable Maturity (Details) Sheet http://acceleratediagnostics.com/role/LeasesSalesTypeLeaseReceivableMaturityDetails Leases - Sales-type Lease Receivable Maturity (Details) Details 64 false false R65.htm 2417402 - Disclosure - Industry, Geographic and Revenue Disaggregation - Narrative (Details) Sheet http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationNarrativeDetails Industry, Geographic and Revenue Disaggregation - Narrative (Details) Details 65 false false R66.htm 2417403 - Disclosure - Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details) Sheet http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationDisaggregationOfRevenueDetails Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details) Details 66 false false R67.htm 2417404 - Disclosure - Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details) Sheet http://acceleratediagnostics.com/role/IndustryGeographicAndRevenueDisaggregationLongLivedAssetsByGeographicTerritoryDetails Industry, Geographic and Revenue Disaggregation - Long-lived Assets by Geographic Territory (Details) Details 67 false false R68.htm 2418401 - Disclosure - Related Party Transaction (Details) Sheet http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails Related Party Transaction (Details) Details http://acceleratediagnostics.com/role/RelatedPartyTransactions 68 false false R9999.htm Uncategorized Items - axdx-093019x10q.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - axdx-093019x10q.htm Cover 69 false false All Reports Book All Reports axdx-093019x10q.htm a09302019-exh311.htm a09302019-exh312.htm a09302019-exh32.htm axdx-20190930.xsd axdx-20190930_cal.xml axdx-20190930_def.xml axdx-20190930_lab.xml axdx-20190930_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 true true XML 61 R4.htm IDEA: XBRL DOCUMENT v3.19.3
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
    shares in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Income Statement [Abstract]        
    Net sales $ 2,271,000 $ 1,355,000 $ 5,827,000 $ 3,848,000
    Cost of sales 1,117,000 680,000 2,940,000 1,889,000
    Gross profit 1,154,000 675,000 2,887,000 1,959,000
    Costs and expenses:        
    Research and development 6,064,000 7,891,000 19,145,000 20,734,000
    Sales, general and administrative 12,743,000 12,153,000 38,302,000 41,835,000
    Total costs and expenses 18,807,000 20,044,000 57,447,000 62,569,000
    Loss from operations (17,653,000) (19,369,000) (54,560,000) (60,610,000)
    Other income (expense):        
    Interest expense (3,598,000) (3,357,000) (10,585,000) (6,720,000)
    Foreign currency exchange loss (89,000) (133,000) (142,000) (331,000)
    Interest income 676,000 908,000 2,329,000 1,983,000
    Other expense, net (9,000) 0 (12,000) (25,000)
    Total other expense, net (3,020,000) (2,582,000) (8,410,000) (5,093,000)
    Net loss before income taxes (20,673,000) (21,951,000) (62,970,000) (65,703,000)
    Benefit (provision) for income taxes 239,000 (147,000) 0 (432,000)
    Net loss $ (20,434,000) $ (22,098,000) $ (62,970,000) $ (66,135,000)
    Basic and diluted net loss per share (usd per share) $ (0.37) $ (0.41) $ (1.16) $ (1.21)
    Weighted average shares outstanding (shares) 54,553 54,145 54,456 54,591
    Other comprehensive loss:        
    Net loss $ (20,434,000) $ (22,098,000) $ (62,970,000) $ (66,135,000)
    Net unrealized gain (loss) on available-for-sale investments 10,000 1,000 229,000 (54,000)
    Foreign currency translation adjustment (113,000) (26,000) (139,000) (105,000)
    Comprehensive loss $ (20,537,000) $ (22,123,000) $ (62,880,000) $ (66,294,000)
    XML 62 R51.htm IDEA: XBRL DOCUMENT v3.19.3
    Convertible Notes - Narrative (Details)
    		 3 Months Ended 9 Months Ended
    Apr. 04, 2018
    USD ($)
    day
    shares
    Mar. 27, 2018
    USD ($)
    $ / shares
    Sep. 30, 2019
    USD ($)
    Sep. 30, 2018
    USD ($)
    Sep. 30, 2019
    USD ($)
    Sep. 30, 2018
    USD ($)
    Dec. 31, 2018
    USD ($)
    Debt Instrument [Line Items]              
    Over-allotment option, term   13 days          
    Over-allotment option   $ 22,500,000          
    Additional proceeds $ 21,500,000            
    Conversion ratio   0.0323428          
    Outstanding principal     $ 171,500,000   $ 171,500,000   $ 171,500,000
    Unamortized debt issuance     2,566,000   2,566,000   $ 2,996,000
    Stock price conversion threshold, percentage 130.00%            
    Consecutive trading days | day 20            
    Threshold trading days | day 30            
    Trading price threshold, percentage 98.00%            
    Repurchase principal balance, percent 100.00%            
    Interest expense     1,100,000 $ 1,100,000 3,200,000 $ 2,200,000  
    Amortization of debt issuance costs     100,000 100,000 400,000 300,000  
    Amortization of the debt discount     $ 2,400,000 $ 2,100,000 $ 6,900,000 $ 4,300,000  
    Net proceeds from notes to fund Prepaid Forward $ 45,100,000            
    Aggregate number of shares (shares) | shares 1,858,500            
    Unsecured obligations | 2.50% Convertible notes due 2023              
    Debt Instrument [Line Items]              
    Aggregate principal amount $ 171,500,000 $ 150,000,000.0          
    Interest rate   2.50%          
    Proceeds received 171,500,000            
    Conversion multiple 1,000            
    Initial conversion price (usd per share) | $ / shares   $ 30.92          
    Outstanding principal 116,600,000            
    Equity component (54,900,000)            
    Unamortized debt issuance $ 5,000,000.0            
    Contractual term 5 years            
    Effective interest rate 11.52%            
    Unsecured obligations | 2.50% Convertible notes due 2023 | Long-term debt              
    Debt Instrument [Line Items]              
    Unamortized debt issuance $ 3,400,000            
    Unsecured obligations | 2.50% Convertible notes due 2023 | Contributed capital              
    Debt Instrument [Line Items]              
    Unamortized debt issuance $ 1,600,000            
    XML 63 R30.htm IDEA: XBRL DOCUMENT v3.19.3
    Property and Equipment (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Property, Plant and Equipment [Abstract]  
    Property and Equipment
    Property and equipment consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30,
    December 31,
     
    2019
    2018
    Computer equipment
    $
    2,726

    $
    2,700

    Technical equipment
    3,949

    3,868

    Facilities
    4,016

    4,037

    Instruments
    7,747

    5,318

    Capital projects in progress
    206

    91

    Total property and equipment
    $
    18,644

    $
    16,014

    Accumulated depreciation
    (10,078
    )
    (8,711
    )
    Property and equipment, net
    $
    8,566

    $
    7,303
    XML 64 R34.htm IDEA: XBRL DOCUMENT v3.19.3
    Employee Equity-Based Compensation (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Share-based Payment Arrangement [Abstract]  
    Stock Option Activity
    The following table summarizes option activity under all plans during the nine months ended September 30, 2019:

     
    Number of Shares
    Weighted Average Exercise Price per Share
    Options Outstanding January 1, 2019
    8,090,636

    $
    12.22

    Granted
    2,883,596

    14.47

    Forfeited
    (420,098
    )
    20.74

    Exercised
    (327,215
    )
    14.91

    Expired
    (67,574
    )
    23.41

    Options Outstanding September 30, 2019
    10,159,345

    $
    12.34
    Inputs to Calculate Estimated Fair Value of Options Awarded
    The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

     
    Three Months Ended
     
    September 30,
    September 30,
     
    2019
    2018
    Expected term (in years)
    6.46

    5.53

    Volatility
    59
    %
    58
    %
    Expected dividends
    —

    —

    Risk free interest rates
    1.47
    %
    2.75
    %
    Weighted average fair value
    $
    9.66

    $
    11.48
    Stock Option Supplemental Information
    The following table shows summary information for outstanding options and options that are exercisable (vested) as of September 30, 2019:

     
    Options
    Outstanding
    Options
    Exercisable
    Number of options
    10,159,345

    6,137,856

    Weighted average remaining contractual term (in years)
    6.14

    4.32

    Weighted average exercise price
    $
    12.34

    $
    9.03

    Weighted average fair value
    $
    8.01

    $
    6.06

    Aggregate intrinsic value (in thousands)
    $
    76,923

    $
    65,271
    Restricted Stock Unit (RSU) Activity
    The following table summarizes RSU and restricted stock award activity during the nine months ended September 30, 2019:

     
    Number of Shares
    Weighted Average Grant Date Fair Value per Share
    Outstanding January 1, 2019
    76,000

    $
    18.70

    Granted
    11,000

    20.32

    Forfeited
    (60,500
    )
    19.74

    Vested/released
    (7,000
    )
    19.47

    Outstanding September 30, 2019
    19,500

    16.13
    Equity-Based Compensation Expenses
    Equity-based compensation expense is summarized below (in thousands):

     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
    September 30,
     
    September 30,
    September 30,
     
    2019
    2018
     
    2019
    2018
    Cost of sales
    $
    65

    $
    68

     
    $
    172

    $
    172

    Research and development
    897

    1,476

     
    3,226

    3,926

    Sales, general and administrative
    2,169

    1,921

     
    6,011

    8,378

     
    $
    3,131

    $
    3,465

     
    $
    9,409

    $
    12,476
    XML 65 R38.htm IDEA: XBRL DOCUMENT v3.19.3
    Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Movement in Standard Product Warranty Accrual [Roll Forward]        
    Beginning balance $ 196 $ 199 $ 215 $ 192
    Provisions 77 128 147 394
    Warranty incurred (51) (138) (140) (397)
    Ending balance $ 222 $ 189 $ 222 $ 189
    XML 66 R17.htm IDEA: XBRL DOCUMENT v3.19.3
    Earnings Per Share
    		 9 Months Ended
    Sep. 30, 2019
    Earnings Per Share [Abstract]  
    Earnings Per Share
    NOTE 11. EARNINGS PER SHARE

    Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company’s losses.
    The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect for the three and nine months ended September 30, 2019 and 2018 (in thousands):

     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
    September 30,
     
    September 30,
    September 30,
     
    2019
    2018
     
    2019
    2018
    Shares issuable upon the release of restricted stock awards
    20

    66

     
    20

    66

    Shares issuable upon exercise of stock options
    10,159

    8,182

     
    10,159

    8,182

     
    10,179

    8,248

     
    10,179

    8,248



    Potentially dilutive common shares would also include common shares that would be outstanding if Notes convertible at the balance sheet date were converted. As discussed in Note 10, Convertible Notes, the Company issued $171.5 million of Notes due 2023. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes. As of September 30, 2019, no Notes were convertible pursuant to their terms. The number of shares issuable upon conversion of the Notes is 5.5 million shares.
    In connection with the Notes, the Company entered into a prepaid forward stock repurchase transaction. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company.
    XML 67 R13.htm IDEA: XBRL DOCUMENT v3.19.3
    Property and Equipment
    		 9 Months Ended
    Sep. 30, 2019
    Property, Plant and Equipment [Abstract]  
    Property and Equipment
    NOTE 7. PROPERTY AND EQUIPMENT

    Property and equipment consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30,
    December 31,
     
    2019
    2018
    Computer equipment
    $
    2,726

    $
    2,700

    Technical equipment
    3,949

    3,868

    Facilities
    4,016

    4,037

    Instruments
    7,747

    5,318

    Capital projects in progress
    206

    91

    Total property and equipment
    $
    18,644

    $
    16,014

    Accumulated depreciation
    (10,078
    )
    (8,711
    )
    Property and equipment, net
    $
    8,566

    $
    7,303



    Depreciation expense for the three months ended September 30, 2019 and 2018 was $0.6 million and $0.7 million, respectively, and $1.7 million for each of the nine months ended September 30, 2019 and 2018.

    The underlying gross assets under operating leases where the Company is the lessor is $1.3 million at September 30, 2019. The underlying accumulated depreciation under operating leases where the Company is the lessor is $0.2 million at September 30, 2019.
    XML 68 R54.htm IDEA: XBRL DOCUMENT v3.19.3
    Earnings Per Share - Narrative (Details)
    		 9 Months Ended
    Apr. 04, 2018
    USD ($)
    shares
    Mar. 27, 2018
    USD ($)
    Sep. 30, 2019
    shares
    Debt Instrument [Line Items]      
    Aggregate number of shares (shares) 1,858,500    
    Conversion ratio   0.0323428  
    Unsecured obligations | 2.50% Convertible notes due 2023      
    Debt Instrument [Line Items]      
    Aggregate principal amount | $ $ 171,500,000 $ 150,000,000.0  
    Conversion multiple | $ $ 1,000    
    Shares issued (shares)     0
    Conversion of Stock, Shares Converted     5,500,000
    XML 69 R5.htm IDEA: XBRL DOCUMENT v3.19.3
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
    $ in Thousands
    		 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Cash flows from operating activities:    
    Net loss $ (62,970) $ (66,135)
    Adjustments to reconcile net loss to net cash used in operating activities:    
    Depreciation and amortization 1,862 1,749
    Amortization of investment discount (400) (413)
    Equity-based compensation 9,409 12,476
    Amortization of debt discount and issuance costs 7,370 4,529
    Loss on disposal of property and equipment 577 540
    (Increase) decrease in assets:    
    Accounts receivable (782) 506
    Inventory (3,286) (5,206)
    Prepaid expense and other (319) (212)
    Increase (decrease) in liabilities:    
    Accounts payable 788 (524)
    Accrued liabilities, and other (2,115) (18)
    Accrued interest (1,071) 191
    Deferred revenue and income 33 (918)
    Deferred compensation (25) 5
    Net cash used in operating activities (50,929) (53,430)
    Cash flows from investing activities:    
    Purchases of equipment (148) (842)
    Purchase of marketable securities (20,710) (115,634)
    Proceeds from sales of marketable securities 13,400 3,000
    Maturities of marketable securities 78,922 74,496
    Net cash provided by (used in) investing activities 71,464 (38,980)
    Cash flows from financing activities:    
    Proceeds from issuance of common stock 1,363 447
    Proceeds from exercise of options 4,879 3,710
    Proceeds from issuance of convertible note 0 171,500
    Prepayment of forward stock repurchase transaction 0 (45,069)
    Payment of debt issuance costs 0 (4,992)
    Net cash provided by financing activities 6,242 125,596
    Effect of exchange rate on cash (99) (77)
    Increase in cash and cash equivalents 26,678 33,109
    Cash and cash equivalents, beginning of period 66,260 28,513
    Cash and cash equivalents, end of period 92,938 61,622
    Non-cash investing activities:    
    Transfer of instruments from inventory to property and equipment 3,225 4,061
    Supplemental cash flow information:    
    Interest paid 4,288 2,001
    Income taxes paid $ 54 $ 435
    XML 70 R1.htm IDEA: XBRL DOCUMENT v3.19.3
    Cover Page - shares
    		 9 Months Ended
    Sep. 30, 2019
    Nov. 05, 2019
    Cover page.    
    Document Type 10-Q  
    Document Quarterly Report true  
    Document Period End Date Sep. 30, 2019  
    Document Transition Report false  
    Entity File Number 001-31822  
    Entity Registrant Name ACCELERATE DIAGNOSTICS, INC.  
    Entity Incorporation, State or Country Code DE  
    Entity Tax Identification Number 84-1072256  
    Entity Address, Address Line One 3950 South Country Club Road,  
    Entity Address, Address Line Two Suite 470  
    Entity Address, City or Town Tucson,  
    Entity Address, State or Province AZ  
    Entity Address, Postal Zip Code 85714  
    City Area Code 520  
    Local Phone Number 365-3100  
    Title of 12(b) Security Common Stock, $0.001 par  
    Trading Symbol AXDX  
    Security Exchange Name NASDAQ  
    Entity Current Reporting Status Yes  
    Entity Interactive Data Current Yes  
    Entity Filer Category Large Accelerated Filer  
    Entity Small Business true  
    Entity Emerging Growth Company false  
    Entity Shell Company false  
    Entity Common Stock, Shares Outstanding   54,644,960
    Entity Central Index Key 0000727207  
    Amendment Flag false  
    Current Fiscal Year End Date --12-31  
    Document Fiscal Period Focus Q3  
    Document Fiscal Year Focus 2019  
    XML 71 R50.htm IDEA: XBRL DOCUMENT v3.19.3
    Deferred Revenue and Remaining Performance Obligations (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Dec. 31, 2018
    Disaggregation of Revenue [Line Items]          
    Deferred revenue and income $ 250   $ 250   $ 217
    Revenues recognized included in contract liabilities balances 200 $ 30 300 $ 65  
    Revenue expected to be recognized from remaining performance obligations 2,500   $ 2,500    
    Contact period     These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically in a straight-line pattern.    
    Products and services not yet delivered          
    Disaggregation of Revenue [Line Items]          
    Deferred revenue and income $ 250   $ 250   $ 217
    XML 72 R9.htm IDEA: XBRL DOCUMENT v3.19.3
    Concentration of Credit Risk
    		 9 Months Ended
    Sep. 30, 2019
    Risks and Uncertainties [Abstract]  
    Concentration of Credit Risk
    NOTE 3. CONCENTRATION OF CREDIT RISK

    Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.

    The Company has financial institutions for banking operations that hold 10% or more of the Company’s cash and cash equivalents. As of September 30, 2019, two of the Company's financial institutions held 71% and 26% of the Company’s cash and cash equivalents, respectively. As of December 31, 2018, two of the Company's financial institutions held 46% and 43% of the Company’s cash and cash equivalents, respectively.

    The Company grants credit to domestic and international customers. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company had one customer that accounted for 14% of the Company’s net accounts receivable balance as of September 30, 2019, and one customer that accounted for 10% of the Company's net accounts receivable balance as of December 31, 2018.

    Customers who represented 10% or more of the Company’s total revenue for the three and nine months ended September 30, 2019 and 2018 were as follows:
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
    2018
     
    2019
    2018
    Company A
    *
    20%
     
    *
    *
    Company B
    *
    18%
     
    *
    *
    Company C
    *
    17%
     
    *
    *

    * Less than 10% for the period indicated
    XML 73 R58.htm IDEA: XBRL DOCUMENT v3.19.3
    Employee Equity-Based Compensation - Restricted Stock Activity (Details) - RSUs and RSAs
    		 9 Months Ended
    Sep. 30, 2019
    $ / shares
    shares
    Number of Shares  
    Beginning balance (shares) | shares 76,000
    Granted (shares) | shares 11,000
    Forfeited (shares) | shares (60,500)
    Vested/Released (shares) | shares (7,000)
    Ending balance (shares) | shares 19,500
    Weighted Average Grant Date Fair Value per Share  
    Beginning balance (dollars per share) | $ / shares $ 18.70
    Granted (dollars per share) | $ / shares 20.32
    Forfeited (dollars per share) | $ / shares 19.74
    Vested/Released (dollars per share) | $ / shares 19.47
    Ending balance (dollars per share) | $ / shares $ 16.13
    XML 74 R39.htm IDEA: XBRL DOCUMENT v3.19.3
    Recently Issued Accounting Pronouncements (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Jan. 01, 2019
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
    Right of use assets $ 3,834  
    Lessee lease liabilities $ 3,879 $ 600
    ASU 2016-02    
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
    Right of use assets   $ 600
    XML 75 R31.htm IDEA: XBRL DOCUMENT v3.19.3
    Deferred Revenue and Remaining Performance Obligations (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Deferred Revenue Disclosure [Abstract]  
    Deferred Revenue and Income Summary A summary of the balances as of September 30, 2019 and December 31, 2018 follows (in thousands):
     
    September 30,
    December 31,
     
    2019
    2018
    Products and services not yet delivered
    $
    250

    $
    217
    XML 76 R35.htm IDEA: XBRL DOCUMENT v3.19.3
    Leases (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Leases [Abstract]  
    Assets And Liabilities
    The following presents supplemental information related to our leases in which we are the lessee for the three and nine months ended September 30, 2019 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
     
    2019
    Cash paid for amounts included in lease liabilities
     
     
     
    Operating cash flows from operating leases
    $
    168

     
    $
    333

    ROU assets obtained in exchange for lease obligations
     
     
     
    Operating leases
    $
    3,639

     
    $
    3,639

    Lease Cost
     
     
     
    Operating leases
    $
    213

     
    $
    378

    Short-term leases
    $
    103

     
    $
    697
    Lease Costs
    The following presents supplemental information related to our leases in which we are the lessee for the three and nine months ended September 30, 2019 (in thousands):
     
    Three Months Ended
     
    Nine Months Ended
     
    September 30,
     
    September 30,
     
    2019
     
    2019
    Cash paid for amounts included in lease liabilities
     
     
     
    Operating cash flows from operating leases
    $
    168

     
    $
    333

    ROU assets obtained in exchange for lease obligations
     
     
     
    Operating leases
    $
    3,639

     
    $
    3,639

    Lease Cost
     
     
     
    Operating leases
    $
    213

     
    $
    378

    Short-term leases
    $
    103

     
    $
    697
    Maturities of Lease Liabilities
    The following presents maturities of operating lease liabilities in which we are the lessee as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    180

    2020
    637

    2021
    687

    2022
    818

    2023
    913

    Thereafter
    1,583

    Total lease payments
    4,818

    Less imputed interest
    (939
    )
     
    $
    3,879
    Sales-type Lease Receivable Maturity The following presents maturities of lease receivables under sales-type leases as of September 30, 2019 (in thousands):
    Remainder of 2019
    $
    62

    2020
    197

    2021
    139

    2022
    106

    2023
    53

    Thereafter
    13

    Total undiscounted cash flows
    570

    Less imputed interest
    (3
    )
    Present value of lease payments
    $
    567
    XML 77 axdx-093019x10q_htm.xml IDEA: XBRL DOCUMENT 0000727207 2019-01-01 2019-09-30 0000727207 2019-11-05 0000727207 2019-09-30 0000727207 2018-12-31 0000727207 2019-07-01 2019-09-30 0000727207 2018-07-01 2018-09-30 0000727207 2018-01-01 2018-09-30 0000727207 2018-09-30 0000727207 2017-12-31 0000727207 us-gaap:CommonStockMember 2017-12-31 0000727207 us-gaap:CommonStockMember 2019-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0000727207 us-gaap:CommonStockMember 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-12-31 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000727207 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0000727207 us-gaap:CommonStockMember 2018-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000727207 us-gaap:CommonStockMember 2019-09-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000727207 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000727207 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-06-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000727207 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000727207 us-gaap:TreasuryStockMember 2019-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-12-31 0000727207 us-gaap:RetainedEarningsMember 2019-09-30 0000727207 us-gaap:TreasuryStockMember 2018-12-31 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2018-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000727207 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000727207 us-gaap:RetainedEarningsMember 2018-01-01 0000727207 us-gaap:RetainedEarningsMember 2019-06-30 0000727207 us-gaap:RetainedEarningsMember 2017-12-31 0000727207 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0000727207 us-gaap:TreasuryStockMember 2018-06-30 0000727207 us-gaap:TreasuryStockMember 2017-12-31 0000727207 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000727207 srt:MinimumMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember 2019-01-01 2019-09-30 0000727207 axdx:InstrumentsMember 2019-01-01 2019-09-30 0000727207 2019-06-30 0000727207 2018-06-30 0000727207 srt:MinimumMember 2019-09-30 0000727207 srt:MaximumMember 2019-09-30 0000727207 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000727207 2019-01-01 0000727207 axdx:FinancialInstitutionAMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:FinancialInstitutionBMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0000727207 axdx:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:FinancialInstitutionBMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:FinancialInstitutionAMember us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-09-30 0000727207 axdx:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-03-27 0000727207 2018-04-04 2018-04-04 0000727207 2018-03-27 2018-03-27 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-12-31 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 2018-04-04 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:AssetBackedSecuritiesMember 2019-09-30 0000727207 us-gaap:USTreasuryAndGovernmentMember 2019-09-30 0000727207 us-gaap:CorporateDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:CertificatesOfDepositMember 2019-09-30 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-09-30 0000727207 us-gaap:CertificatesOfDepositMember 2018-12-31 0000727207 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000727207 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000727207 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000727207 us-gaap:AssetsLeasedToOthersMember 2019-09-30 0000727207 axdx:InstrumentsMember 2018-12-31 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2018-12-31 0000727207 us-gaap:ConstructionInProgressMember 2018-12-31 0000727207 us-gaap:TechnologyEquipmentMember 2019-09-30 0000727207 us-gaap:ConstructionInProgressMember 2019-09-30 0000727207 us-gaap:ComputerEquipmentMember 2018-12-31 0000727207 axdx:InstrumentsMember 2019-09-30 0000727207 us-gaap:ComputerEquipmentMember 2019-09-30 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2019-09-30 0000727207 us-gaap:TechnologyEquipmentMember 2018-12-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2019-07-01 2019-09-30 0000727207 us-gaap:GrantMember 2018-01-01 2018-01-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-07-01 2018-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2019-01-01 2019-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2015-02-28 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2019-09-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-01-01 2018-09-30 0000727207 axdx:ProductsandServicesnotYetDeliveredMember 2018-12-31 0000727207 axdx:ProductsandServicesnotYetDeliveredMember 2019-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 us-gaap:AdditionalPaidInCapitalMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 2018-04-04 0000727207 us-gaap:LongTermDebtMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-04 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0000727207 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2019-01-01 2019-09-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2019-09-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2018-12-31 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2019-01-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0000727207 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000727207 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2019-01-01 2019-09-30 0000727207 us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2018-01-01 2018-09-30 0000727207 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0000727207 us-gaap:PerformanceSharesMember 2019-09-30 0000727207 srt:MinimumMember axdx:Grantedin2018Member us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember axdx:Grantedin2018Member us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 srt:MaximumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2019-07-01 2019-09-30 0000727207 srt:MinimumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2018-07-01 2018-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-07-01 2019-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-09-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-12-31 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-07-01 2018-09-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-01-01 2019-09-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2019-07-01 2019-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-07-01 2018-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2019-01-01 2019-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-07-01 2018-09-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-01-01 2018-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2019-07-01 2019-09-30 0000727207 us-gaap:GeographicDistributionForeignMember 2019-01-01 2019-09-30 0000727207 axdx:AcceleratePhenoMember 2018-07-01 2018-09-30 0000727207 axdx:AcceleratePhenoMember 2019-07-01 2019-09-30 0000727207 axdx:OtherRevenueMember 2019-01-01 2019-09-30 0000727207 axdx:OtherRevenueMember 2019-07-01 2019-09-30 0000727207 axdx:AcceleratePhenoMember 2018-01-01 2018-09-30 0000727207 axdx:OtherRevenueMember 2018-07-01 2018-09-30 0000727207 axdx:OtherRevenueMember 2018-01-01 2018-09-30 0000727207 axdx:AcceleratePhenoMember 2019-01-01 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2019-09-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2018-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2019-09-30 0000727207 us-gaap:ServiceMember 2019-01-01 2019-09-30 0000727207 us-gaap:ProductMember 2018-01-01 2018-09-30 0000727207 us-gaap:ServiceMember 2018-01-01 2018-09-30 0000727207 us-gaap:ServiceMember 2018-07-01 2018-09-30 0000727207 us-gaap:ProductMember 2018-07-01 2018-09-30 0000727207 us-gaap:ProductMember 2019-07-01 2019-09-30 0000727207 us-gaap:ServiceMember 2019-07-01 2019-09-30 0000727207 us-gaap:ProductMember 2019-01-01 2019-09-30 0000727207 srt:ChiefOperatingOfficerMember 2019-08-20 2019-08-20 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2018-03-31 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2019-05-31 0000727207 2019-08-20 2019-08-20 0000727207 2019-08-19 0000727207 srt:DirectorMember axdx:ConvertibleNoteHolderMember 2019-09-30 iso4217:USD shares iso4217:USD axdx:day shares pure axdx:segment P5Y false --12-31 Q3 2019 0000727207 100000 100000 0.001 0.001 75000000 85000000 54231876 54641187 54231876 54641187 0.0323428 P5Y 1700000 1100000 P6Y P2Y 0 0 0 600000 200000 0.001 0.001 5000000 5000000 0 0 200000 These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically in a straight-line pattern. 10-Q true 2019-09-30 false 001-31822 ACCELERATE DIAGNOSTICS, INC. DE 84-1072256 3950 South Country Club Road, Suite 470 Tucson, AZ 85714 520 365-3100 Common Stock, $0.001 par AXDX NASDAQ Yes Yes Large Accelerated Filer true false false 54644960 92938000 66260000 28978000 100218000 2642000 1860000 7881000 7746000 1163000 980000 793000 576000 134395000 177640000 8566000 7303000 3834000 483000 322000 147278000 185265000 2281000 1322000 2985000 4962000 191000 1262000 250000 217000 421000 6128000 7763000 3458000 28000 53000 127444000 120074000 137058000 127890000 0 0 55000 54000 448609000 432885000 45067000 45067000 -393318000 -330348000 -59000 -149000 10220000 57375000 147278000 185265000 2271000 1355000 5827000 3848000 1117000 680000 2940000 1889000 1154000 675000 2887000 1959000 6064000 7891000 19145000 20734000 12743000 12153000 38302000 41835000 18807000 20044000 57447000 62569000 -17653000 -19369000 -54560000 -60610000 3598000 3357000 10585000 6720000 -89000 -133000 -142000 -331000 676000 908000 2329000 1983000 9000 0 12000 25000 -3020000 -2582000 -8410000 -5093000 -20673000 -21951000 -62970000 -65703000 -239000 147000 0 432000 -20434000 -22098000 -62970000 -66135000 -0.37 -0.41 -1.16 -1.21 54553000 54145000 54456000 54591000 -20434000 -22098000 -62970000 -66135000 10000 1000 229000 -54000 -113000 -26000 -139000 -105000 -20537000 -22123000 -62880000 -66294000 -62970000 -66135000 1862000 1749000 400000 413000 9409000 12476000 7370000 4529000 -577000 -540000 782000 -506000 3286000 5206000 319000 212000 788000 -524000 -2115000 -18000 -1071000 191000 33000 -918000 -25000 5000 -50929000 -53430000 148000 842000 20710000 115634000 13400000 3000000 78922000 74496000 71464000 -38980000 1363000 447000 4879000 3710000 0 171500000 0 45069000 0 4992000 6242000 125596000 -99000 -77000 26678000 33109000 66260000 28513000 92938000 61622000 3225000 4061000 4288000 2001000 54000 435000 54512000 54091000 54232000 55674000 56000 56000 66000 98000 334000 360000 7000 8000 19000 22000 1859000 54641000 54197000 54641000 54197000 55000 54000 54000 56000 1000 2000 55000 54000 55000 54000 443857000 426091000 432885000 360620000 1000000 1000000 510000 954000 4879000 3710000 112000 171000 362000 447000 53283000 3130000 3518000 9483000 12674000 448609000 430734000 448609000 430734000 -372884000 -286058000 -330348000 -241972000 -49000 -20434000 -22098000 -62970000 -66135000 -393318000 -308156000 -393318000 -308156000 -45067000 -45067000 -45067000 0 45067000 -45067000 -45067000 -45067000 -45067000 44000 -134000 -149000 0 10000 1000 229000 -54000 -113000 -26000 -139000 -105000 -59000 -159000 -59000 -159000 10220000 77406000 10220000 77406000 <div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accelerate Diagnostics, Inc. (“we” or “us” or “our” or “Accelerate” or the “Company”) is an </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">in vitro</span><span style="font-family:Arial;font-size:10pt;"> diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">, as filed with the SEC on March 1, 2019.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The condensed consolidated balance sheet as of </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending </span><span style="font-family:Arial;font-size:10pt;">December 31, 2019</span><span style="font-family:Arial;font-size:10pt;">, or any future period.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">All amounts are rounded to the nearest thousand dollars unless otherwise indicated.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Principles of Consolidation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, tax valuation accounts and equity–based compensation. Actual results could differ materially from those estimates.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Estimated Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company follows ASC 820</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">, Fair Value Measurement,</span><span style="font-family:Arial;font-size:10pt;"> which has defined fair value and requires the Company to establish a framework for measuring and disclosing fair value. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, and other current liabilities approximate the related fair values due to the short-term maturities of these instruments.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The estimated fair value of the Company’s long-term debt represents a Level 2 measurement. See </span><span style="font-family:Arial;font-size:10pt;color:#000000;">Note 10, Convertible Notes</span><span style="font-family:Arial;font-size:10pt;"> for further detail on the Company’s long-term debt.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cash and Cash Equivalents</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe, however, that the market risk arising from holding these financial instruments is minimal.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Investments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company invests in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificates of deposit, U.S. government and agency securities, commercial paper, asset-backed securities, and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive loss, a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive loss</span><span style="font-family:Times New Roman;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Inventory</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Inventory is stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first out method. The Company estimates the recoverability of inventory by reference to internal estimates of future demands and product life cycles, including expiration. The Company periodically analyzes its inventory levels to identify inventory that may expire prior to expected sale or has a cost basis in excess of its estimated net realizable value and records a charge to expense for such inventory as appropriate.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Accounts Receivable</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accounts receivable consist of amounts due to the Company for sales to customers and are based on what we expect to collect in exchange for goods and services. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis by recording adjustments to revenue, if necessary. No allowances were recorded at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Property and Equipment</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from </span><span style="font-family:Arial;font-size:10pt;"><span>one year</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>seven years</span></span><span style="font-family:Arial;font-size:10pt;">. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment includes Accelerate Pheno™ systems (also referred to as instruments) used for sales demonstrations, instruments under rental agreements and instruments used for research and development. Depreciation expense for instruments used for sales demonstrations is recorded as a component of sales, general and administrative expense. Depreciation expense for instruments placed at customer sites pursuant to reagent rental agreements is recorded as a component of cost of sales. Depreciation expense for instruments used in our laboratory and research is recorded as a component of research and development expense. The Company retains title to these instruments and depreciates them over </span><span style="font-family:Arial;font-size:10pt;"><span>five years</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Long-lived Assets</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Warranty Reserve</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Instruments are typically sold with a </span><span style="font-family:Arial;font-size:10pt;"><span>one year</span></span><span style="font-family:Arial;font-size:10pt;"> limited warranty, while kits and accessories are typically sold with a </span><span style="font-family:Arial;font-size:10pt;"><span>sixty days</span></span><span style="font-family:Arial;font-size:10pt;"> limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Warranty reserve activity for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> is as follows (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>215</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>192</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Provisions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>394</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Warranty incurred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(51</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(138</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(140</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(397</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Convertible Notes</span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company issued convertible notes in 2018 that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We determine revenue recognition through the following steps:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Identification of the contract with a customer</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Identification of the performance obligations in the contract</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Determination of the transaction price</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Allocation of the transaction price to the performance obligations</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Recognition of revenue as we satisfy a performance obligation</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized and the term between invoicing and when payment is due is not typically significant.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Service revenue is derived from the sale of extended service agreements which are generally non-cancellable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine relative standalone selling prices based on the price charged to customers for each individual performance obligation.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cost of Sales</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cost of sales includes cost of materials, direct labor, equity-based compensation, facility and other manufacturing overhead costs for consumable tests and instruments sold to customers. Cost of sales for instruments also includes depreciation on revenue generating instruments that have been placed with our customers under a reagent rental agreement. Cost of sales includes repair and maintenance cost for instruments covered by a service agreement or instruments covered by a reagent rental agreement. Cost of sales also includes warranty related expenses.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Shipping and Handling</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the condensed consolidated statements of operations and comprehensive loss. Most such billable shipping and handling costs are in connection with consumable test kits. Unlike test kits, for instruments the Company typically pays for shipping and handling.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Leases</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company accounts for leases in accordance with ASC 842, </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Leases</span><span style="font-family:Arial;font-size:10pt;">, which was adopted on January 1, 2019. We determine if an arrangement is or contains a lease and the type of lease at inception. The Company classifies leases as finance leases (lessee) or sales-type leases (lessor) when there is either a transfer of ownership of the underlying asset by the end of the lease term, the lease contains an option to purchase the asset that we are reasonably certain will be exercised, the lease term is for the major part of the remaining economic life of the asset, the present value of the lease payments and any residual value guarantee equals or substantially exceeds all the fair value of the asset, or the asset is of such a specialized nature that it will have no alternative use to the lessor at the end of the lease term. Payments contingent on future events (i.e. based on usage) are considered variable and </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">excluded from lease payments for the purposes of classification and initial measurement. Several of our leases include options to renew or extend the term upon mutual agreement of the parties and others include one-year extensions exercisable by the lessee. None of our leases contain residual value guarantees, restrictions, or covenants.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">To determine whether a contract contains a lease, the Company uses its judgment in assessing whether the lessor retains a material amount of economic benefit from an underlying asset, whether explicitly or implicitly identified, which party holds control over the direction and use of the asset, and whether any substantive substitution rights over the asset exist.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:174%;padding-bottom:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Lessee</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases are included in right-of-use (“ROU”) assets and operating lease liabilities within our condensed consolidated balance sheets. These assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and their related liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Typically, we use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. We use the implicit rate when readily determinable. ROU assets are net of lease payments made and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term, which may include options to extend or terminate the lease when it is reasonably certain that we will exercise the option. As of adoption of ASC 842 and as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the Company was not party to finance lease arrangements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our leases consist primarily of leased office, factory, and laboratory space in the United States and office space and automobiles in Europe, have between </span><span style="font-family:Arial;font-size:10pt;">two</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">six</span><span style="font-family:Arial;font-size:10pt;">-year terms, and typically contain penalizing, early-termination provisions.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:174%;padding-bottom:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Lessor</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company leases instruments to customers under “reagent rental” agreements, whereby the customer agrees to purchase consumable products over a stated term, typically </span><span style="font-family:Arial;font-size:10pt;"><span>five years</span></span><span style="font-family:Arial;font-size:10pt;"> or less, for a volume-based price that includes an embedded rental for the instruments. When collectibility is probable, that amount is recognized as income at lease commencement for sales-type leases and on a straight-line basis over the term for operating leases, which typically include a termination without cause or penalty provision given a short notice period.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consideration is allocated between lease and non-lease components based on stand-alone selling price in accordance with ASC 606, Revenue from Contracts with Customers.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Net investment in sales-type leases are included within our condensed consolidated balance sheets as a component of other current assets and other non-current assets, which include the present value of lease payments not yet received and the present value of the residual asset, which is determined using the information available at commencement, including the lease term and estimated useful life and expected fair value of the instrument.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Equity-Based Compensation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company may award stock options, restricted stock units (“RSUs”), performance-based options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method) except for performance-based options. Performance-based stock options vest based on the achievement of performance targets. Compensation costs associated with performance-based option awards are recognized over the requisite service period based on probability of achievement. Performance-based stock options require management to make assumptions regarding the likelihood of achieving performance targets.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company estimates the fair value of service based and performance based stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Volatility: The expected volatility is based on the historical volatility of the Company's stock price over the most recent period commensurate with the expected term of the stock option award.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected term: The estimated expected term for employee awards is based on the calculation published by the SEC in SAB110 for use when there is not a sufficient history of employee exercise patterns. For consultant awards, the estimated expected term is the same as the life of the award.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Risk-free interest rate: The risk-free interest rate is based on published U.S. Treasury rates for a term commensurate with the expected term.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Dividend yield: The dividend yield is estimated as </span><span style="font-family:Arial;font-size:10pt;"><span>zero</span></span><span style="font-family:Arial;font-size:10pt;"> as the Company has not paid dividends in the past and does not have any plans to pay any dividends in the foreseeable future.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company records the fair value of RSUs or stock grants based on published closing market price on the day before the grant date.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company accounts for forfeitures as they occur rather than on an estimated basis.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Deferred Tax Assets</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company follows the provisions of ASC 740, </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</span><span style="font-family:Arial;font-size:10pt;">, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not certain of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Foreign Currency Translation and Foreign Currency Transactions</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Earnings Per Share</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Potentially dilutive common shares consist of shares issuable from stock options and unvested RSUs. Potentially dilutive common shares would also include common shares that would be outstanding if notes convertible at the balance sheet date were converted. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Earnings per share are restated when certain transactions or events, including rights offerings determined to have bonus elements, have occurred.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">, as filed with the SEC on March 1, 2019.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The condensed consolidated balance sheet as of </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending </span><span style="font-family:Arial;font-size:10pt;">December 31, 2019</span><span style="font-family:Arial;font-size:10pt;">, or any future period.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">All amounts are rounded to the nearest thousand dollars unless otherwise indicated.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Principles of Consolidation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, tax valuation accounts and equity–based compensation. Actual results could differ materially from those estimates.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Estimated Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company follows ASC 820</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">, Fair Value Measurement,</span><span style="font-family:Arial;font-size:10pt;"> which has defined fair value and requires the Company to establish a framework for measuring and disclosing fair value. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, and other current liabilities approximate the related fair values due to the short-term maturities of these instruments.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div>The estimated fair value of the Company’s long-term debt represents a Level 2 measurement. <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cash and Cash Equivalents</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe, however, that the market risk arising from holding these financial instruments is minimal.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Investments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company invests in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificates of deposit, U.S. government and agency securities, commercial paper, asset-backed securities, and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive loss, a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive loss</span><span style="font-family:Times New Roman;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Inventory</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Inventory is stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first out method. The Company estimates the recoverability of inventory by reference to internal estimates of future demands and product life cycles, including expiration. The Company periodically analyzes its inventory levels to identify inventory that may expire prior to expected sale or has a cost basis in excess of its estimated net realizable value and records a charge to expense for such inventory as appropriate.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Accounts Receivable</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div>Accounts receivable consist of amounts due to the Company for sales to customers and are based on what we expect to collect in exchange for goods and services. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis by recording adjustments to revenue, if necessary. <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Property and Equipment</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from </span><span style="font-family:Arial;font-size:10pt;"><span>one year</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>seven years</span></span><span style="font-family:Arial;font-size:10pt;">. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment includes Accelerate Pheno™ systems (also referred to as instruments) used for sales demonstrations, instruments under rental agreements and instruments used for research and development. Depreciation expense for instruments used for sales demonstrations is recorded as a component of sales, general and administrative expense. Depreciation expense for instruments placed at customer sites pursuant to reagent rental agreements is recorded as a component of cost of sales. Depreciation expense for instruments used in our laboratory and research is recorded as a component of research and development expense. The Company retains title to these instruments and depreciates them over </span><span style="font-family:Arial;font-size:10pt;"><span>five years</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> P1Y P7Y P5Y <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Long-lived Assets</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Warranty Reserve</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Instruments are typically sold with a </span><span style="font-family:Arial;font-size:10pt;"><span>one year</span></span><span style="font-family:Arial;font-size:10pt;"> limited warranty, while kits and accessories are typically sold with a </span><span style="font-family:Arial;font-size:10pt;"><span>sixty days</span></span><span style="font-family:Arial;font-size:10pt;"> limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> P1Y P60D <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Warranty reserve activity for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> is as follows (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>215</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>192</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Provisions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>394</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Warranty incurred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(51</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(138</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(140</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(397</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>222</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 196000 199000 215000 192000 77000 128000 147000 394000 51000 138000 140000 397000 222000 189000 222000 189000 <div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Convertible Notes</span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company issued convertible notes in 2018 that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We determine revenue recognition through the following steps:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Identification of the contract with a customer</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Identification of the performance obligations in the contract</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Determination of the transaction price</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Allocation of the transaction price to the performance obligations</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;padding-left:36px;"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><span style="font-family:Arial;font-size:10pt;">Recognition of revenue as we satisfy a performance obligation</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized and the term between invoicing and when payment is due is not typically significant.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Service revenue is derived from the sale of extended service agreements which are generally non-cancellable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine relative standalone selling prices based on the price charged to customers for each individual performance obligation.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cost of Sales</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cost of sales includes cost of materials, direct labor, equity-based compensation, facility and other manufacturing overhead costs for consumable tests and instruments sold to customers. Cost of sales for instruments also includes depreciation on revenue generating instruments that have been placed with our customers under a reagent rental agreement. Cost of sales includes repair and maintenance cost for instruments covered by a service agreement or instruments covered by a reagent rental agreement. Cost of sales also includes warranty related expenses.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Shipping and Handling</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the condensed consolidated statements of operations and comprehensive loss. Most such billable shipping and handling costs are in connection with consumable test kits. Unlike test kits, for instruments the Company typically pays for shipping and handling.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Leases</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company accounts for leases in accordance with ASC 842, </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Leases</span><span style="font-family:Arial;font-size:10pt;">, which was adopted on January 1, 2019. We determine if an arrangement is or contains a lease and the type of lease at inception. The Company classifies leases as finance leases (lessee) or sales-type leases (lessor) when there is either a transfer of ownership of the underlying asset by the end of the lease term, the lease contains an option to purchase the asset that we are reasonably certain will be exercised, the lease term is for the major part of the remaining economic life of the asset, the present value of the lease payments and any residual value guarantee equals or substantially exceeds all the fair value of the asset, or the asset is of such a specialized nature that it will have no alternative use to the lessor at the end of the lease term. Payments contingent on future events (i.e. based on usage) are considered variable and </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">excluded from lease payments for the purposes of classification and initial measurement. Several of our leases include options to renew or extend the term upon mutual agreement of the parties and others include one-year extensions exercisable by the lessee. None of our leases contain residual value guarantees, restrictions, or covenants.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">To determine whether a contract contains a lease, the Company uses its judgment in assessing whether the lessor retains a material amount of economic benefit from an underlying asset, whether explicitly or implicitly identified, which party holds control over the direction and use of the asset, and whether any substantive substitution rights over the asset exist.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:174%;padding-bottom:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Lessee</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases are included in right-of-use (“ROU”) assets and operating lease liabilities within our condensed consolidated balance sheets. These assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and their related liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Typically, we use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. We use the implicit rate when readily determinable. ROU assets are net of lease payments made and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term, which may include options to extend or terminate the lease when it is reasonably certain that we will exercise the option. As of adoption of ASC 842 and as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the Company was not party to finance lease arrangements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our leases consist primarily of leased office, factory, and laboratory space in the United States and office space and automobiles in Europe, have between </span><span style="font-family:Arial;font-size:10pt;">two</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">six</span><span style="font-family:Arial;font-size:10pt;">-year terms, and typically contain penalizing, early-termination provisions.</span></div> <div style="line-height:174%;padding-bottom:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Lessor</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company leases instruments to customers under “reagent rental” agreements, whereby the customer agrees to purchase consumable products over a stated term, typically </span><span style="font-family:Arial;font-size:10pt;"><span>five years</span></span><span style="font-family:Arial;font-size:10pt;"> or less, for a volume-based price that includes an embedded rental for the instruments. When collectibility is probable, that amount is recognized as income at lease commencement for sales-type leases and on a straight-line basis over the term for operating leases, which typically include a termination without cause or penalty provision given a short notice period.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consideration is allocated between lease and non-lease components based on stand-alone selling price in accordance with ASC 606, Revenue from Contracts with Customers.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Net investment in sales-type leases are included within our condensed consolidated balance sheets as a component of other current assets and other non-current assets, which include the present value of lease payments not yet received and the present value of the residual asset, which is determined using the information available at commencement, including the lease term and estimated useful life and expected fair value of the instrument.</span></div> P5Y <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Equity-Based Compensation</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company may award stock options, restricted stock units (“RSUs”), performance-based options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method) except for performance-based options. Performance-based stock options vest based on the achievement of performance targets. Compensation costs associated with performance-based option awards are recognized over the requisite service period based on probability of achievement. Performance-based stock options require management to make assumptions regarding the likelihood of achieving performance targets.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company estimates the fair value of service based and performance based stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Volatility: The expected volatility is based on the historical volatility of the Company's stock price over the most recent period commensurate with the expected term of the stock option award.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected term: The estimated expected term for employee awards is based on the calculation published by the SEC in SAB110 for use when there is not a sufficient history of employee exercise patterns. For consultant awards, the estimated expected term is the same as the life of the award.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Risk-free interest rate: The risk-free interest rate is based on published U.S. Treasury rates for a term commensurate with the expected term.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Dividend yield: The dividend yield is estimated as </span><span style="font-family:Arial;font-size:10pt;"><span>zero</span></span><span style="font-family:Arial;font-size:10pt;"> as the Company has not paid dividends in the past and does not have any plans to pay any dividends in the foreseeable future.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company records the fair value of RSUs or stock grants based on published closing market price on the day before the grant date.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company accounts for forfeitures as they occur rather than on an estimated basis.</span></div> 0 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Deferred Tax Assets</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company follows the provisions of ASC 740, </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</span><span style="font-family:Arial;font-size:10pt;">, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not certain of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Foreign Currency Translation and Foreign Currency Transactions</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Earnings Per Share</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Potentially dilutive common shares consist of shares issuable from stock options and unvested RSUs. Potentially dilutive common shares would also include common shares that would be outstanding if notes convertible at the balance sheet date were converted. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Earnings per share are restated when certain transactions or events, including rights offerings determined to have bonus elements, have occurred.</span></div> <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</span></div><div style="line-height:120%;padding-bottom:0px;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Standards that were recently adopted</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases, which together with subsequent amendments is included in ASC 842. ASC 842 requires a lessee to recognize a liability to make lease payments and an asset with respect to its right to use the underlying asset for the lease term. ASC 842 also addresses accounting and reporting by lessors, which is not significantly different from accounting and reporting under the prior standard, and further provides for qualitative and quantitative disclosures. We adopted ASC 842 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;"> using the optional transition method allowed by ASU 2018-11. This optional transition method allowed the Company to apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. For contracts where we are the lessee, we recorded lease liabilities and right of use assets for contracts in effect on January 1, 2019 based on the facts and circumstances as of that date. The Company elected not to reassess whether any expired or existing contracts are or contain leases, not to reassess the lease classification for any expired or existing leases, not to reassess initial direct costs for any existing leases, and not to separate the lease components from the non-lease components for all classes of underlying assets. No cumulative-effect adjustment was recorded to the opening balance of retained earnings. We recognized right of use assets and lessee lease liabilities of </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> with respect to operating leases where we are the lessee. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The adoption of ASC 842 did not have a material effect on our consolidated financial position, results of operations or cash flows.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718); Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to ASC 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. The Company adopted ASU 2018-07 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as all share-based awards granted to nonemployees are fully vested.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) that the FASB refers to as having been stranded in AOCI. The Company adopted ASU 2018-02 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as no amounts were reclassified from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In March 2017, the FASB issued ASU 2017-08, Receivable - Nonrefundable Fees and Other Costs (Topic 310-20); Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted ASU 2017-08 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as we do not carry callable securities held at a premium.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Standards not yet adopted</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820); Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. This ASU is effective for us on January 1, 2020, with early adoption permitted. We are currently assessing the impact this will have on our consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which was subsequently clarified and amended by ASU 2019-05, ASU 2019-04 and ASU 2018-19. ASU 2016-13 amends the guidance on measuring credit losses on financial assets </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this will have a significant impact on our consolidated financial statements.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Standards that were recently adopted</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases, which together with subsequent amendments is included in ASC 842. ASC 842 requires a lessee to recognize a liability to make lease payments and an asset with respect to its right to use the underlying asset for the lease term. ASC 842 also addresses accounting and reporting by lessors, which is not significantly different from accounting and reporting under the prior standard, and further provides for qualitative and quantitative disclosures. We adopted ASC 842 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;"> using the optional transition method allowed by ASU 2018-11. This optional transition method allowed the Company to apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. For contracts where we are the lessee, we recorded lease liabilities and right of use assets for contracts in effect on January 1, 2019 based on the facts and circumstances as of that date. The Company elected not to reassess whether any expired or existing contracts are or contain leases, not to reassess the lease classification for any expired or existing leases, not to reassess initial direct costs for any existing leases, and not to separate the lease components from the non-lease components for all classes of underlying assets. No cumulative-effect adjustment was recorded to the opening balance of retained earnings. We recognized right of use assets and lessee lease liabilities of </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> with respect to operating leases where we are the lessee. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The adoption of ASC 842 did not have a material effect on our consolidated financial position, results of operations or cash flows.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718); Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to ASC 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. The Company adopted ASU 2018-07 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as all share-based awards granted to nonemployees are fully vested.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) that the FASB refers to as having been stranded in AOCI. The Company adopted ASU 2018-02 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as no amounts were reclassified from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In March 2017, the FASB issued ASU 2017-08, Receivable - Nonrefundable Fees and Other Costs (Topic 310-20); Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted ASU 2017-08 on </span><span style="font-family:Arial;font-size:10pt;">January 1, 2019</span><span style="font-family:Arial;font-size:10pt;">, which had no impact to our consolidated financial statements as we do not carry callable securities held at a premium.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Standards not yet adopted</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820); Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. This ASU is effective for us on January 1, 2020, with early adoption permitted. We are currently assessing the impact this will have on our consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which was subsequently clarified and amended by ASU 2019-05, ASU 2019-04 and ASU 2018-19. ASU 2016-13 amends the guidance on measuring credit losses on financial assets </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this will have a significant impact on our consolidated financial statements.</span></div> 600000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 3. CONCENTRATION OF CREDIT RISK</span><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has financial institutions for banking operations that hold 10% or more of the Company’s cash and cash equivalents. As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, two of the Company's financial institutions held </span><span style="font-family:Arial;font-size:10pt;"><span>71%</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>26%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Company’s cash and cash equivalents, respectively. As of </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">, two of the Company's financial institutions held </span><span style="font-family:Arial;font-size:10pt;"><span>46%</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>43%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Company’s cash and cash equivalents, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company grants credit to domestic and international customers. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company had one customer that accounted for </span><span style="font-family:Arial;font-size:10pt;"><span>14%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Company’s net accounts receivable balance as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, and one customer that accounted for </span><span style="font-family:Arial;font-size:10pt;"><span>10%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Company's net accounts receivable balance as of </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Customers who represented 10% or more of the Company’s total revenue for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:39%;"/><td style="width:15%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company A</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>18%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company C</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">* Less than 10% for the period indicated</span></div> 0.71 0.26 0.46 0.43 0.14 0.10 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Customers who represented 10% or more of the Company’s total revenue for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:39%;"/><td style="width:15%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company A</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>18%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Company C</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">*</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">* Less than 10% for the period indicated</span></div> 0.20 0.18 0.17 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS</span><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total investments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,977</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>81,751</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,977</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>98,728</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>39,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>78,098</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>60,564</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>79,591</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>140,155</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Highly liquid investments with an original maturity of three months or less at time of purchase are included in cash and cash equivalents on the condensed consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">March 27, 2018</span><span style="font-family:Arial;font-size:10pt;">, the Company issued </span><span style="font-family:Arial;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;"><span>2.50%</span></span><span style="font-family:Arial;font-size:10pt;"> Convertible Senior Notes due 2023 (“Notes”). In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a </span><span style="font-family:Arial;font-size:10pt;"><span>13</span></span><span style="font-family:Arial;font-size:10pt;">-day option to purchase up to an additional </span><span style="font-family:Arial;font-size:10pt;"><span>$22.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in </span><span style="font-family:Arial;font-size:10pt;"><span>$21.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> of additional proceeds, for total proceeds of </span><span style="font-family:Arial;font-size:10pt;"><span>$171.5 million</span></span><span style="font-family:Arial;font-size:10pt;">, as described in </span><span style="font-family:Arial;font-size:10pt;color:#000000;">Note 10, Convertible Notes</span><span style="font-family:Arial;font-size:10pt;">. At </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Notes was </span><span style="font-family:Arial;font-size:10pt;"><span>$142.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$121.4 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. The fair value of the Notes is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>69,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total investments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,977</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>81,751</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,977</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>98,728</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>38,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,493</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>39,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>78,098</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>60,564</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>79,591</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>140,155</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 69750000 0 0 69750000 69750000 0 0 69750000 0 4183000 0 4183000 12001000 0 0 12001000 0 1505000 0 1505000 0 1107000 0 1107000 0 10182000 0 10182000 12001000 16977000 0 28978000 81751000 16977000 0 98728000 38444000 0 0 38444000 0 1493000 0 1493000 38444000 1493000 0 39937000 0 10787000 0 10787000 22120000 0 0 22120000 0 7980000 0 7980000 0 17025000 0 17025000 0 11998000 0 11998000 0 30308000 0 30308000 22120000 78098000 0 100218000 60564000 79591000 0 140155000 150000000.0 0.0250 P13D 22500000 21500000 171500000 142500000 121400000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 5. INVESTMENTS</span></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables summarize the Company’s available-for-sale investments at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gains</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Losses</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,975</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br/>Unrealized<br/>Gains</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br/>Unrealized<br/>Losses</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,185</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(66</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,024</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,007</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,361</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,389</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(173</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the maturities of the Company’s available-for-sale securities at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Due in less than 1 year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>83,030</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>82,893</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Due in 1-3 years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,359</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,325</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,389</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There were no sales of marketable securities for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">. Proceeds from sales of marketable securities (including principal paydowns) for the for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> were </span><span style="font-family:Arial;font-size:10pt;"><span>$13.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> material realized gains from sales of marketable securities for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">. No material balances were reclassified out of accumulated other comprehensive loss for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company monitors investments for other-than-temporary impairment. It was determined that unrealized gains and losses as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> are temporary in nature because the change in market value for those securities has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables summarize the Company’s available-for-sale investments at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gains</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Losses</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,183</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,975</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,001</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,505</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,182</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br/>Unrealized<br/>Gains</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br/>Unrealized<br/>Losses</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certificates of deposit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,787</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,185</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(66</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>22,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">U.S. Agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,024</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,980</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,025</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Asset-backed securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,007</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,998</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,361</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30,308</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,389</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(173</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 4163000 21000 1000 4183000 11975000 26000 0 12001000 1505000 0 0 1505000 1107000 0 0 1107000 10170000 12000 0 10182000 28920000 59000 1000 28978000 10787000 0 0 10787000 22185000 1000 66000 22120000 8024000 1000 45000 7980000 17025000 0 0 17025000 12007000 0 9000 11998000 30361000 0 53000 30308000 100389000 2000 173000 100218000 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the maturities of the Company’s available-for-sale securities at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30, 2019</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br/>Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Due in less than 1 year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>83,030</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>82,893</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Due in 1-3 years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,359</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>17,325</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>28,978</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,389</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>100,218</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 28920000 28978000 83030000 82893000 0 0 17359000 17325000 28920000 28978000 100389000 100218000 13400000 3000000.0 0 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 6. INVENTORY</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Inventories consisted of the following at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,088</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,064</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>495</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,189</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,187</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,881</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,746</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Inventories consisted of the following at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,088</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,064</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>495</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,189</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,187</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,881</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,746</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 5088000 4064000 1604000 495000 1189000 3187000 7881000 7746000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 7. PROPERTY AND EQUIPMENT</span></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment consisted of the following at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Computer equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Technical equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,949</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,868</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,016</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,037</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Instruments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,747</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Capital projects in progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total property and equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>18,644</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,014</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accumulated depreciation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(10,078</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(8,711</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,566</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,303</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Depreciation expense for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$1.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> for each of the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The underlying gross assets under operating leases where the Company is the lessor is </span><span style="font-family:Arial;font-size:10pt;"><span>$1.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">. The underlying accumulated depreciation under operating leases where the Company is the lessor is </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment consisted of the following at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Computer equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Technical equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,949</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,868</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Facilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,016</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,037</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Instruments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,747</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Capital projects in progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total property and equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>18,644</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>16,014</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accumulated depreciation</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(10,078</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(8,711</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,566</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,303</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 2726000 2700000 3949000 3868000 4016000 4037000 7747000 5318000 206000 91000 18644000 16014000 10078000 8711000 8566000 7303000 600000 700000 1700000 1300000 200000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 8. LICENSE AGREEMENTS AND GRANTS</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">National Institute of Health Grant</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2015, the National Institute of Health awarded Denver Health and the Company a </span><span style="font-family:Arial;font-size:10pt;">five</span><span style="font-family:Arial;font-size:10pt;">-year, </span><span style="font-family:Arial;font-size:10pt;"><span>$5.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The grant is paid to the Company incrementally through sub-awards. The cumulative amount awarded to date under these subawards is </span><span style="font-family:Arial;font-size:10pt;"><span>$1.3 million</span></span><span style="font-family:Arial;font-size:10pt;">. The amount invoiced for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;"><span>$42,000</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$69,000</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, and for each of the </span><span style="font-family:Arial;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Arizona Commerce Authority</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In August 2012, the Company entered into a Grant Agreement (the “Grant Agreement”) with the Arizona Commerce Authority, an agency of the State of Arizona (the “Authority”), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona. Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, which was recognized in January 2018 as an offset to expense after the achievement of all grant requirements.</span></div> 5000000.0 1300000 42000 69000 200000 1000000.0 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 9. DEFERRED REVENUE AND REMAINING PERFORMANCE OBLIGATIONS</span></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred revenue consists of amounts received for commitments not yet fulfilled. If we anticipate revenue will not be earned within the following twelve months, the amount is reported as other non-current liabilities. A summary of the balances as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> follows (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Products and services not yet delivered</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>217</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We recognized </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> of revenues that were included in the beginning contract liabilities balances during the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively. We recognized </span><span style="font-family:Arial;font-size:10pt;"><span>$30,000</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$65,000</span></span><span style="font-family:Arial;font-size:10pt;"> of revenues that were included in the contract liabilities balances during the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2018</span><span style="font-family:Arial;font-size:10pt;">, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Transaction Price Allocated to Remaining Performance Obligations</span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, $</span><span style="font-family:Arial;font-size:10pt;"><span>2.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed service contracts that begin as warranty periods expire. These service contracts typically provide for four-year terms and revenue is recognized on a straight-line basis. The balance also includes product shipments for reagent rental, sales-type lease agreements. The agreements have between two and four year terms and revenue is recognized as product is shipped, typically on a straight-line basis.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.</span></div> A summary of the balances as of <span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> follows (in thousands):</span><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Products and services not yet delivered</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>217</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 250000 217000 200000 300000 30000 65000 2500000 <div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 10. CONVERTIBLE NOTES</span><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">March 27, 2018</span><span style="font-family:Arial;font-size:10pt;">, the Company issued </span><span style="font-family:Arial;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;"><span>2.50%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Convertible Notes due 2023. In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a </span><span style="font-family:Arial;font-size:10pt;"><span>13</span></span><span style="font-family:Arial;font-size:10pt;">-day option to purchase up to an additional </span><span style="font-family:Arial;font-size:10pt;"><span>$22.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> aggregate principal amount of the Notes on the same terms and conditions. On </span><span style="font-family:Arial;font-size:10pt;">April 4, 2018</span><span style="font-family:Arial;font-size:10pt;"> the option was partially exercised, which resulted in </span><span style="font-family:Arial;font-size:10pt;"><span>$21.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> of additional proceeds, for total proceeds of </span><span style="font-family:Arial;font-size:10pt;"><span>$171.5 million</span></span><span style="font-family:Arial;font-size:10pt;">. The Notes are the Company's senior unsecured obligations and mature on </span><span style="font-family:Arial;font-size:10pt;">March 15, 2023</span><span style="font-family:Arial;font-size:10pt;"> (the “Maturity Date”), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of </span><span style="font-family:Arial;font-size:10pt;">32.3428</span><span style="font-family:Arial;font-size:10pt;"> shares of common stock per </span><span style="font-family:Arial;font-size:10pt;"><span>$1,000</span></span><span style="font-family:Arial;font-size:10pt;"> principal amount of the Notes, which is equivalent to an initial conversion price of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$30.92</span></span><span style="font-family:Arial;font-size:10pt;"> per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;"><span>$171.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> of proceeds received from the issuance of the Notes were allocated between long-term debt (the “liability component”) of </span><span style="font-family:Arial;font-size:10pt;"><span>$116.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> and contributed capital (the “equity component”) of </span><span style="font-family:Arial;font-size:10pt;"><span>$54.9 million</span></span><span style="font-family:Arial;font-size:10pt;">. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of </span><span style="font-family:Arial;font-size:10pt;"><span>$171.5 million</span></span><span style="font-family:Arial;font-size:10pt;">, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company incurred approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$5.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> of issuance costs related to the issuance of the Notes, of which </span><span style="font-family:Arial;font-size:10pt;"><span>$3.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$1.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> were recorded to long-term debt and contributed capital, respectively. The </span><span style="font-family:Arial;font-size:10pt;"><span>$3.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the </span><span style="font-family:Arial;font-size:10pt;">five</span><span style="font-family:Arial;font-size:10pt;">-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is </span><span style="font-family:Arial;font-size:10pt;"><span>11.52%</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of </span><span style="font-family:Arial;font-size:10pt;"><span>$1,000</span></span><span style="font-family:Arial;font-size:10pt;"> principal amount at any time prior to December 15, 2022, but only in the following circumstances:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">if the Company’s stock price exceeds </span><span style="font-family:Arial;font-size:10pt;"><span>130%</span></span><span style="font-family:Arial;font-size:10pt;"> of the conversion price for </span><span style="font-family:Arial;font-size:10pt;"><span>20</span></span><span style="font-family:Arial;font-size:10pt;"> of the last </span><span style="font-family:Arial;font-size:10pt;"><span>30</span></span><span style="font-family:Arial;font-size:10pt;"> trading days of any calendar quarter after June 30, 2018;</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">during the 5 business day period after any 5 consecutive trading day period in which the Notes’ trading price is less than </span><span style="font-family:Arial;font-size:10pt;"><span>98%</span></span><span style="font-family:Arial;font-size:10pt;"> of the product of the common stock price times the conversion rate; or</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">the occurrence of certain corporate events, such as a change of control, merger or liquidation.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">At any time on or after December 15, 2022, a holder may convert its Notes in multiples of </span><span style="font-family:Arial;font-size:10pt;"><span>$1,000</span></span><span style="font-family:Arial;font-size:10pt;"> principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to </span><span style="font-family:Arial;font-size:10pt;"><span>100%</span></span><span style="font-family:Arial;font-size:10pt;"> of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Notes at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> consisted of the following (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Outstanding principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>171,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>171,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(41,490</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(48,430</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unamortized debt issuance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(2,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(2,996</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Net carrying amount of the liability component</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>127,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>120,074</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company recorded </span><span style="font-family:Arial;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> for contractual coupon interest for each of the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, and </span><span style="font-family:Arial;font-size:10pt;"><span>$3.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively. The Company also recorded </span><span style="font-family:Arial;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> for amortization of debt issuance for each of the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;">Amortization of the debt discount for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;"><span>$2.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, and for the </span><span style="font-family:Arial;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;"><span>$6.9 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$4.3 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, no Notes were convertible pursuant to their terms.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In connection with the Notes issuance, the Company entered into a prepaid forward stock repurchase transaction (“Prepaid Forward”) with a financial institution (“Forward Counterparty”). Pursuant to the Prepaid Forward, the Company used approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$45.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately </span><span style="font-family:Arial;font-size:10pt;"><span>1,858,500</span></span><span style="font-family:Arial;font-size:10pt;">. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company’s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.</span></div> 150000000.0 0.0250 P13D 22500000 21500000 171500000 1000 30.92 171500000 116600000 -54900000 171500000 5000000.0 3400000 1600000 3400000 0.1152 1000 1.30 20 30 0.98 1000 1 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Notes at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;"> consisted of the following (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Outstanding principal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>171,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>171,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(41,490</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(48,430</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unamortized debt issuance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(2,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(2,996</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Net carrying amount of the liability component</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>127,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>120,074</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 171500000 171500000 41490000 48430000 2566000 2996000 127444000 120074000 1100000 3200000 2200000 100000 400000 300000 2400000 2100000 6900000 4300000 45100000 1858500 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 11. EARNINGS PER SHARE</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company’s losses.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:39%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shares issuable upon the release of restricted stock awards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shares issuable upon exercise of stock options</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,182</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,248</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,248</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Potentially dilutive common shares would also include common shares that would be outstanding if Notes convertible at the balance sheet date were converted. As discussed in </span><span style="font-family:Arial;font-size:10pt;color:#000000;">Note 10, Convertible Notes</span><span style="font-family:Arial;font-size:10pt;">, the Company issued </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>$171.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> of Notes due 2023. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of </span><span style="font-family:Arial;font-size:10pt;color:#000000;">32.3428</span><span style="font-family:Arial;font-size:10pt;"> shares of common stock per </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>$1,000</span></span><span style="font-family:Arial;font-size:10pt;"> principal amount of the Notes. As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> Notes were convertible pursuant to their terms. The number of shares issuable upon conversion of the Notes is </span><span style="font-family:Arial;font-size:10pt;"><span>5.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> shares.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In connection with the Notes, the Company entered into a prepaid forward stock repurchase transaction. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>1,858,500</span></span><span style="font-family:Arial;font-size:10pt;">. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:39%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shares issuable upon the release of restricted stock awards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Shares issuable upon exercise of stock options</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,182</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,182</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,248</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,248</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 20000 66000 20000 66000 10159000 8182000 10159000 8182000 10179000 8248000 10179000 8248000 171500000 1000 0 5500000 1858500 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 12. EMPLOYEE EQUITY-BASED COMPENSATION</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes option activity under all plans during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of Shares</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding January 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>8,090,636</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>12.22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,883,596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>14.47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(420,098</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20.74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(327,215</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>14.91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expired</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(67,574</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>23.41</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>10,159,345</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>12.34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected term (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5.53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Volatility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected dividends</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Risk free interest rates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1.47</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2.75</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9.66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11.48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table shows summary information for outstanding options and options that are exercisable (vested) as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Exercisable</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Number of options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,137,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average remaining contractual term (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average exercise price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9.03</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8.01</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.06</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Aggregate intrinsic value (in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>76,923</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>65,271</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes RSU and restricted stock award activity during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of Shares</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Grant Date Fair Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding January 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>76,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>18.70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(60,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>19.74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Vested/released</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(7,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>19.47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding September 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>19,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>16.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Equity-based compensation expense is summarized below (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,476</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,226</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,926</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Sales, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,921</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,011</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,131</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,465</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9,409</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,476</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">For each of the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments). During the </span><span style="font-family:Arial;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, unrecognized equity-based compensation expense related to unvested stock options and unvested RSUs was </span><span style="font-family:Arial;font-size:10pt;"><span>$27.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. This is expected to be recognized over the years </span><span style="font-family:Arial;font-size:10pt;">2019</span><span style="font-family:Arial;font-size:10pt;"> through </span><span style="font-family:Arial;font-size:10pt;">2024</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Included in the above-noted stock option grants and stock compensation expense are performance-based stock options which vest only upon the achievement of certain targets. Performance-based options are generally granted at-the-money, contingently vest over a period of </span><span style="font-family:Arial;font-size:10pt;"><span>1</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>2</span></span><span style="font-family:Arial;font-size:10pt;"> years, depending on the nature of the performance goal, and have contractual lives of </span><span style="font-family:Arial;font-size:10pt;"><span>10 years</span></span><span style="font-family:Arial;font-size:10pt;">. These options were valued in the same manner as the time-based options, with the assumption that performance goals will be achieved. The inputs for expected volatility, expected dividends, and risk-free rate used in estimating those options’ fair value are the same as the time-based options issued under the plan. The expected term for performance-based options granted in 2018 is </span><span style="font-family:Arial;font-size:10pt;"><span>5</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>6</span></span><span style="font-family:Arial;font-size:10pt;"> years. However, the Company only recognizes stock compensation expense to the extent that the targets are determined to be probable of being achieved, which triggers the vesting of the performance options. In </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, the Company granted </span><span style="font-family:Arial;font-size:10pt;"><span>225,000</span></span><span style="font-family:Arial;font-size:10pt;"> performance based-options to certain employees, of which </span><span style="font-family:Arial;font-size:10pt;"><span>125,000</span></span><span style="font-family:Arial;font-size:10pt;"> were outstanding as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">. The Company recognized </span><span style="font-family:Arial;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> of stock compensation expense for the </span><span style="font-family:Arial;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> for performance-based stock options.</span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes option activity under all plans during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of Shares</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding January 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>8,090,636</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>12.22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,883,596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>14.47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(420,098</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20.74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(327,215</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>14.91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expired</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(67,574</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>23.41</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding September 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>10,159,345</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>12.34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 8090636 12.22 2883596 14.47 420098 20.74 327215 14.91 67574 23.41 10159345 12.34 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected term (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5.53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Volatility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected dividends</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Risk free interest rates</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1.47</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2.75</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9.66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11.48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> P6Y5M15D P5Y6M10D 0.59 0.58 0 0 0.0147 0.0275 9.66 11.48 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table shows summary information for outstanding options and options that are exercisable (vested) as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Exercisable</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Number of options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>10,159,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,137,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average remaining contractual term (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average exercise price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9.03</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Weighted average fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8.01</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6.06</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Aggregate intrinsic value (in thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>76,923</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>65,271</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 10159345 6137856 P6Y1M20D P4Y3M25D 12.34 9.03 8.01 6.06 76923000 65271000 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes RSU and restricted stock award activity during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of Shares</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Grant Date Fair Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding January 1, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>76,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>18.70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>11,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>20.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(60,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>19.74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Vested/released</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(7,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>19.47</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding September 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>19,500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span>16.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 76000 18.70 11000 20.32 60500 19.74 7000 19.47 19500 16.13 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Equity-based compensation expense is summarized below (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,476</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,226</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,926</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Sales, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,921</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,011</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,131</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,465</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>9,409</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>12,476</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 65000 68000 172000 172000 897000 1476000 3226000 3926000 2169000 1921000 6011000 8378000 3131000 3465000 9409000 12476000 100000 300000 400000 27100000 200000 P1Y P2Y P10Y P5Y P6Y 225000 125000 100000 <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 13. INCOME TAXES</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">For the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the Company recorded an income tax benefit amount of </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> to reverse the foreign income tax expense recorded in prior quarters as the Company no longer expects to pay current year income taxes in any of the foreign jurisdictions. For the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the Company did </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;">t carry an income tax provision amount as the Company does not recognize tax benefits from current year tax losses in the U.S. and other foreign jurisdictions. The Company’s tax expense for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of </span><span style="font-family:Arial;font-size:10pt;"><span>$20.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$63.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards and a deferred tax liability related to amortization of the Notes. The Company provided a valuation allowance against its net deferred tax assets as future realization of such assets is not more likely than not to occur.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company accounts for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</span><span style="font-family:Arial;font-size:10pt;">. For the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax positions within the next 12 months.</span></div> -200000 0 -20700000 -63000000.0 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 14. COMMITMENTS</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Clinical Trial &amp; Study Agreements</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has entered into master agreements with clinical trial and study sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expenses for start-up costs and work performed for these trials and studies is recorded as research and development or sales, general and administrative expenses on the Company's condensed consolidated statements of operations and comprehensive loss. No commitments were recorded in connection with indemnifying these sites for losses.</span></div> <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 15. LEASES</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents supplemental information related to our leases in which we are the lessee for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:44px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash paid for amounts included in lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ROU assets obtained in exchange for lease obligations</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Lease Cost</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Short-term leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>697</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The weighted average remaining lease term on our operating leases is </span><span style="font-family:Arial;font-size:10pt;"><span>5.6</span></span><span style="font-family:Arial;font-size:10pt;"> years. The weighted average discount rate on those leases is </span><span style="font-family:Arial;font-size:10pt;"><span>7.1%</span></span><span style="font-family:Arial;font-size:10pt;">. Rent expense including common area charges was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2018</span><span style="font-family:Arial;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents maturities of operating lease liabilities in which we are the lessee as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>637</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>818</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,583</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,818</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(939</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,879</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The net investment in sales-type leases, where we are the lessor, is a component of other current assets and other non-current assets in our condensed consolidated balance sheet. As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the total net investment in these leases was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;">. The following presents maturities of lease receivables under sales-type leases as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>197</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>139</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total undiscounted cash flows</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>570</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Present value of lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>567</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 15. LEASES</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents supplemental information related to our leases in which we are the lessee for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:44px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash paid for amounts included in lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ROU assets obtained in exchange for lease obligations</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Lease Cost</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Short-term leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>697</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The weighted average remaining lease term on our operating leases is </span><span style="font-family:Arial;font-size:10pt;"><span>5.6</span></span><span style="font-family:Arial;font-size:10pt;"> years. The weighted average discount rate on those leases is </span><span style="font-family:Arial;font-size:10pt;"><span>7.1%</span></span><span style="font-family:Arial;font-size:10pt;">. Rent expense including common area charges was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2018</span><span style="font-family:Arial;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents maturities of operating lease liabilities in which we are the lessee as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>637</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>818</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,583</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,818</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(939</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,879</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The net investment in sales-type leases, where we are the lessor, is a component of other current assets and other non-current assets in our condensed consolidated balance sheet. As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">, the total net investment in these leases was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;">. The following presents maturities of lease receivables under sales-type leases as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>197</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>139</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total undiscounted cash flows</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>570</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Present value of lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>567</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents supplemental information related to our leases in which we are the lessee for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:44px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash paid for amounts included in lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ROU assets obtained in exchange for lease obligations</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Lease Cost</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Short-term leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>697</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents supplemental information related to our leases in which we are the lessee for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:44px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash paid for amounts included in lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ROU assets obtained in exchange for lease obligations</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,639</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Lease Cost</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Short-term leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>697</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 168000 333000 3639000 3639000 213000 378000 103000 697000 P5Y7M6D 0.071 300000 1000000.0 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents maturities of operating lease liabilities in which we are the lessee as of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>637</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>818</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,583</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,818</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(939</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,879</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 180000 637000 687000 818000 913000 1583000 4818000 939000 3879000 600000 The following presents maturities of lease receivables under sales-type leases as of <span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>197</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>139</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total undiscounted cash flows</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>570</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Less imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Present value of lease payments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>567</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 62000 197000 139000 106000 53000 13000 570000 3000 567000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION</span></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company operates as </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> operating segment. Sales to customers outside the United States represented </span><span style="font-family:Arial;font-size:10pt;"><span>23%</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>14%</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>26%</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>22%</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As of </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December 31, 2018</span><span style="font-family:Arial;font-size:10pt;">, balances due from foreign customers, in U.S. dollars, were </span><span style="font-family:Arial;font-size:10pt;"><span>$1.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by geographic territory for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,308</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,988</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>514</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,519</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>860</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by line of business for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accelerate Pheno™ revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,702</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Other revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by products and services for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,331</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,798</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Services</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Lease income included in net sales was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> for each of the </span><span style="font-family:Arial;font-size:10pt;color:#000000;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">2018</span><span style="font-family:Arial;font-size:10pt;">, respectively, which does not represent revenues recognized from contracts with customers.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents </span><span style="font-family:Arial;font-size:10pt;">property and equipment, net</span><span style="font-family:Arial;font-size:10pt;"> by geographic territory (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,309</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>840</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>994</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,566</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,303</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 1 0.23 0.14 0.26 0.22 1500000 900000 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by geographic territory for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,172</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>4,308</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,988</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>514</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>183</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,519</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>860</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by line of business for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Accelerate Pheno™ revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,702</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,760</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Other revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents total net sales by products and services for the </span><span style="font-family:Arial;font-size:10pt;">three and nine</span><span style="font-family:Arial;font-size:10pt;"> months ended </span><span style="font-family:Arial;font-size:10pt;color:#000000;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,331</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,798</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Services</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>2,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>1,355</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>5,827</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>3,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 1757000 1172000 4308000 2988000 514000 183000 1519000 860000 2271000 1355000 5827000 3848000 2221000 1325000 5702000 3760000 50000 30000 125000 88000 2271000 1355000 5827000 3848000 2143000 1331000 5531000 3798000 128000 24000 296000 50000 2271000 1355000 5827000 3848000 200000 600000 400000 <div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following presents </span><span style="font-family:Arial;font-size:10pt;">property and equipment, net</span><span style="font-family:Arial;font-size:10pt;"> by geographic territory (in thousands):</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>6,309</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>840</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>994</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>8,566</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><span>7,303</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div> 7726000 6309000 840000 994000 8566000 7303000 <div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 17. RELATED PARTY TRANSACTIONS</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As discussed in </span><span style="font-family:Arial;font-size:10pt;">Note 10, Convertible Notes</span><span style="font-family:Arial;font-size:10pt;"> the Company issued Notes in March 2018. As part of this issuance, an entity controlled by one member of the Company's board of directors purchased an aggregate of </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>$30.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> of the Notes. In May 2019, this affiliate purchased an additional </span><span style="font-family:Arial;font-size:10pt;"><span>$10.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> of Notes on the open market. The affiliated entity is a Qualified Institutional Buyer which purchased and holds an aggregate of </span><span style="font-family:Arial;font-size:10pt;"><span>$40.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> of the Notes at </span><span style="font-family:Arial;font-size:10pt;">September 30, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 20, 2019, the Company and an entity affiliated with the Chief Operating Officer of the Company entered into a securities purchase agreement (the “Purchase Agreement”) for the issuance and sale by the Company of an aggregate of </span><span style="font-family:Arial;font-size:10pt;"><span>55,586</span></span><span style="font-family:Arial;font-size:10pt;"> shares of the Company’s common stock (the “Shares”) in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The Shares were sold at a purchase price (determined in accordance with Nasdaq rules relating to the “market value” of the shares) of </span><span style="font-family:Arial;font-size:10pt;"><span>$17.99</span></span><span style="font-family:Arial;font-size:10pt;"> per share, which was equal to the consolidated closing bid price reported by Nasdaq immediately preceding the time the Company entered into the Purchase Agreement. The </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> of proceeds were recorded to contributed capital.</span></div> 30000000.0 10000000.0 40000000.0 55586 17.99 1000000.0 XML 78 R16.htm IDEA: XBRL DOCUMENT v3.19.3
    Convertible Notes
    		 9 Months Ended
    Sep. 30, 2019
    Debt Disclosure [Abstract]  
    Convertible Notes
    NOTE 10. CONVERTIBLE NOTES

    On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Senior Convertible Notes due 2023. In connection with the offering of the Notes, the Company granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the Notes on the same terms and conditions. On April 4, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes are the Company's senior unsecured obligations and mature on March 15, 2023 (the “Maturity Date”), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.

    The $171.5 million of proceeds received from the issuance of the Notes were allocated between long-term debt (the “liability component”) of $116.6 million and contributed capital (the “equity component”) of $54.9 million. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of $171.5 million, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

    The Company incurred approximately $5.0 million of issuance costs related to the issuance of the Notes, of which $3.4 million and $1.6 million were recorded to long-term debt and contributed capital, respectively. The $3.4 million of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the five-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is 11.52%.

    The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of $1,000 principal amount at any time prior to December 15, 2022, but only in the following circumstances:

    •
    if the Company’s stock price exceeds 130% of the conversion price for 20 of the last 30 trading days of any calendar quarter after June 30, 2018;

    •
    during the 5 business day period after any 5 consecutive trading day period in which the Notes’ trading price is less than 98% of the product of the common stock price times the conversion rate; or

    •
    the occurrence of certain corporate events, such as a change of control, merger or liquidation.

    At any time on or after December 15, 2022, a holder may convert its Notes in multiples of $1,000 principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.

    The Notes at September 30, 2019 and December 31, 2018 consisted of the following (in thousands):
     
    September 30,
    December 31,
     
    2019
    2018
    Outstanding principal
    $
    171,500

    $
    171,500

    Unamortized debt discount
    (41,490
    )
    (48,430
    )
    Unamortized debt issuance
    (2,566
    )
    (2,996
    )
    Net carrying amount of the liability component
    127,444

    120,074



    The Company recorded $1.1 million for contractual coupon interest for each of the three months ended September 30, 2019 and 2018, and $3.2 million and $2.2 million for the nine months ended September 30, 2019 and 2018, respectively. The Company also recorded $0.1 million for amortization of debt issuance for each of the three months ended September 30, 2019 and 2018, and $0.4 million and $0.3 million for the nine months ended September 30, 2019 and 2018, respectively. Amortization of the debt discount for the three months ended September 30, 2019 and 2018 was $2.4 million and $2.1 million, respectively, and for the nine months ended September 30, 2019 and 2018 was $6.9 million and $4.3 million, respectively. As of September 30, 2019, no Notes were convertible pursuant to their terms.

    In connection with the Notes issuance, the Company entered into a prepaid forward stock repurchase transaction (“Prepaid Forward”) with a financial institution (“Forward Counterparty”). Pursuant to the Prepaid Forward, the Company used approximately $45.1 million of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company’s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.
    XML 79 R12.htm IDEA: XBRL DOCUMENT v3.19.3
    Inventory
    		 9 Months Ended
    Sep. 30, 2019
    Inventory Disclosure [Abstract]  
    Inventory
    NOTE 6. INVENTORY

    Inventories consisted of the following at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30,
    December 31,
     
    2019
    2018
    Raw materials
    $
    5,088

    $
    4,064

    Work in process
    1,604

    495

    Finished goods
    1,189

    3,187


    $
    7,881

    $
    7,746
    XML 80 R24.htm IDEA: XBRL DOCUMENT v3.19.3
    Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies)
    		 9 Months Ended
    Sep. 30, 2019
    Accounting Policies [Abstract]  
    Basis of Presentation
    Basis of Presentation

    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the SEC on March 1, 2019.

    The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

    The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2019, or any future period.

    All amounts are rounded to the nearest thousand dollars unless otherwise indicated.
    Principles of Consolidation
    Principles of Consolidation

    The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.
    Use of Estimates
    Use of Estimates

    The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, tax valuation accounts and equity–based compensation. Actual results could differ materially from those estimates.
    Estimated Fair Value of Financial Instruments
    Estimated Fair Value of Financial Instruments

    The Company follows ASC 820, Fair Value Measurement, which has defined fair value and requires the Company to establish a framework for measuring and disclosing fair value. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

    •
    Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

    •
    Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

    •
    Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

    The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, and other current liabilities approximate the related fair values due to the short-term maturities of these instruments.

    The estimated fair value of the Company’s long-term debt represents a Level 2 measurement.
    Cash and Cash Equivalents
    Cash and Cash Equivalents

    All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe, however, that the market risk arising from holding these financial instruments is minimal.
    Investments
    Investments

    The Company invests in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificates of deposit, U.S. government and agency securities, commercial paper, asset-backed securities, and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive loss, a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

    The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive loss.
    Inventory
    Inventory

    Inventory is stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first out method. The Company estimates the recoverability of inventory by reference to internal estimates of future demands and product life cycles, including expiration. The Company periodically analyzes its inventory levels to identify inventory that may expire prior to expected sale or has a cost basis in excess of its estimated net realizable value and records a charge to expense for such inventory as appropriate.
    Accounts Receivable
    Accounts Receivable

    Accounts receivable consist of amounts due to the Company for sales to customers and are based on what we expect to collect in exchange for goods and services. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis by recording adjustments to revenue, if necessary.
    Property and Equipment
    Property and Equipment

    Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one year to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less.

    Property and equipment includes Accelerate Pheno™ systems (also referred to as instruments) used for sales demonstrations, instruments under rental agreements and instruments used for research and development. Depreciation expense for instruments used for sales demonstrations is recorded as a component of sales, general and administrative expense. Depreciation expense for instruments placed at customer sites pursuant to reagent rental agreements is recorded as a component of cost of sales. Depreciation expense for instruments used in our laboratory and research is recorded as a component of research and development expense. The Company retains title to these instruments and depreciates them over five years.
    Long-lived Assets
    Long-lived Assets

    Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.
    Warranty Reserve
    Warranty Reserve

    Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a sixty days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.
    Convertible Notes
    Convertible Notes

    The Company issued convertible notes in 2018 that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.
    Revenue Recognition
    Revenue Recognition

    The Company recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.

    We determine revenue recognition through the following steps:

    •
    Identification of the contract with a customer

    •
    Identification of the performance obligations in the contract

    •
    Determination of the transaction price

    •
    Allocation of the transaction price to the performance obligations

    •
    Recognition of revenue as we satisfy a performance obligation

    Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized and the term between invoicing and when payment is due is not typically significant.

    Service revenue is derived from the sale of extended service agreements which are generally non-cancellable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

    Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine relative standalone selling prices based on the price charged to customers for each individual performance obligation.

    Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the three and nine months ended September 30, 2019.

    Cost of Sales

    Cost of sales includes cost of materials, direct labor, equity-based compensation, facility and other manufacturing overhead costs for consumable tests and instruments sold to customers. Cost of sales for instruments also includes depreciation on revenue generating instruments that have been placed with our customers under a reagent rental agreement. Cost of sales includes repair and maintenance cost for instruments covered by a service agreement or instruments covered by a reagent rental agreement. Cost of sales also includes warranty related expenses.

    Shipping and Handling

    Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the condensed consolidated statements of operations and comprehensive loss. Most such billable shipping and handling costs are in connection with consumable test kits. Unlike test kits, for instruments the Company typically pays for shipping and handling.
    Leases, Lessee
    Leases

    The Company accounts for leases in accordance with ASC 842, Leases, which was adopted on January 1, 2019. We determine if an arrangement is or contains a lease and the type of lease at inception. The Company classifies leases as finance leases (lessee) or sales-type leases (lessor) when there is either a transfer of ownership of the underlying asset by the end of the lease term, the lease contains an option to purchase the asset that we are reasonably certain will be exercised, the lease term is for the major part of the remaining economic life of the asset, the present value of the lease payments and any residual value guarantee equals or substantially exceeds all the fair value of the asset, or the asset is of such a specialized nature that it will have no alternative use to the lessor at the end of the lease term. Payments contingent on future events (i.e. based on usage) are considered variable and
    excluded from lease payments for the purposes of classification and initial measurement. Several of our leases include options to renew or extend the term upon mutual agreement of the parties and others include one-year extensions exercisable by the lessee. None of our leases contain residual value guarantees, restrictions, or covenants.

    To determine whether a contract contains a lease, the Company uses its judgment in assessing whether the lessor retains a material amount of economic benefit from an underlying asset, whether explicitly or implicitly identified, which party holds control over the direction and use of the asset, and whether any substantive substitution rights over the asset exist.

    Lessee

    Operating leases are included in right-of-use (“ROU”) assets and operating lease liabilities within our condensed consolidated balance sheets. These assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and their related liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Typically, we use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. We use the implicit rate when readily determinable. ROU assets are net of lease payments made and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term, which may include options to extend or terminate the lease when it is reasonably certain that we will exercise the option. As of adoption of ASC 842 and as of September 30, 2019, the Company was not party to finance lease arrangements.

    Our leases consist primarily of leased office, factory, and laboratory space in the United States and office space and automobiles in Europe, have between two and six-year terms, and typically contain penalizing, early-termination provisions.
    Leases, Lessor
    Lessor

    The Company leases instruments to customers under “reagent rental” agreements, whereby the customer agrees to purchase consumable products over a stated term, typically five years or less, for a volume-based price that includes an embedded rental for the instruments. When collectibility is probable, that amount is recognized as income at lease commencement for sales-type leases and on a straight-line basis over the term for operating leases, which typically include a termination without cause or penalty provision given a short notice period.

    Consideration is allocated between lease and non-lease components based on stand-alone selling price in accordance with ASC 606, Revenue from Contracts with Customers.

    Net investment in sales-type leases are included within our condensed consolidated balance sheets as a component of other current assets and other non-current assets, which include the present value of lease payments not yet received and the present value of the residual asset, which is determined using the information available at commencement, including the lease term and estimated useful life and expected fair value of the instrument.
    Equity-Based Compensation
    Equity-Based Compensation

    The Company may award stock options, restricted stock units (“RSUs”), performance-based options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method) except for performance-based options. Performance-based stock options vest based on the achievement of performance targets. Compensation costs associated with performance-based option awards are recognized over the requisite service period based on probability of achievement. Performance-based stock options require management to make assumptions regarding the likelihood of achieving performance targets.

    The Company estimates the fair value of service based and performance based stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

    •
    Volatility: The expected volatility is based on the historical volatility of the Company's stock price over the most recent period commensurate with the expected term of the stock option award.

    •
    Expected term: The estimated expected term for employee awards is based on the calculation published by the SEC in SAB110 for use when there is not a sufficient history of employee exercise patterns. For consultant awards, the estimated expected term is the same as the life of the award.

    •
    Risk-free interest rate: The risk-free interest rate is based on published U.S. Treasury rates for a term commensurate with the expected term.

    •
    Dividend yield: The dividend yield is estimated as zero as the Company has not paid dividends in the past and does not have any plans to pay any dividends in the foreseeable future.

    The Company records the fair value of RSUs or stock grants based on published closing market price on the day before the grant date.

    The Company accounts for forfeitures as they occur rather than on an estimated basis.
    Deferred Tax Assets
    Deferred Tax Assets

    Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

    The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not certain of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.
    Foreign Currency Translation and Foreign Currency Transactions
    Foreign Currency Translation and Foreign Currency Transactions

    Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive loss.

    The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.
    Earnings Per Share
    Earnings Per Share

    Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Potentially dilutive common shares consist of shares issuable from stock options and unvested RSUs. Potentially dilutive common shares would also include common shares that would be outstanding if notes convertible at the balance sheet date were converted. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.

    Earnings per share are restated when certain transactions or events, including rights offerings determined to have bonus elements, have occurred.
    Standards That Were Recently Adopted and Standards not Yet Adopted
    Standards that were recently adopted

    In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases, which together with subsequent amendments is included in ASC 842. ASC 842 requires a lessee to recognize a liability to make lease payments and an asset with respect to its right to use the underlying asset for the lease term. ASC 842 also addresses accounting and reporting by lessors, which is not significantly different from accounting and reporting under the prior standard, and further provides for qualitative and quantitative disclosures. We adopted ASC 842 on January 1, 2019 using the optional transition method allowed by ASU 2018-11. This optional transition method allowed the Company to apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. For contracts where we are the lessee, we recorded lease liabilities and right of use assets for contracts in effect on January 1, 2019 based on the facts and circumstances as of that date. The Company elected not to reassess whether any expired or existing contracts are or contain leases, not to reassess the lease classification for any expired or existing leases, not to reassess initial direct costs for any existing leases, and not to separate the lease components from the non-lease components for all classes of underlying assets. No cumulative-effect adjustment was recorded to the opening balance of retained earnings. We recognized right of use assets and lessee lease liabilities of $0.6 million with respect to operating leases where we are the lessee. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The adoption of ASC 842 did not have a material effect on our consolidated financial position, results of operations or cash flows.

    In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718); Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to ASC 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. The Company adopted ASU 2018-07 on January 1, 2019, which had no impact to our consolidated financial statements as all share-based awards granted to nonemployees are fully vested.

    In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) that the FASB refers to as having been stranded in AOCI. The Company adopted ASU 2018-02 on January 1, 2019, which had no impact to our consolidated financial statements as no amounts were reclassified from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act.

    In March 2017, the FASB issued ASU 2017-08, Receivable - Nonrefundable Fees and Other Costs (Topic 310-20); Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted ASU 2017-08 on January 1, 2019, which had no impact to our consolidated financial statements as we do not carry callable securities held at a premium.

    Standards not yet adopted

    In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820); Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. This ASU is effective for us on January 1, 2020, with early adoption permitted. We are currently assessing the impact this will have on our consolidated financial statements.

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which was subsequently clarified and amended by ASU 2019-05, ASU 2019-04 and ASU 2018-19. ASU 2016-13 amends the guidance on measuring credit losses on financial assets
    (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this will have a significant impact on our consolidated financial statements.
    XML 81 R20.htm IDEA: XBRL DOCUMENT v3.19.3
    Commitments
    		 9 Months Ended
    Sep. 30, 2019
    Commitments and Contingencies Disclosure [Abstract]  
    Commitments
    NOTE 14. COMMITMENTS

    Clinical Trial & Study Agreements

    The Company has entered into master agreements with clinical trial and study sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expenses for start-up costs and work performed for these trials and studies is recorded as research and development or sales, general and administrative expenses on the Company's condensed consolidated statements of operations and comprehensive loss. No commitments were recorded in connection with indemnifying these sites for losses.
    XML 82 R28.htm IDEA: XBRL DOCUMENT v3.19.3
    Investments (Tables)
    		 9 Months Ended
    Sep. 30, 2019
    Investments, Debt and Equity Securities [Abstract]  
    Schedule of Available-for-Sale Investments
    The following tables summarize the Company’s available-for-sale investments at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30, 2019
     
    Amortized
    Cost
    Gross
    Unrealized
    Gains
    Gross
    Unrealized
    Losses
    Fair Value
    Certificates of deposit
    $
    4,163

    $
    21

    $
    (1
    )
    $
    4,183

    U.S. Treasury securities
    11,975

    26

    —

    12,001

    U.S. Agency securities
    1,505

    —

    —

    1,505

    Asset-backed securities
    1,107

    —

    —

    1,107

    Corporate notes and bonds
    10,170

    12

    —

    10,182

    Total
    $
    28,920

    $
    59

    $
    (1
    )
    $
    28,978


     
    December 31, 2018
     
    Amortized
    Cost
    Gross
    Unrealized
    Gains
    Gross
    Unrealized
    Losses
    Fair Value
    Certificates of deposit
    $
    10,787

    $
    —

    $
    —

    $
    10,787

    U.S. Treasury securities
    22,185

    1

    (66
    )
    22,120

    U.S. Agency securities
    8,024

    1

    (45
    )
    7,980

    Commercial paper
    17,025

    —

    —

    17,025

    Asset-backed securities
    12,007

    —

    (9
    )
    11,998

    Corporate notes and bonds
    30,361

    —

    (53
    )
    30,308

    Total
    $
    100,389

    $
    2

    $
    (173
    )
    $
    100,218
    Schedule of Available-For-Sale Investment Maturities
    The following table summarizes the maturities of the Company’s available-for-sale securities at September 30, 2019 and December 31, 2018 (in thousands):

     
    September 30, 2019
    December 31, 2018
     
    Amortized
    Cost
    Fair Value
    Amortized
    Cost
    Fair Value
    Due in less than 1 year
    $
    28,920

    $
    28,978

    $
    83,030

    $
    82,893

    Due in 1-3 years
    —

    —

    17,359

    17,325


    $
    28,920

    $
    28,978

    $
    100,389

    $
    100,218
    XML 83 R66.htm IDEA: XBRL DOCUMENT v3.19.3
    Industry, Geographic and Revenue Disaggregation - Disaggregation of Revenue (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Disaggregation of Revenue [Line Items]        
    Net sales $ 2,271 $ 1,355 $ 5,827 $ 3,848
    Accelerate Pheno™ revenue        
    Disaggregation of Revenue [Line Items]        
    Net sales 2,221 1,325 5,702 3,760
    Other revenue        
    Disaggregation of Revenue [Line Items]        
    Net sales 50 30 125 88
    Products        
    Disaggregation of Revenue [Line Items]        
    Net sales 2,143 1,331 5,531 3,798
    Services        
    Disaggregation of Revenue [Line Items]        
    Net sales 128 24 296 50
    Domestic        
    Disaggregation of Revenue [Line Items]        
    Net sales 1,757 1,172 4,308 2,988
    Foreign        
    Disaggregation of Revenue [Line Items]        
    Net sales $ 514 $ 183 $ 1,519 $ 860
    XML 84 R62.htm IDEA: XBRL DOCUMENT v3.19.3
    Leases - Assets and Liabilities (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Cash paid for amounts included in lease liabilities        
    Operating cash flows from operating leases $ 168   $ 333  
    ROU assets obtained in exchange for lease obligations        
    Operating leases 3,639   3,639  
    Lease Cost        
    Operating leases 213   378  
    Short-term leases $ 103   $ 697  
    Weighted average remaining lease term (years) 5 years 7 months 6 days   5 years 7 months 6 days  
    Weighted average discount rate (%) 7.10%   7.10%  
    Rent expense   $ 300   $ 1,000
    XML 85 R49.htm IDEA: XBRL DOCUMENT v3.19.3
    License Agreements and Grants - Arizona Commerce Authority (Details)
    $ in Millions
    		 1 Months Ended
    Jan. 31, 2018
    USD ($)
    Arizona Commerce Authority  
    Research and Development Arrangement, Contract to Perform for Others [Line Items]  
    Arizona Commerce Authority grant $ 1.0
    XML 86 R41.htm IDEA: XBRL DOCUMENT v3.19.3
    Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2019
    Dec. 31, 2018
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value $ 28,978 $ 100,218
    Fair value on a recurring basis    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 69,750 39,937
    Fair Value 28,978 100,218
    Total assets measured at fair value 98,728 140,155
    Fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 69,750 38,444
    Fair Value 12,001 22,120
    Total assets measured at fair value 81,751 60,564
    Fair value on a recurring basis | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 0 1,493
    Fair Value 16,977 78,098
    Total assets measured at fair value 16,977 79,591
    Fair value on a recurring basis | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 0 0
    Fair Value 0 0
    Total assets measured at fair value 0 0
    Fair value on a recurring basis | Certificates of deposit    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 4,183 10,787
    Fair value on a recurring basis | Certificates of deposit | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Certificates of deposit | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 4,183 10,787
    Fair value on a recurring basis | Certificates of deposit | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | U.S. Treasury securities    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 12,001 22,120
    Fair value on a recurring basis | U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 12,001 22,120
    Fair value on a recurring basis | U.S. Treasury securities | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | U.S. Treasury securities | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | U.S. Agency securities    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 1,505 7,980
    Fair value on a recurring basis | U.S. Agency securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | U.S. Agency securities | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 1,505 7,980
    Fair value on a recurring basis | U.S. Agency securities | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Commercial paper    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value   17,025
    Fair value on a recurring basis | Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value   0
    Fair value on a recurring basis | Commercial paper | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value   17,025
    Fair value on a recurring basis | Commercial paper | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value   0
    Fair value on a recurring basis | Asset-backed securities    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 1,107 11,998
    Fair value on a recurring basis | Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Asset-backed securities | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 1,107 11,998
    Fair value on a recurring basis | Asset-backed securities | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Corporate notes and bonds    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 10,182 30,308
    Fair value on a recurring basis | Corporate notes and bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Corporate notes and bonds | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 10,182 30,308
    Fair value on a recurring basis | Corporate notes and bonds | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Fair Value 0 0
    Fair value on a recurring basis | Money market funds    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 69,750 38,444
    Fair value on a recurring basis | Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 69,750 38,444
    Fair value on a recurring basis | Money market funds | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 0 0
    Fair value on a recurring basis | Money market funds | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents $ 0 0
    Fair value on a recurring basis | Commercial paper    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents   1,493
    Fair value on a recurring basis | Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents   0
    Fair value on a recurring basis | Commercial paper | Significant Other Observable Inputs (Level 2)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents   1,493
    Fair value on a recurring basis | Commercial paper | Significant Unobservable Inputs (Level 3)    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents   $ 0
    XML 87 R45.htm IDEA: XBRL DOCUMENT v3.19.3
    Investments - Narrative (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2019
    Sep. 30, 2018
    Sep. 30, 2019
    Sep. 30, 2018
    Investments, Debt and Equity Securities [Abstract]        
    Proceeds from sales of marketable securities     $ 13,400 $ 3,000
    Gross realized gains or losses from sales of marketable securities $ 0 $ 0 $ 0 $ 0

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�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